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Abstract 
New methodology for the synthesis of several 4H-pyrido[1,2-a]pyrimidin-4-ones has been developed 
from commercially available 2-aminopyridines and -oxo esters catalysed by Montmorillonite under 
solvent-free conditions in good yields. This methodology was expanded for the synthesis of 4H-
pyrimido[1,2-a]pyrimidin-4-one derivatives from 2-aminopyrimidine and different β-keto esters. 
The new methodology for the synthesis of N-alkylated 6-methyl 2-pyridones and N-alkylated 2-
methyl 4-pyridones, from commercially available starting materials was developed. For the synthesis 
of N-alkylated 6-methyl 2-pyridones, 2-methoxy-6-methyl pyridine and a number of different 
alkylating reagents have been employed as starting materials. For the synthesis of N-alkylated 2-
methyl 4-pyridones, 4-chloro 2-methyl pyridine was used successfully to make the desired pyridone 
in 3 steps. 
Selective mono-metallation at the 6-methyl substituent of N-alkylated 6-methyl 2-pyridones and N-
alkylated 2-methyl 4-pyridones with n-BuLi/KHMDS at -78 °C proceeded smoothly, and the reactivity 
of the lithiated intermediates towards a wide range of electrophile (diketones, aldehydes, alkylating 
reagents) was studied. 
A straightforward synthesis of desirable 4H-quinolizin-4-one scaffolds by condensation of N-benzyl 
6-methyl 2-pyridones with dicarbonyl compounds, and the formation of the desired quinolizinone 
after the condensation step was achieved. An unexpected quinolizinone bearing a fused -lactam 
ring was isolated and its structure confirmed by single crystal X-ray diffraction analysis. 
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Introduction 
The pharmaceutical industry is interested in heterocyclic motifs, because over 60% of the top 
retailing drugs contain at least one heterocyclic nucleus as part of the overall compound scaffold.1,2 
In addition, the agrochemical industry is interested in this important class of compounds, since 
heterocycles can display activity as herbicides or pesticides.3,4,5 Many heterocyclic compounds  have 
shown good properties as new bioactive agents. 1,3,6 Heteroaromatic scaffolds are associated with 
desirable physicochemical properties, and provide good building blocks for a new biological targets.7  
New studies are looking for novel ring systems, in order to improve properties over existing 
frameworks, for example: to improve metabolic stability, solubility, or lower log P.1 Another 
interesting area is the development of novel synthetic routes to introduce new substituents, which 
will allow a change in the reactivity in the compound to improve these properties. The introduction 
of new substituents will change the shape conformation, or electronic properties of the molecule 
affording a new range of biological effects. 
Furthermore, bacteria have started to show resistance to a broad range of the known antibacterial 
agents. Consequently, the development of new heterocyclic derivatives is still required by the 
pharmaceutical industry. 
Among the heterocyclic compounds, those containing a Nitrogen atom at the ring junction are of 
great interest, since these compounds have a wide range of biological and  pharmaceutical 
applications.6 
The following ring systems (Figure 1), 4H-quinolizin-4-one 1, 2H-quinolizin-2-one 2,  4H-pyrido[1,2-
a]pyrimidin-4-one 3 and 4H-pyrimido[1,2-a]pyrimidin-4-one 4, have shown highly important 
biological activities.8-9 These moieties are important targets, and there have been several studies 
looking at the cheapest and mildest appropriate synthetic conditions in order to decrease the cost of 
production and to allow easy synthesis in industrial processes.  
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Figure 1: Bicyclic compounds containing a N atom at the ring junction. 
 
Some of the properties and characteristics of heteroaromatic rings are explained next, together with 
reasons for selecting them as good building blocks for drug development: i) their structure and 
associated physicochemical properties often lead to efficient binding to a biological target with 
selectivity, ii) heteroaromatic derivatives are often readily available via common synthetic 
transformations, iii) there are no complications due to stereochemistry.1 
Part of our studies was focused at the following monocyclic motifs (Figure 2). These scaffolds started 
as an essential building block of the desirable quinolizinones. However, 2- and 4-pyridones are 
important structures. They are found in many natural compounds and also they have shown several 
biological activities. For example, (-)-cytisine,10 which is a potent α4β2 subtype selective partial 
agonist at nicotinic acetylcholine receptors, or the antibiotic ciprofloxacin.11  Furthermore, they can 
be used as precursors for more complex biological compounds. For these reasons, 2- and 4-
pyridones became as an essential part of this study.  
 
Figure 2: 2- and 4-pyridone scaffolds. 
 
This report firstly summarizes the more relevant biological activities of each scaffold and secondly it 
explains some of the previous methods of synthesis for each ring system (1 to 6).  
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1- Pyridopyrimidine derivatives. 
1.1- Biological activities. 
 
The 4H-pyrido[1,2-a]pyrimidin-4-one scaffold 3 has been of great interest in the pharmaceutical 
industry because of its various biological properties.12 Also, this scaffold consisting of two fused 
heterocyclic rings usually meets the criteria of the “rule of five” for orally active drugs with good 
bioavailability.13,14 
Several 4H-pyrido[1,2-a]pyrimidin-4-one derivatives have diverse biological activities such as 
analgesic, anti-inflammatory, and anti-allergenic properties.15  
M.S. Youssouf et al. have studied the immunopharmacological profile of one particular derivative, 2, 
7- dimethyl-3-nitro-4H-pyrido[1,2-a] pyrimidin-4-one 7  (Figure 3), in both in vitro and in vivo 
models, representing various features of Type I allergy. It showed a promising profile as an anti-
asthmatic agent.16 
 
Figure 3: 2, 7-dimethyl-3-nitro-4-H-pyrido[1,2-a]pyrimidin-4-one. 
 
Risperidone 8,17 a derivative of 4H-pyrido[1,2-a]pyrimidin-4-one, was explored and used as a potent 
antipsychotic agent due to its significant dopamine D2 and serotonin 5HT2 blocking activities, and 
was one of the drugs most widely prescribed worldwide in 2007 (Figure 4).5 
 
Figure 4: Risperidone. 
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A series of pyrido[1,2-a]pyrimidin-4-ones 9a-g have been identified as new agonists enhancing the 
transcriptional functions of ERRα (Figure 5). The nuclear estrogen-related receptor α (ERRα) plays a 
central role in the regulation of expression of the genes. Consequently, the compounds improved 
glucose and fatty acid uptake in C2C12 muscle cells.18  
 
Figure 5: Compounds 9a-g agonize the transcriptional function of ERRα at 10 µM. 
 
Two more examples that demonstrate the importance of this privileged scaffold are shown  in Figure 
6, Lusaperidone 1019 which is an antidepressant and SSR69071 1120 which is a human leukocite 
elastase inhibitor.  Besides the 4H-pyrido[1,2-a]pyrimidin-4-one scaffold is found as part of many 
fused heterocyclic compounds which show anti-malarial,21 anti-cancer22 and anti-oxidant activities.23    
 
Figure 6: Lusaperidone and SSR69071 structures. 
 
1.2- Previous synthesis of pyrido[1,2-a]pyrimidines. 
 
There are a number of different ways available to synthesize the 4H-pyrido[1,2-a]pyrimidin-4-one 
moiety, and since this scaffold shows important  pharmaceutical properties, there have been a lot of 
synthetic studies undertaken. Some authors have reported the synthesis of 4H-pyrido[1,2-
a]pyrimidin-4-one derivatives using 2-aminopyridines and β-keto esters as starting materials under 
different reaction conditions. Also there are others synthetic routes using different starting materials 
to synthesize this interesting scaffold, as described in the following pages. 
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In 2005 Kim et al.24 reported the synthesis of risperidone 8. This paper describes the synthesis of 
risperidone beginning from readily available 2-aminopyridine 12 and 1-(4-(2,4-(2,4-
difluorobenzoyl)piperidin-1-yl)ethanone compound 20 in Scheme 1 and Scheme 2 respectively. The 
first step of this synthesis of 4-methyl-2-oxo-(2H)-pyrido[1,2-a]pyrimidines 14a was by 
cyclocondensation of 2-aminopyridine 12 and ethyl acetoacetate 13a catalysed by p-TsOH in toluene 
at 104-105 °C over 12 h, to afford 95 % yield (Scheme 1).24  
The pyridopyrimidone 14a was then reduced and brominated to give 16 and an aldehyde group 
added via Stille coupling and hydroboration-oxidation forming 19. This was then coupled to the 
amine 21 by reductive amination before the benisoxazole of 8 was formed by cyclisation of oxime 
23. 
 
Scheme 1: Synthesis of compound 19. 
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Scheme 2: Synthesis of Risperidone. 
 
Yoichiro Kuninobu and co-workers25 reported, in 2006, that 4H-pyrido[1,2-a]pyrimidines-4-one 
derivatives could be synthesized, using the reaction of ketimines bearing a pyridyl or a picolyl group 
on a nitrogen atom of the imine moiety with tosylisocyanate in toluene at 80-135 °C over 10 to 60 
min to afford compound 31 in good yield (Scheme 3). 
The proposed mechanism is shown in Scheme 3. The imine 24 is in equilibrium with the 
corresponding enamine 25; addition of an isocyanate 26 to the enamine afforded imine 27.  In order 
to synthesize compound 31, intermediate 27 would lose 4-toluensulfonamide, possibly helped 
internally by the pyridine, generating compound 30 which would undergo an intramolecular 
cyclisation in order to generate product 31. 
 
7 
 
 
Scheme 3: Synthesis of 4-H-pyrido[1,2-a]pyrimidines-4-one derivates, from ketimines bearing a 
pyridyl or a picolyl group. 
 
Bonacorso et al.26 reported, in 2006, a new efficient approach for the synthesis of 2-alkyl(aryl) 
substituted 4H-pyrido[1,2-a]pyrimidines-4-ones 34b-h (Scheme 4). The synthesis was carried out 
from β-alkoxyvinyl tri-chloromethyl ketones 32a-h with 2-aminopyrimidine 12 under mild conditions; 
the reaction delivered the products in low to good yield (45-80%). 
 
Scheme 4: Synthesis of 2-alkyl(aryl) substituted 4H-pyrido[1,2-a]pyrimidines-4-ones. 
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In 2011 Peng et al.18 reported the synthesis of 3-phenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivatives 
9a-g (Scheme 5). The synthesis of these scaffolds was by direct condensation/cyclization of 2-
aminopyridines 36a-d with substituted β-keto esters 37a-c in PPA (polyphosphoric acid) at 100 °C.  
After 1 h, the mixture was cooled in an ice bath and neutralized with 5% aqueous sodium hydroxide. 
The solid precipitate was collected by filtration, and washed with water. The crude products were 
purified by recrystallization from ethanol. The authors did not report any yield data. 
 
Scheme 5: Synthesis 3-phenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivatives 9a-g. 
 
The use of 2-aminopyridines and -oxo esters is the traditional methodology for the synthesis of 4H-
pyrido[1,2-a]pyrimidin-4-ones. In these previous methodologies, corrosive acids were used such as 
polyphosphoric acid (PPA), p-toluenesulphonic acid and also high temperatures (150-250 °C) were 
required.24,18,27 
Recently, in 2015, Roslan and co-workers13 reported the synthesis of 4H-pyrido[1,2-a]pyrimidin-4-
ones from the commercially available 2-aminopyridines and -oxo esters catalyzed by bismuth 
compounds. The novelty of this strategy is that the reaction was catalyzed by a non-corrosive 
Brønsted acid such as BiCl3 or Bi(OTf)3. 
They optimized the reaction conditions for 2-aminopyridine 12 and methyl acetoacetate 13a. Firstly 
they used as a catalyst Bi(OTf)3, and several solvents were tested, such as dioxane, MeNO2, H2O, 
toluene and the reaction worked in moderate to good yields. The best result was obtained when the 
reaction was performed solvent free, when the product was obtained in 100% yield.  
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Scheme 6: The optimized conditions for the synthesis of 2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one 
(14a). 
 
They tried without any catalyst; however the reaction did not work. Also, they screened other Lewis 
acids such as InCl3 and ZnCl2, however only traces of the product were obtained. The conclusion was 
that the bismuth(III) salt was necessary to obtain the product. Furthermore, other bismuth(III) salts 
were also used such as BiCl3 and Bi(OAc). BiCl3 was found to be as good as Bi(OTf)3. BiCl3 was chosen 
as the catalyst for the following synthesis of 4H-pyrido[1,2-a]pyrimidin-4-one derivatives, because it 
is cheaper than Bi(OTf)3.  
The optimized conditions for the synthesis of 4H-pyrido[1,2-a]pyrimidin-4-one derivatives 14a-i were 
2-aminopyrimidine 12 (0.5 mmol), -oxo ester (1 mmol) and BiCl3 (0.025 mmol) neat at 100 °C for 3 
h. 
 
Scheme 7: Synthesis of 4H-pyrido[1,2-a]pyrimidin-4-ones using BiCl3 as catalyst. 
 
They also employed this procedure when 2-aminopyrimidine 39 was used as starting material, 
however, the reaction failed to give 40. A reason could be that the nucleophilicity of the NH2 group 
may be reduced due to the additional nitrogen atom on the pyrimidine ring. 
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Scheme 8: Attempted synthesis of 2-methyl-4H-pyrimido[1,2-a]pyrimidin-4-one using BiCl3 as 
catalyst. 
 
They developed an efficient and green new methodology for the synthesis of 4H-pyrido[1,2-
a]pyrimidin-4-ones using BiCl3 as catalyst. The starting materials are commercially available and 
cheap and BiCl3 is a mild, moisture and air stable Lewis acid. It is easy to handle and is not 
carcinogenic. Furthermore, the reaction proceeds under mild conditions, (no solvent and no inert 
atmosphere were required) and in excellent yields. In addition, the co-products formed were only 
alcohol and water.  
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2- Pyrimidopyrimidine derivatives. 
 
Pyrimidopyrimidines are bicyclic pyrimidine derivatives containing two fused pyrimidine rings or two 
fused pyridine and pyrimidine rings. 
Numerous pyrimidine and pyrimidopyrimidine derivatives show interesting pharmaceutical 
properties. It is known that pyrimidine rings containing sulfonamides form part of the antibacterial 
agents group. The pyrimidopyrimidine derivatives have shown other interesting pharmaceutical 
properties such as antiviral, anti-HIV, antiallergic, and antitumoral activities. Also, derivatives of 
aminopyrimidines with diverse substituents on the pyrimidine ring show biological activities.9  
Pyrimido[1,2-a]pyrimidines (Figure 7) derivative group is a less studied group of bicyclic pyrimidine 
heterocycles. There are not a high number of methods for the synthesis of this group in the 
literature. One of the reasons could be because of the lack of a widely applicable method for their 
synthesis.9 
 
Figure 7: Isomers of pyrimido[1,2-a]pyrimidinone. 
 
2.1- Biological activities. 
 
In both medicinal chemistry and the agrochemical industry it is common to use phosphorylated 
azaheterocycles.4 These versatile scaffolds are also important intermediates in organic synthesis. 
Some examples are: 2-pyridylthionophosphonate 42 which is an important constituent of various 
preparations of pesticides, 2-pyridylphosphonate 43 is an agonist of cyclic adenosine 
monophosphate-dependent protein kinase (i.e., it is potential blood platelet aggregation inhibitor, 
smooth muscle relaxant, and inflammation inhibitor) and compound 44 which is a potent and 
selective AMPA/kainate antagonist with neuroprotective properties.4  
12 
 
 
Figure 8: The importance of phosphorus group and the fused heterocycles as biological active 
molecules. 
 
On the other hand compound 45 is a derivative of nalidixic acid which is a well-known antibacterial 
agent28 and 4-oxopyrimidobenzimidazole-3-carboxylic acid 46, is a central nervous system 
depressant and anti-inflammatory agent.29 Both of them are carboxy-substituted azaheterocycles 
with interesting biological properties. For this reason the synthesis of phosphorus analogous of 
these carboxylic acids is under study. 
These new scaffolds are the combination of two interesting parts; one part is the phosphorus group, 
which has shown biological properties. The other part is a fusion of two or more heterocycles 
forming a new single moiety, which also possesses biological properties.4 
For these reasons; the following compounds could be an interesting profile for new drugs 
development. 
 
Figure 9: New phosphorylated azaheterocyclic compounds. 
 
Moreover, the compounds could be also interesting synthetic intermediates for further reactions. 
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2.2- Previous synthesis of pyrimido[1,2-a]pyrimidines. 
 
One of the most interesting routes to the synthesis of pyrimido[1,2-a]pyrimidines was reported by 
Güllü and co-workers in 2010.9  They reported the reaction of 2-aminopyrimidine with active 
malonates. The active malonates used are highly reactive, with good leaving groups, namely 
bis(2,4,6-trichlorophenyl) or bis(pentachlorophenyl). The reactions were carried out in an inert 
solvent, and a tertiary amine was employed as catalyst. 
Table 1: Reaction of 2-aminopyrimidines with bis(2,4,6-trichlorophenyl) malonates. 
 
Entry R1 R2 R3 R4 Solvent Time (h) Product  Yield % 
1 H H CH3 H CHCl3 6 51a 84 
2 H H H H Acetone 2 51b  75 
3 CH3 H OCH3 H CHCl3 8 51c  78 
4 CH3 H OCH3 butyl Et2O 24 51d  86 
 
A study of several substituted-pyrimidines 49 with bis(2,4,6-trichlorophenyl) 50 at room 
temperatures in different solvents and different time of reactions, gave the results shown above in 
Table 1. The reaction worked in good yields, and this methodology gave a straightforward synthesis 
of several 2-hydroxy-4H-pyrimido[1,2-a]pyrimidin-4-one derivatives bearing 4 different substituents. 
Modranka and Janecki reported in 20114 the synthesis of diverse phosphorylated ortho-fused 
azaheterocycles, by the reaction of pyridopyrimidone and pyrimidopyrimidone scaffolds as part of 
the phosphorylated ortho-fused azaheterocycles compounds:  
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Table 2: Synthesis of 2-diethoxyphosphoryl-3-aminoacrylates (reaction A) and intermolecular 
cyclization of acrylates (reaction B). 
  
Entry Amine Producte Yield % Product Yield % 
1 12. R=H; X=C 55aa  86% 56a.c R=H; X=C 75% 
2 53a. R=3-Me; X=C 55ba  84% 56b.c R=3-Me; X=C 84% 
3 53b. R=4-Me; X=C 55ca  90% 56c.c R=4-Me; X=C 67% 
4 53c. R=5-Me X=C 55da  83% 56d.c R=5-Me X=C 68% 
5 53d. R=6-Me; X=C 55ea  81% 56e.d R=6-Me; X=C 14% 
6 39. R=H; X=N 55fb  72% 57.d R=H; X=N 73% 
aReaction A time: 16h. bReaction A time: 8 h. cReaction B time: 40 h. dReaction B time 60 h. eE/Z Ratio (30:70). 
 
A mixture of 2-diethoxyphosphoryl-3-methoxyacrylate 54 with several heteroaromatic amines (12, 
53a-d and 39) was heated in xylene over 8-16 h. Depending on the heteroaromatic amine (Table 2), 
this led to a mixture of E and Z isomers of ethyl 2-diethoxyphosphoryl-3-aminoacrylates 55a-f in a 
(30:70)  ratio in most of the cases, in mostly excellent yields. Subsequently, the optimal conditions 
for the intramolecular cyclization were applied to the ethyl-2-diethoxyphosphoryl-3-aminoacrylates 
intermediates 55a-f. The reactions underwent fully regioselective intramolecular N-cyclization, 
followed by deprotonation to give pyridopyrimidones 56a-e and pyrimidopyrimidone 57.  
An efficient two-step synthesis of a variety of phosphorylated pyridopyrimidinones and 
pyrimidopyrimidone via intramolecular N-cyclization has been described.  
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Recently, in 2015, Lengyel et al.30 developed the synthesis of pyridopyrimidones by the Gould-Jacobs 
reactions in a three-mode pyrolysis reactor. They demonstrated the capabilities of the pyrolysis 
instrument for the synthesis of heterocyclic systems that require the reaction to cross a high 
activation barrier. 
Firstly the synthesis of the key intermediate was required (Scheme 9). 
 
Scheme 9: Synthesis of the precursor, compound 61. 
 
Having the key intermediate precursors 61 in hand, they synthesized the compound 4 under two 
different methodologies: i) firstly under conventional batch conditions: 
 
Scheme 10: Synthesis of 4H-pyrimido[1,2-a]pyrimidin-4-one under conventional batch conditions. 
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After they obtained the 4H-pyrimido[1,2-a]pyrimidin-4-one using conventional conditions, they 
studied different conditions for the synthesis of 4H-pyrimido[1,2-a]pyrimidin-4-one  in the modules 
of the pyrolysis reactor. The three modules of the pyrolysis reactor are: i) a flash vacuum pyrolysis 
(FVP) module that applies high vacuum (10−3 mbar), allowing the starting material to pass through 
the reactor chamber which is heated up to 1000 °C; (ii) a pneumatic spray pyrolysis (PSP) module 
that can inject non-volatile reactants to the heated reactor zone; and (iii) a high-pressure pyrolysis 
(HPP) continuous-flow module that operates from atmospheric to 400 bar pressure and between 
room temperature and 600 °C. 
Among the three modules, the FVP module was the more effective for this thermal cyclisation. For 
the synthesis of 4H-pyrimido[1,2-a]pyrimidin-4-one 4, in the FVP reactor the following parameters 
were used: Tf  (furnace temperature) = 450 °C;  Ti (inlet temperature) = 140 °C; P (pressure) = 5 x 10
-1 
mbar; t (pyrolysis time) = 20 min; tube dimensions (30 cm × 2 cm) (Scheme 11). 
 
Scheme 11: Synthesis of 4H-pyrimido[1,2-a]pyrimidin-4-one using FVP technique.  
 
The product 4 was collected successfully from the tube as orange crystals in 86% yield. 
The advantage of this technique is that the flash pyrolysis method is the shortest reaction time and 
gave better results. Also this technique delivered the product pure; no work-up was needed and the 
reaction was performed under solvent-free conditions.  
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3- Pyridone derivatives. 
 
2-Pyridone 5 and 4-pyridone 6 derivatives are interesting and important scaffolds among the N-
alkylated heterocycles; these structural motifs are an essential core in natural products and 
medicinal targets. Moreover, they often serve as synthetic precursors for nitrogen-containing six-
membered ring compounds. 
 
Figure 10: 2- and 4-pyridone scaffold. 
 
The Figure 10 shows the general core of N-alkylated 2-and 4-pyridone scaffolds. 
 
3.1- Biological activities. 
 
The presence of N-alkylated-2-pyridone scaffold in several natural products such as (-)-cytisine 62,10 
(-)-anagyrine 63,31 and (-)-thermopsine 64,10 makes this core a remarkable scaffold. It represents an 
important group of natural products, and also it represents a numerous groups of pharmacologically 
active structures containing 2-pyridone as an essential core (Figure 11). 
An example of a natural product and a precursor of a pharmacologically active structure is (-)-
cytisine10 62, which is present in several plants of the leguminosae family (Cytisus, Sophora, Ulex, 
Baptisia).32 It is a potent α4β2 subtype selective partial agonist at nicotinic acetylcholine 
receptors.10,33 The cytosine analogues have been studied for the treatment of various CNS disorders 
and for assisting smoking cessation.33 
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Figure 11: (-)-Cytisine, (-)-anargyrine, (-)-thermopsine structure.  
 
20(S)-Camptothecin (CTP) 65a is a natural product, which belongs to the Lupin alkaloid family, It was 
isolated for the first time from the chinese tree Camptotheca by Wall and co-workers in 1966.34  
 
Figure 12: 20(S)-Camptothecin structure. 
 
This compound (Figure 12) has attracted much attention because has shown impressive activity 
against leukemia and wide range of solid tumors.35  
Although this natural product showed good biological activity, in clinical trials it showed poor water 
solubility, and this is an obstacle to the supply of this treatment in patients. Also, CTP showed severe 
toxicities such as myelosuppresion, vomiting, and diarrhea; therefore the use of CTP was ceased in 
clinical trials. The investigation of new CTP derivatives was required and moreover the research aim 
was to design water-soluble camptothecin derivatives that maintained the antitumor activity. 
Later on, based on this natural product, the following family of topoisomerase poisons 65b and 65c 
were synthesized by Huber Josien et al. in 1998. The solubility of these derivatives was improved and 
furthermore these compounds are shown some of the most promising agents for the treatment of 
solid tumours by chemotherapy (Figure 13).36  
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Figure 13:  Topotecan and Irinotecan structure. 
 
Other examples showing the importance of N-alkylated-2-pyridones in pharmaceutical and 
medicinal chemistry are: Ricinine 66 as a simple bioactive molecule and aurodox 68 as an example of 
a more complex compound. Funiculisin 67, isolated from Penicillium funiculosum, is a 2-pyridone 
derivative which bears substituents at C-3 and C-5 (Figure 14).37  
 
 
Figure 14: Ricine, Funiculosin and Aurodox structure.37 
 
An example of a 4-pyridone derivative of a pharmaceutical compound and natural product is 
levofloxacin 69 (Figure 15).38   
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Figure 15: Levofloxacin compound. 
 
Among all natural products or pharmaceutical compounds that have been described before, either 
the 2-pyridone or 4-pyridone rings are an essential part of the scaffold, hence the pursuit of a large 
number of pathways to synthesize 2- and 4-pyridone scaffolds are wanted. There is especial interest 
in the development of new reactions to functionalize these special scaffolds, in order to form the 
skeleton for the synthesis more complex molecules. 
3.2- Previous synthesis of 2-pyridones. 
 
There are several pathways to synthesize 2-pyridones. However, in this report we are focusing in the 
synthesis of N-alkyl 2-pyridones from 2-pyridones (section 3.2.1) and from 2-alkoxypyridines (section 
3.2.2). 
3.2.1- Synthesis of N-alkyl 2-pyridones from 2-pyridones. 
 
2-Alkoxypyridines 72 and N-alkyl-2-pyridones 5 are valuable synthetic intermediates. A common 
synthetic method to synthesize N-alkyl-2-pyridones 5 is using 2-pyridone as starting material. The 
reason to study this in depth was due to the ambident nucleophilic character of 2-oxopyridines.39  
One of the problems has been to control the N-alkylation vs O-alkylation of 2-pyridone derivatives, 
for example 2-pyridone 70.39,40 The synthesis of N-alkylated products is difficult to achieve without 
forming mixtures of N- and O-alkylated products. A general procedure to obtain N-alkylation 
involves treating a metal salt of the 2-pyridone 71 with an alkyl halide (Scheme 12).41,42  
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Scheme 12:  N-alkylation vs O alkylation product.39 
 
There are some variables that need to be taken into account in controlling the regioselectivity 
between N- and O- alkylation. Increasing the size of the alkyl halide favours O-alkylation, due to the 
steric hindrance in the transition state leading to the N-alkylated product as the minor product. In 
previous investigations, the use of a silver salt in non-polar solvent was frequently used as a good 
procedure to obtain the O-alkylation product. Although, the O-alkylation was achieved using silver 
salts, they are expensive,42 which is the main reason to continue working in the development of 
cheaper synthetic routes.  
These are the four important variables to consider in order to favouring one or the other isomers:   
- The nature of the metal. 
- The structure of the alkyl halide.  
- The substituents on the pyridone ring.  
- The solvent. 
 
Depending on these, it is possible to control N-alkylation vs O-alkylation. In general, the N-alkylated 
product had been performed using sodium salts.41,42,43 However, the continuous development of 
new methodologies to perform a selective N-alkylation of 2-pyridones was needed, due to the 
competition of O-alkylation and N-alkylation and therefore the formation of mixtures of both 
products.  
 In 1994 Daniel L. Comins and Gao Jianjua reported a study of “N- vs O-alkylation in the Mitsunobu 
reaction of 2-pyridone”. The authors chose to investigate the Mitsunobu reaction, because it 
operates under mild conditions. The 2-pyridone is a good candidate for this reaction, the essential 
requirement is to use a nucleophile (HA) with a pKa less than 13, and the pKa of 2-pyridone is 11.62.
39 
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In this reaction, standard reagents were used: 2-pyridone (1 mmol), PhP3 (1.5 eq.) and diethyl 
azodicarboxylate (1.5 eq.) in  THF (20 mL) at RT, and the other reagents used in the reactions are 
summarised in the following Table 3: 
Table 3 : Mitsunobu reaction of 2-Pyridone with alcohols (R1R2CHOH). 
 
Entry R1 R2 73 (%) 74 (%) 73:74 
1 Ph H 73a (20) 74a (67) 1:4 
2 PhCH2 H 73b (88) - 10:1 
3 PhCH2 CH3 73c (63) 74c (0) 1:0 
4 Ph CH3 73d (60) 74d (0) 1:0 
5 PhCHCH3 H 73e (89) 74e (0) 1:0 
6 2-Naphth H 73f (15) 74f (54) 1:3.5 
 
They reported the alkylation of 2-pyridones which does not required the presence of a strong base, 
and as electrophiles, 1° or 2° alcohols were used. Under these conditions, it was possible to control 
N- and O-alkylation and to achieve O-alkylation as a major product.    
This procedure gave an alternative to O-alkylate 2-pyridones avoiding the use of expensive silver 
salts. However, only in entries 3, 4 and 5, was a selective O-alkylation achieved. In the other 
reactions a mixture of N and O-alkylated product was obtained and in some cases, such as entries 1 
and 6, the N-alkylated product was the major product. 
In 1995, Sato et al.43 reported that the selectivity for the N or O-alkylation of 2-pyridone, under mild 
conditions, depended on the alkyl halide. 
The alkylation of 2-pyridones was performed under standard mild conditions (Table 4), and primary 
and secondary alkyl halides were studied. 
The highest N-alkylation selectivity was found with primary alkyl halides, such as benzyl and allyl 
halides; furthermore the alkyl chlorides have better selectivity (entries 1 and 3) than the 
corresponding bromides and iodides (entries 2, 4 and 5). On the other hand a selective O-alkylation 
was obtained when secondary halides were used (entries 9, 10 and 11) (Table 4). 
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Table 4: CsF-Promoted alkylation of 2-pyridone. 
 
Entry R1 R2 X 75 (%)b 76 (%)b 75:76 
1 Ph H Cl 75a (7) 76a (93) 7:93 
2 Ph H Br 75a (10) 77a (68) 13:87 
3 CH2=CH H Cl 75g  (8) 76g (85)  9:91 
4 CH2=CH H Br 75g (7) 76g (55) 11:89 
5 CH2=CH H I 75g (9) 76g (58) 13:87 
6 CH3 H Br 75h (29) 76h (71) 29:71 
7 CH3 H I 75h (40) 76h (60) 40:60 
8 CH3 H OMs 75h (32) 76h (41) 44:56 
9 CH3 CH3 Br 75i (72) 76i (28) 72:28 
10 CH3 CH3 I 75i (55) 77i (7) 89:11 
11 CH3 CH3 OMs 75i (41) 76i (9) 82:18 
b Determinated by GLC.  
 
For bulky alkyl halides (Scheme 13) no N-alkylation or O-alkylation product was obtained.  
 
Scheme 13: Attempt to CsF-promote alkylation of bulky haliders of 2-pyridone. 
 
In 1998, Curran et al.36 reported the synthesis of 20(S)-Camptothecin family. As a part of this total 
synthesis, they synthesized the following pyridones 82a-d. One of the concerns in the N-alkylation 
reaction was the ambident behaviour of the pyridone anion.  
Even though they overcame this problem using NaH and LiBr dissolved in a mixture of DMF and DME 
and the desirable pyridone was produced in 88% yield, a small quantity of the unwanted O-
alkylpyridine was still formed and needed to be separated (Scheme 14).44 
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Scheme 14 : Synthesis of N-substituted-2-pyridones. 
 
The O and N-alkylation of 2-pyridone has been studied intensely, to try to control the ambident 
behaviour of the 2-pyridone anion. The O and N alkylation has been controlled to some extent with 
the use of CsF, or using the conditions reported by Curran et al., however, small amounts of 
unwanted O-alkylated product were always formed.  
The following authors used as starting material 2-alkoxypyridines, trying to avoid the O and N-
alkylation competition. 
3.2.2- Synthesis of N-alkyl 2-pyridones from 2-alkoxypyridines. 
 
Bowman and Bridge reported in 1999 a facile and selective one-pot conversion of 
methoxypyridines to N-alkylpyridones (Scheme 15).44 The reaction was performed in acetonitrile 
as solvent and the use of NaI was needed to activate the halide, in order to speed up alkylation by 
conversion of the bromide into the iodide in situ. 
 
Scheme 15 : Selective synthesis of N-alkylpyridones. 
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The mechanism is described in Scheme 15 where an initial alkylation, to generate the pyridinium 
salt, was required in order to initiate C-O cleavage.  The reaction worked in good yields and no O-
alkyl products were detected, however the pyridone products required some purification.44  
The benefit of this methodology is the conversion step of α-methoxypyridine to the corresponding 
pyridone using TMSI reported by Curran et al.36 was not needed. One drawback of this reaction 
pathway however was the reaction did not work with a range of unactivated halides, such as ethyl 4-
bromobutanoate, 4-bromobutanonitrile or 2-bromo-1-(bromoethyl)benzene. Also we need to take 
into account the fact that Bowman’s methodology was only applied to unsubstituted 2-
alkoxypyridines.  
In 2002, Ruda and co-workers reported a similar approach for the regioselective solid-phase 
synthesis of N-alkylated 2-pyridones.45  
Ruda’s group studied a model solution-phase reaction of the N-alkylation of substituted 2-
alkoxypyridines with alkyl halides. This strategy was studied as a solution of the problems shown in 
the following scheme: 
 
Scheme 16: Attempt to synthesize N-alkylate of 2-benzyloxipyridine with propyl iodide. 
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The study of the effect of the alkoxy group on the 2-alkoxypyridine was essential in this reaction, 
since, the alkoxy group was the source of new alkyl halide reagent which was generated in situ as a 
by-product. 
When the alkylating reagent formed in situ (benzyl iodide) was more reactive than the selected 
alkylating reagent (1-iodopropane), the former reacted faster with the remaining 2-alkoxypiridone, 
generating the N-benzyl-2-pyridone 91 as a major product (Scheme 16). 
This problem was solved in an interesting way. By linking the benzyloxy group to a solid support, it 
was possible to avoid the formation of the free alkylating reagent. The by-product was also linked to 
the solid support, avoiding side reactions (Table 5). 
The Wang resins were exposed to t-BuOK, the resultant products were subsequently reacted with 2-
halopyridines 93a-c and via aromatic nucleophilic substitution, the intermediate resins 94a-c were 
obtained. The coupled products were N-alkylated with several alkylating reagents. Once the coupled 
products were alkylated, the reaction to form the pyridone compounds 95a-f, 96a-f and 97a-f 
occurred, and no O-alkylated products were isolated (Table 5). 
Using this methodology, competition reactions between the alkylating reagents added to the 
reaction mixture and the alkylating reagents formed in situ, were avoided. Another advantage of this 
methodology was the use of several substituted 2-alkoxypyridone was possible, also including 6-
substituted 2-alkoxypyridones. The drawbacks of this methodology were: the impossibility to attach 
pyridines bearing acidic protons. Unalkylated pyridone was also formed; presumably, traces of water 
in the reaction mixture caused cleavage of unalkylated pyridine from the resin. The yields were 
generally moderate (19-86%), (Table 5). 
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Table 5:  Coupling 2-halopyridines to the Wang resin and the synthesis of 2-pyridones on solid 
phase. 
 
R’X PhCH2Br      
 
Resin 
94a 
95a  
58%a 
95b  
79%a 
 95cb 95db 95eb 95d  
19%a 
95f 
17%a 
Resin 
94b 
96a 
24%e(1:2)d 
96b  
78%a 
96c 85%a 
96dc 96e 
27%e(1:2)d 
96d c 96f 
33%e(1:3:1)d 
Resin 
94c 
97a 
62%a 
97bc 97c 
17%e(1:2)d 
97dc 97e 
51%a 
97d 
35%a 
97f 
81%a 
a 
Overall isolated yield (loading +cleavage). Loading yields appear to be 100% on the basis of 1H MAS NMR. 
b 
Not attempted.
 c
 Product could only be 
detected by ES-MS. 
d 
Alkylated product versus unalkylated product. 
e 
Yield of the N-alkylated product. 
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In 2008, Lanni and co-workers46 reported the conversion of O-alkylated pyridines to the 
corresponding N-alkylated pyridones in good to excellent yields.  Using this methodology a wide 
range of substituted benzyl groups could be used for O- to N-alkyl migration. 
In order to start the study, the synthesis of O-alkylated pyridines 100a-o was required (Table 6). The 
2-chloropyridine derivatives 99 were exposed to potassium tert-butoxide in dioxane at 98 °C and the 
corresponding alcohol was added to the mixture, after the necessary purification step, the reaction 
leading to the required O-alkylated product.  
In the screening to synthesize N-alkyl-2-pyridones, the following variables were studied: solvents 
(acetonitrile, neat reaction); additives (CF3COOH, BF3OEt2 or LiI) and temperatures (from rt to 200 
°C). After the screening, the best conditions were LiI (0.5 eq.) and conventional heating at 100 °C and 
no solvent, due to the reaction having a better yield when the concentration of pyridine was 
increased. Good yields were obtained after 8 h, and slightly better yields were obtained after 26 h 
(Table 6). 
Table 6 shown, the reaction conditions worked in good to excellent yield for benzyl groups, which 
bears substituents in ortho, meta and para position (entries 1-10). On the other hand, a methyl 
group at 2-position on the pyridine ring had a negative effect in the O- to N migration, 1 eq. of LiI 
was needed and the yield dropped to 57 %, (entry 12). Pyridine 100n bearing a substituent on the 
benzylic position gave the desirable pyridone in even lower yield 34% (entry 13). Furthermore, an 
extra methylene on the chain in the alkyl derivative was even more problematic (entry 14). The 
reaction did not work and only starting material was recovered. The migration could fail due to the 
less electrophile nature of the oxygen-bound carbon. In this development, the study the O-to N-alkyl 
migration for 6-substituted pyridines was not developed. 
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Table 6 : Synthesis of 2-alkoxypyridines. 
 
Entry R1 R2 R3 R4 R5 Product (%)a,b Product (%)c,d 
1 H H H H C6H5 100a (77) 101a (94) 
2 H H H H 4-CH3C6H4 100b (92) 101b (99) 
3 H H H H 4-CH3OC6H4 100c (89) 101c (88) 
4 H H H H 4-ClC6H4 100d (93) 101d (90) 
5 H H H H 3-CH3C6H4 100e (91) 101e (91) 
6 H H H H 3-CH3OC6H4 100f (97) 101f (96) 
7 H H H H 3-ClC6H4 100g (94) 101g (93) 
8 H H H H 2-CH3C6H4 100h (84) 101h (97) 
9 H H H H 2-CH3OC6H4 100i (87) 101i (85) 
10 H H H H 2-ClC6H4 100j (97) 101j (75) 
11 H CH3 H H C6H5 100k (78) 101k (93) 
12 H H CH3 H C6H5 100l (98) 101l (57)
f 
13 H H H CH3 C6H5 100m (89) 101m (34) 
14 H H H H CH2C6H5 100n (58) 101n (NR) 
15 H H H H 3-pyridyl 100o (92) 101o (NP) 
a Conditions: 2-chloropyridine or a substituted analogue (1.0 eq.), RR’OH (1.5eq.), KOtBu (1.5 eq.), 1.4-dioxane (0.22M), 98 °C, 18 h. 
bIsolated yields. c Conditions: substrate (1.0 eq.), LiI (0.5 eq.), 100 °C. d Isolated yield. e Mean values from duplicate experiments (±3%). f 
1.0 eq. of LiI used. g NR = no reaction, starting material recovered. h NP = no product, a number of unidentified byproducts were 
observed in addition to recovered starting material. 
 
Control reactions showed that the migration of requires LiI and heat to occur. However, the 
advantage of this methodology is that a substoichiometric amount of LiI was used in all the 
reactions, apart from entry 12 where 1 eq of LiI was needed to effect the reaction. This method 
allows the O- to N- migration of a wide range of substituted benzyl groups in high yields. 
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Later on, in 2012, Tasker, Lanni and co-workers continued the study of the synthesis of 2-pyridones 
via O- to N-alkyl migration of 2-benzyloxy, 2-allyloxy and 2-propargyloxypyridines.47 The study 
started with the synthesis of the essential 2-alkyloxypyridines, following the synthetic route reported 
by Lanni and co-workers in 2008.46 
An extension of the previous paper, they studied the O-to N-alkyl migration for 6-substituted 
pyridines and the synthesis of 2-pyridones via O- to N-alkyl migration of other substituted benzyl 
groups. 
The required alcohols (benzyl, allyl, and propargyl alcohol), were treated with potassium tert-
butoxide in dioxane, the 2-chloropyridine was added to the mixture to obtain the desired 2-
alkoxypyridine derivative. 
Table 7 : Synthesis of N-alkyl-2-pyridone derivatives from 2-chloro-pyridines. 
 
Entry R1 R2 R3 R4 R5 Product Yield (%)a,b 
1 H H CH3 H C6H5 101m 57
c,d,e 
2 CH3 H H H C6H5 101p 59
d 
3 H H H H 2,6-Cl2C6H4 101q 85
c,e 
4 H H H H 2-naphthyl 101r 95c 
5 H H H H 4-CF3C6H5 101s 84
d 
6 H H H H 4-CNC6H5 101t 60
d 
aConditions: substrate (1.0 eq.), LiI (0.5 eq.), 100 °C, 8 h. bIsolated yield. Mean values from duplicate experiments (±3%). cReference 46. 
dReaction duration = 26 h. e1.0 eq. of LiI used. 
 
The synthesis of several N-benzyl pyridones is summarised in Table 7. The reaction took place under 
the optimized conditions: LiI (0.5 eq.), neat reaction, conventional heating, from 8 h to 26 h 
depending on the ring substitution. For the compounds with electron-withdrawing groups on the 
aryl group, 26 h were needed to take the reaction to completion. The 3-methyl-substituted pyridine 
needed 1 eq. of LiI and 26 h at 100 °C to afford the 2-pyridone 101m (entry 1), and the 6-methyl-
substituted pyridine needed 26 h to afford the corresponding pyridone 101p.  
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The main advantage of this reaction is this 6-methyl pyridine (entry 2) has been found by others 
authors to be unreactive in other O to N-alkyl migration methods, and using this methodology, the 
6-methyl pyridone 101p was synthesized in 59% yield. 
Furthermore, the optimized conditions were evaluated on heterocycle analogues, some of them 
with an extra heteroatom in the scaffold such as dibenzylpyridazine, pyrimidine and quinolone. 
However the migration was less successful:  higher quantities of LiI and a longer time were needed 
to obtain the products. 
In a continuation of the study, in Table 8 are shown the synthesis of new 2-allyloxypyridines and 2-
propargyloxypyridines. Under the following standard conditions, the synthesis of 2-alkoxypyridines 
worked in good yields. 
Table 8 : Formation of 2 allyloxy- and 2-propargyloxypyridines. 
 
Entry R5 R4 R3 R2 R1 product Yield(%)a,b 
1 (E)-CH=CH(CH2)2Ph H H H H E-102a 77 
2 (Z)-CH=CH(CH2)2Ph H H H H Z-102a 85 
3 C≡C(CH2)4CH3 H H H H 102b 95 
4 C≡C(CH2)2Ph H H H H 102c 90 
5 C≡CCy H H H H 102d 94 
6 C≡CPh H H H H 102e 58 
7 C≡C(CH2)4CH3 H Me H H 102f 91 
8 C≡C(CH2)4CH3 H H Me H 102g 60 
9 C≡C(CH2)4CH3 H H H Me 102h 75 
 
Having the 2-allyloxypyridine and 2-propargyloxypyridines in hand, they evaluated the standard 
conditions for promoting O to N alkyl migration. The migration worked successfully, (Scheme 17, and 
Table 9). However, the ideal amount of LiI was optimized for each substrate, and most of the time, 
longer reaction times were needed to obtain the product. 
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Scheme 17 : Migration of allyl group in allyloxypiridines. 
 
The O- to N-alkyl migration of 2-propargyloxypyridine derivatives is shown in Table 9. The migration 
occurred more slowly than for the corresponding benzyl substituted analogues (26 h vs 8 h) and in 
most all the cases the amount of LiI had to be increased. The amount of LiI was optimised for each 
substrate. 
Table 9 : Formation of N-propargyl 2-pyridones. 
 
Entry R R’ R’’ R’’’ LiI (eq.) Product Yield (%) 
1 Pentyl H H H 05 103b 81 
2 CH2CH2Ph H H H 0.8 103c 85 
3 Cy H H H 1.2 103d 77 
4 Ph H H H 2.0 103e 66 
5 Pentyl Me H H 0.5 103f NP 
6 Pentyl H Me H 1.0 103g 64 
7 Pentyl H H Me 0.5 103h 15 
 
The reaction worked in moderate yields, and the 2-alkoxypyridones bearing substituent at position 
3, the migration did not occur. The reason could be that the additional substituent interferes with 
coordination of lithium to the heteroatoms and thus impedes the migration. 
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In 2011 Charles et al. developed a Ru-catalyzed O- to N-alkyl migratory rearrangement reaction.  The 
first part of Charles and co-workers’ work was an optimization study of the promotion of O- to N-
migration, with different transitions metals such as: Pd, Ni, Fe or Rh; were unsuccessful in promoting 
the O- to N-migration. Until they found the excellent catalyst ([Ru(arene)Cl2]2/PPh3). The study 
showed that the reaction needs a weak inorganic base K2CO3, since using a strong base or organic 
base such as NaOtBu or NEt3 caused the reaction to fail. 
The optimal reaction conditions are shown in Scheme 18. 
 
Scheme 18: O-to N-Migratory rearrangement of substituted-2-benzoxypyridines. 
 
The O- to N-alkylation migration in 2-substituted benzoxypyridines worked successfully when the 
phenyl group bore different substituents such as electron-neutral, electron-deficient, or electron-
donating groups in the ortho, metha or para positions. However, in the reactions involving ortho 
substituents, higher temperatures were required (Scheme 18). 
The optimized conditions were studied for pyridine derivatives bearing different substituents in all 
possible positions, (positions 3, 4, 5 and 6 were studied). For pyridine derivatives bearing electron-
donating and electron-deficient substituents in positions 3, 4 and 5 the reactions worked in good 
yields. However the reaction with 6-substituted pyridines bearing electron-withdrawing 107 and 
electron-donating 109 groups did not work due to steric effects (Scheme 19). 
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Scheme 19 : O-to N-Migratory rearrangement of 2-benzoxy-6-substituted-pyridines. 
 
In addition, the general strategy for O-to N-alkyl migratory rearragement also worked for pyridines 
bearing large aryl- and heteroaryl substituents such as naphthyl, benzodioxolyl, furyl and benzofuryl 
at the 2-position.  
This methodology was challenging since ethereal C-O bonds are typically inert. Normally it is difficult 
to do a direct insertion into electron-rich bonds. They reported a new methodology for sp3 ethereal 
C-O activation in 2-alkoxypyridines and several other O-alkylated N-containing heterocycles such as 
3-alkoxypyridazines. 
Overall, the synthesis of N-pyridones has been reviewed, and there are several methods for 
synthesising O-alkyl pyridines and N-alkyl pyridones. The problem of competition of O and N 
alkylation has been minimised.  
The literature presents many examples of the synthesis of O-alkyl pyridones as a mean of 
synthesizing N-alkyl-2-pyridones. However, in some cases of pyridines bearing a substituent at 
position 6, the reaction did not take place.  
In our research, we are interested in the synthesis of N-alkyl 6-methyl-2-pyridone as a starting 
material to synthesize quinolizinone derivatives. Base on Bowman’s work, we aimed to develop a 
new strategy for the synthesis of N-alkyl 6-methyl-2-pyridone using 2-methoxy-6-methylpyridine as 
the starting material. 
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3.3- Pyridone as building blocks in synthesis. 
3.3.1- Functionalization of 2- and 4-pyridone ring. 
 
The brief summary of biological activities highlighted the importance of 2- and 4-pyridone cores as 
constituents of natural products and pharmaceutical compounds. Also, these scaffolds are very 
important as precursors of new, complex pharmaceutical targets, since the pharmaceutical industry 
is in a continuous development of new compounds.  
In the following pages different pathways for the functionalization at position 6 are described. 
Nakao48 in 2009 reported the C(6)-H alkenylation and alkylation of pyridone derivatives using 
Ni/AlMe3 catalysis. They reported the inter- and intramolecular insertion of an unsaturated bond 
into the C(6)-H. The insertion could be activated by Ni(0) upon coordination to a Lewis acid. 
After the screening of ligands and Lewis acids, the optimum combination was used for non-
substituted pyridines (Scheme 20) and for methyl-substituted pyridines (Table 10). 
 
Scheme 20: C(6)-H alkenylation of  N-benzyl and N-methyl 2-pyridones. 
 
For pyridone 111a the product 113a was obtained in 6 h, however for the synthesis of product 113b 
a longer time was required (30 h). And a small amount of 4,6-dialkylated product was formed in both 
examples. 
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Table 10: C(6)-H alkenylation of N-methyl-substituted-pyridones. 
 
Entry Pyridone Time Product (yield %) 
1 115. R = 3-Me 16 119 R = 3-Me (62%) 
2 116. R = 4-Me 6 120 R = 4-Me (88%) 
3 117. R = 5-Me 44 121 R = 5-Me (29%)* 
*The 4,6-dialkylated product was obtained in 1%. 
 
A methyl group at position 3 and 4 did not affect the reaction, (entry 1 and entry 2), however a 
methyl group at position 5 resulted in a lower yield (entry 3), and the reason could be due to steric 
repulsions (Table 10).  
The intramolecular reaction worked in good yields, using the standard conditions but a higher 
temperature (100 °C) was needed. The intramolecular addition to alkenes proceeds normally in an 
exo-trig fashion to give bicyclic products 124a,b and 125a,b. 
 
Scheme 21: Intramolecular insertion of unsaturated bond into the C(6)-H. 
 
The regio- and stereo-selective alkenylation and alkylation of pyridones was demonstrated. Later on, 
in 2012, Tamura, Nakao and co-workers continued the study of the C(6)-H insertion with unactivated 
alkenes (linear alkenes 126),38 using the optimal conditions reported in 2009.48 
Using 1-methyl-2-pyridones (0.5 mmol) as a starting material and 1-tridecene (0.55 mmol) as the 
unactivated alkene, the optimised conditions reported in the previous paper48 [Ni(cod)2] (5 mol %); 
P(i-Pr)3 (10 mol%); AlMe (20 mol %); toluene, 80 °C  worked in low yield.  
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Screening for the best conditions showed that 1,3-bis(2,6-diisopropylphenyl)imidazole-2-ylidene 
(IPr) was the optimal ligand and (2,6-tBu2-4-Me-C6H2O)2AlMe (MAD) the best Lewis acid. 
The reaction was performed on double the scale using the effective combination of ligand and Lewis 
acid (IPr and MAD). The reaction yielded the product 150 in 92% yield, and as a by-product, a small 
amount of the 4,6-dialkylation product was also obtained. However, the alkylation proceeded mainly 
at position 6 (Table 11).  
Table 11: The study of the C(6)-H insertion with lineal alkenes. 
 
Entry Pyridone R R’ R’’ R’’’ Time (h) Product (%) 
1 111a Me H H H 15 127 (92%)* 
2 111b Bn H H H 10 128 (64%)* 
3 115 Me Me H H 9 129 (82%) 
4 116 Me H Me H 8 130 (94%) 
5 117 Me H H Me 9 131 (62%)* 
*Dialkylation product was also obtained (entry1: 2%; entry 2: 16%; entry 5: 13%) 
 
In order to complete their study, 1-methyl-4-pyridone was also alkylated directly at the C2-position ( 
Scheme 22).  
 
Scheme 22 : C-2-Alkylation of 1-methyl-4-pyridones. 
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They also reported the unprecedented C(6)-selective functionalization of pyridone. Through these 
two papers, both regio- and stereoselective alkylation reactions with active and unactivated alkenes 
were developed, using nickel/Lewis acid catalysis. Depending on the alkene, the ligand and the 
catalyst were optimized for each reaction. The drawback was that the 4,6-dialkylation product was 
obtained as a by-product in small yield. 
Focusing on the functionalization of 4-pyridone, Patel and Joule in 1985, were the first research 
group to study the lithiation of 4-pyridone.49 
They exposed the 1-methyl-4-pyridone 132 to 1 eq. of n-butyllithium (n-BuLi) at -78 °C and allowed 
the mixture to warm up to 0 °C over 30 min to afford the 2-lithiated species.  The reaction was 
quenched with D2O at -78 °C, and the 2-deuteriated 4-pyridone 135b was recovered in 91% yield 
(Scheme 23). 
 
Scheme 23:  2-Deuterated 4-pyridone.  
 
Following the condition described above, the 2-lithiopyridone 135a was treated in THF at -78 °C to 0 
°C with a range of alkylating and acylating agents during 2 to 3 h. Lithiation at the C-2 position led to 
the following series of 2-substituted 4-pyridones (Scheme 24).  
 
 
Scheme 24:  C-2-Lithiation of 1-methyl-4-pyridone. 
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The reaction occurred smoothly at the C-2 position in most of the cases, however there were some 
problems, for example, in the synthesis of compound 135c (the methylation). Compound 135h was 
obtained as a by-product, and in the synthesis of compound 135d (the benzylation), the reaction 
underwent a second alkylation in the benzyl chain leading compound 135i as the mayor product. 
 
Scheme 25: By-product of the methylation and benzylation reactions. 
 
The same conditions were applied to the N-methyl-2-pyridone, however, the lithiation did not occur 
at the C6 position, it reacted instead at the methyl group (which must have deprotonated more 
rapidly than the C6 position) and reacted with the unreactive pyridone forming a dimer 136, 
(Scheme 26).  
 
Scheme 26: Dimer formation in the lithiation of N-methyl-2-pyridone. 
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These results opened a new chapter in this study, selective metallation of 2-picoline and N-
substututed-6-methyl-2-pyridones and N-substututed-2-methyl-4-pyridones.  
 
3.3.2- Metallation of 2-picoline. 
 
In 2010 two research groups were focused on the study of the conjugate addition of lithiated methyl 
pyridones to enones as part of a total synthesis of three alkaloid derivatives. 
In February DeLorbe et al.50 reported the total synthesis of the Lycopodium alkaloid lycopladine A. As 
an essential part of this synthesis, a novel strategy involving the 1,4-addition of lithiated methyl 
pyridines to cyclic enones was presented as shown below (Scheme 27). 
 
Scheme 27: 1,4-addition of lithiated methyl pyridine (179) to cyclic enone (180). 
 
In previous publications, it had been found that 1,2-addition was a significant side reaction. In order 
to confirm this affirmation, some reactions of 139 with organocopper derivatives of 138 were 
performed, and they yielded, in approximately (1:1) ratio, both 1,4- and 1,2 addition products. In 
DeLorbe and co-workers’ paper it is reported how they achieved the 1,4-addition product as the 
major product.  
There are important variables which favour the 1,4 addition: Firstly, the use of CuI salt to generate 
the organocopper reagent and performing the reaction at low temperature (-30 °C). Secondly the 
yield of 1,4-addition product is higher when THF was used as the solvent instead of Et2O.  
Two months later, Taber and co-workers51 reported the study of conjugate addition of lithiated 
methyl pyridines to cyclic and acyclic enones,  (Table 12) as part of the synthesis of (±)-senepodine G 
and (±)-cermizine C. 
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A search of the literature showed that 1,4-conjugate addition of metallated 2-picolines to α,β-
unsaturated esters worked successfully. However, the conjugated addition with enones did not work 
efficiently and moreover the 1,2-addition product was obtained as main product. In these previous 
studies, the required organocopper reagent was made at 0 °C.52 That could be the reason for the low 
reactivity, as at this temperature (0 °C) the organocopper reagent could be decomposed. Taber et al. 
modified the procedure and they prepared the cuprate reagent at -30 °C instead at 0 °C. In their 
study, firstly they chose 2-picoline and cyclohexanone as model substrates and extensively screened 
the following two parameters: several copper salts (CuCN, CuCN2LiCl, CuI and CuBrSMe2) and 
different temperatures of the addition of the cyclohexanone (-20 and -78°C). After the screening the 
best result was obtained when a more soluble salt, CuBrSMe2 was used, and the addition of the 
enone was a lower temperature. The ratio up to 7:1 (1,4- : 1,2-product) and obtaining compound 
143 in 79%. Furthermore, the optimised conditions were applied to acyclic enones and the reactions 
proceeded efficiently (Table 12).  
 
Table 12: Conjugate addition of Lithiated Pyridone to enones. 
 
Entry Enone Product (%)* 
1 
  
2 
  
*Yields are for pure isolated conjugate additions products. The corresponding 1,2-adducts were observed but were not characterized. 
 
They developed a general synthetic method for the conjugate addition of lithiated methyl pyridines 
to cyclic and acyclic enones.  
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4- Quinolizinone derivatives. 
 
4.1- Biological activities. 
 
The quinolone family, in particular fluoroquinolones, has been one of the most important classes of 
broad-spectrum antibacterial agents. For example, Ciprofloxacin (Figure 16) is the most potent of 
the fluoroquinolone derivatives against Gram-negative bacteria.28 It is used for the treatment of 
bacterial infections of the respiratory and urinary tracts, skin and soft tissues.53  
 
Figure 16: Ciprofloxacin. 
 
The fluoroquinolones are effective against gram-negative infections; however they have only limited 
activity against gram-positive bacteria.54 Also, due to the increasing frequency of bacterial resistance 
to quinolones, it was and still is, necessary to develop new analogues compounds to overcome 
antibiotic resistance.  
Looking for new classes of antibacterial agents, the quinolizin-4-ones were developed as the new 
antibacterial agents. The structure differs from the quinolone scaffold by the relocation of the 
nitrogen atom to the ring junction.  
Abbott laboratories developed the following quinolizin-4-one family (Figure 17).  
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Figure 17: Quinolizin-4-ones synthesized at Aboott laboratories.54,55 
 
The quinolizin-4-one and the quinolones have been shown to be  inhibitors of bacterial DNA 
gyrase.56 ABT-719 147c is a representative quinolizin-4-one which exhibits potent broad spectrum in 
vitro activity (Figure 17).  
It has been found that ABT-719 147c was more potent than ciprofloxacin against the E. faecalis 
strain. Also, ABT-719 147c has abroad spectrum activity against a wide array of Gram-positive and 
Gram-negative bacteria and anaerobic bacteria.55 
This highlighted that further research in this area is needed, due to the increasing resistance of many 
particular pathogens against antibacterial and antimicrobial compounds. This interesting new 
scaffold (4H-quinolizin-4-one) has been studied in more detail.  
The 4H-quinolizin-4-one 1 is an interesting scaffold to study.57 There have been a number of studies 
reporting the biological activities of their related, partially or fully-saturated systems. Partially or 
fully-saturated 4H-quinolizin-4-one derivatives have shown significant biological activities as ligands 
for a variety of receptors targets, including Alzheimer´s disease,58 Type 2 diabetes,59 and HIV.60,61 
 
 
Figure 18 : 4H-quinolizin-4-one scaffold.1 
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Herein we are interested in the quinolizinone scaffold; looking at the structure in Figure 19 the 
scaffolds are predicted to have favourable physico-chemical properties as a result of their polar and 
nearly zwitterionic character.3 
 
Figure 19: The 4-H-quinolizinone system and its dipolar canonical form.3 
 
Hepatitis C is a disease affecting the liver, caused by the hepatitis virus.62 Currently, about 3% of the 
world’s population has been infected with HCV (Hepatitis C virus) and the disease may progress to 
chronic liver disease in about 60-80% of patients, 20% of whom develop cirrhosis. 
There are five different genotypes of HCV and, thus far, there is no universally effective therapy for 
all HCV genotypes. For this reason, it is important to know which genotype is affecting each patient, 
because the treatment is different for every genotype. 
For example, genotype 2 and 3 HCV need treatment for 24 weeks, whilst genotype 1 and 4 HCV 
require prolonged treatment for 48 weeks. This is the reason why patients of genotype 1 have 
difficulty in tolerating the treatment, due to the long duration and side effects produced, such as flu-
like symptoms, depression, gastrointestinal symptoms, fatigue, pulmonary effects, and others. 
Taking into account these limitations, Wang et al.8 were interested in the discovery and 
development of novel compounds that target the viral and host proteins, such as a series of 
quinolizinone benzothiadiazines, which exhibit potent inhibition of HCV NS5B polymerase. The most 
active compound in the replicon system was compound 148a (Figure 20). 
 
Figure 20: Most active compound in replicon system. 
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The following compound also exhibited excellent replicon activity. 
 
Figure 21: These four derivatives 203b-d show excellent replicon activity. 
 
Wang et al. studied the anti-HCV activity of all these compounds 148a-e, (Figure 20 and Figure 21) 
and found they inhibited HCV NS5B polymerase. Wang and co-workers therefore perceived the 
quinolizinone ring to be a promising scaffold for the development anti-HCV activity. 
Quinolizinone derivatives can be also used for other applications beyond the pharmaceutical area, 
Rosas-Sanchez and co-workers synthesized interesting photoluminiscencent compounds, based on 
quinolizinones (149-152), which exhibited fluorescence. These compounds are yellow in colour and 
display bright yellow/green fluorescence in solution. This property makes them potential precursors 
for optical applications (Figure 22).  
 
Figure 22: Quinolizinone derivatives as potential precursors for optical applications. 
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4.2- Previous synthesis of quinolizinone. 
 
In 1951 Boekelheide et al. reported the synthesis of quinolizone derivatives from ethyl or methyl 2-
pyridylacetate 153a or 153b as starting material.63 The cyclocondensation of ethyl 2-pyridylacetate 
153a with diethyl ethoxymethylenemalonate 60, at 180 °C was studied and afforded a 52% yield of 
154a after 8 h (Scheme 28). The same procedure was followed with methyl 2-pyridylacetate 153b 
and diethyl ethoxymethylenemalonate 60 to afford compound 154b in 26% yield (Scheme 28). 
 
Scheme 28:  Synthesis of quinolizinone derivatives. 
 
In 2009 Wang et al.8 reported the synthesis of compounds 159a-c which are quinolizinone 
derivatives. In this synthesis, also starting from ethyl pyridylacetate.  
The 1-substituted quinolizinones 159a-c were obtained by cyclization under thermal conditions in 
25-38% yield. The products 159a-c were synthesized in six steps in 25-38 % yield, as shown in 
Scheme 29. 
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Scheme 29 : Synthesis of quinolizinone precursors to HCV NS5B inhibitors. 
 
In 2009, Makoto et al.64 reported the synthesis of 4H-quinolizin-4-ones 162a-d by the reaction of 2-
alkynylpyridines 160a-c with several malonic esters 161a-d in moderate to good yields (36-77%), 
(Scheme 30). 
 
Scheme 30: Synthesis of 3,4,5,6-tetrasubstituted-2-pyridones 162a-d using addition of active 
methane compounds 161a-d to alkynyl imines 160a-c. 
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In 2012, E. Ruijter et al.65 reported a straightforward synthesis of benzo[a]quinolizine scaffolds 166, 
using highly substituted 3,4-dihydropyridones 163 as starting material. The reaction pathway 
involved a subsequent allylation and intramolecular Heck-type cyclisation. The authors reported a 
three-step sequence to generate a library of benzo[a]quinolizin-4-ones 166 derivatives, several 
examples of diversely substituted benzo[a]quinolizines and various heterocyclic compounds. 
3,4-Dihydropyridones 163 were deprotonated by NaH followed by the N-alkylation. In this process, 
when an excess of NaH was present, the isocyano group of the 3,4-dihydropyridone derivatives 
underwent facile elimination to give the corresponding 2-pyridones 164 (Scheme 31).  
 
Scheme 31 : N-allylation followed by isocyanide elimination to afford 2-pyridone 164. 
 
When compound 164 bore an O-bromophenyl substituent as the R substituent, compound 165 
became an interesting candidate for the synthesis of benzo[a]quinolizin-4-ones 166 via 
intramolecular Heck-type reaction (Scheme 32). 
 
Scheme 32 : Heck reaction for the construction of benzo*α+quinolizines 166. 
 
The intramolecular Heck-type cross-coupling reaction of 165 was also the next step in the synthesis 
of another tricyclic system. E. Ruijter et al. hypothesized that the intramolecular cyclisation of 
compound 165a proceeds via a 6-exo-trig route to afford the exocyclic form 166a. The endocyclic 
product 166a was obtained by isomerisation of the exocyclic product 167a (Table 13).65  
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Table 13: Intramolecular Heck reaction. 
 
Entry[a] Catalyst Base Yield (%)[b] Ratio 166a:167a [c] 
1 Pd(OAc)2 +PPh3 Et3N 82 92:8 
2 PdCl2 +PPh3 Et3N 79 59:41 
3 Pd(PPh3)4 Et3N 75 54:46 
4d Pd(OAc)2 +PPh3 Et3N 84 78:22 
5 Pd(OAc)2 +PPh3 Cs2CO3 90 100:0 
6 Pd(OAc)2 Et3N 86 100:0 
7e Pd(OAc)2 +PPh3 Et3N <20 n.d. 
a Conditions: 5 mol-% Pd, 10 mol-% L, 20eq. Base, DMF, 120°C, 16h. b Isolate yield. c Determined by 1H NMR spectroscopy. d NMP used as 
solvent. [e] 1mol-% Pd, 2 mol % L. 
 
Table 13 shows the cyclisation of compound 165a was achieved in high conversions in all the tested 
conditions to afford the desired tricyclic system. However the degree of isomerisation varied 
depending on the palladium source. Entries 5 and 6, show the best conditions for the cyclisation 
reaction. The most effective and practical method was obtained in entry 6, the “ligandless” protocol 
using Pd(OAc)2 as the palladium source in combination with Et3N as a base.  
Using the optimized conditions (Table 13, entry 6) for the intramolecular Heck reaction, compounds 
166a-g were synthesized in moderate to very good yields (30-94%). Some examples are shown in 
Figure 23. Moderate yields were observed for compounds bearing a highly electron rich 166g or 
electron deficient 166e, 166f aryl group at the 4-position of the pyridone ring (37%-58%), and the 
remaining benzo[a]quinolizines were typically obtained in good to excellent yields. 
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Figure 23 : Synthesis of polycyclic compounds 166a-166g by intramolecular Heck reaction. Reagent 
and conditions: Pd(OAc)2 (5 mol%), Et3N (2.0 eq.), DMF, 120°C, 16 h. 
 
In March 2013 Calum et al. reported the synthesis of functionalised 4H-quinolizin-4-ones via tandem 
Horner-Wadsworth-Emmons olefination/cyclisation.1 This pathway enabled effective synthesis of 2-
substituted 4H-quinolizin-2-ones 171 which proceeded in good to excellent yields (Scheme 33). 
 
Scheme 33 : Synthesis of quinolizinone derivatives via tandem Horner-Wadsworth-
Emmons/Cyclisation strategy. 
 
A suitable β-carbonyl pyridine 169 was used as the starting material, and the pyridone ring was 
annulated via a tandem Horner-Wadsworth-Emmons olefination/cyclisation event with the 
cyclisation taking place under thermal conditions. 
The first step in the synthesis of 4H-quinolizin-2-ones 171, was the synthesis of β-ketopyridines 169 
(Scheme 34). Calum et al. developed a convenient method of preparing these compounds, via direct 
acylation of the 2-picoline anion, derived from the deprotonation of the methyl group using 
organolithium reagents (e.g., LDA, n-BuLi).  
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Acyl chlorides, esters and Weinreb amides were chosen as three potential acylating reagents. One 
part of their study was to evaluate the reactivity of different acylating agents, (Scheme 34). 
 
 
Scheme 34 : Evaluation of potential acylating agents. 
 
In the preliminary reactions, esters 173 were found to perform equally as well as Weinreb amides 
168. However, acyl chlorides 172 were unsuited to the desired transformation, since the product 
was obtained in just 5 % yield. After several reactions, the optimization study demonstrated that the 
yields for ester-base acylation were consistently lower than those achieved using the corresponding 
Weinreb amide. The acylation reaction operated effectively for both alkyl and aryl Weinreb amides 
bearing a range of functionality, in generally high yields (80-97%), with only two exceptions: 4-nitro-
substituted aryl groups generated a complex mixture of undesired products, presumably through a 
reaction pathway enabled by the NO2 functionality and the 4-OTBS-phenyl-substituted derivative, 
which was isolated in moderate yield (55%). The optimised conditions for the synthesis of β-
ketopyridines 169 are shown in Scheme 35. 
 
 
Scheme 35 : The optimised conditions for the synthesis of β-ketopyridines. 
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The next step in the synthesis of 4H-quinolizin-4-ones, was the pivotal tandem HWE/ cyclisation 
process. The best results were obtained when 1 eq. of β-ketopyridine 169 was exposed to a mixture 
of 2 eq. of triethylphosphonoacetate 170 and 2 eq. of NaH in toluene at 0 °C, followed by heating to 
under reflux for 20 h. This delivered a collection of 4H-quinolizin-2-ones 171 in generally good yields 
(Scheme 36). 
 
Scheme 36: Tandem synthesis of 4H-quinolizin-4-one. 
 
This pathway proceeds via HWE olefination of the carbonyl unit followed by straightforward 
intramolecular N-acylation of the pyridine, proton loss, and electronic reorganisation to provide the 
annulated product 171. Generally high yields of 4H-quinolizin-4-one products 171 were obtained, 
and the assumption was that only the E-olefin E-174a would be able to be converted to the 
annulated product due to the special configuration. An aliquot of the reaction prior to reflux step 
was analysed in order to confirm this hypothesis. 
The E/Z selectivity of the olefination is rather modest at only 4:1 E/Z ratio. However, 100 % 
conversion of 4H-quinolizin-2-ones was observed. This fact suggests that the Z isomer Z-174a must 
be converted to the E isomer E-174a prior to cyclisation. Calum et al. suggested that the reaction 
proceeds through the enolate 175, which allows for olefin isomerisation and subsequent cyclisation 
to 171 (Scheme 37). 
The proposed mechanism for the tandem reaction is shown in Scheme 37. 
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Scheme 37: Proposed mechanism for the tandem reaction. 
 
In 2014 Haitao et al. reported the synthesis of the pyrano[4,3-a]quinolizine-1,4,6(2H)-trione 
derivative 178. This interesting tricycle scaffold is a fusion between 4H-quinolizin-4-one and 2H-
pyran-2,5(6H)dione. Both compounds are important bioactive motifs. Haitao and co-workers have 
been develop a novel straightforward construction of pyrano[4,3-a]quinolizine-1,4,6(2H)-trione 
derivatives via a base-promoted cascade annulation reaction of tertiary α-hydroxyketones 176 and 
dimethyl but-2-ynedioate 177.66 
They developed a new reaction using a variety of tertiary α-hydroxyketones 176 bearing different R1 
and R2 substituents on the alkyl group adjacent to the hydroxyl group with dimethyl but-2-ynedioate 
as the other starting material. Under the optimal conditions showed in (Scheme 38) a library of 
pyrano[4,3-a]quinolizine-1,4,6(2H)-trione derivatives 178 and 180 was synthesized.  
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Scheme 38: Synthesis of pyrano[4,3-a]quinolizine-1,4,6(2H)-trione derivatives. 
 
This strategy showed a good tolerance toward a wide range of functional groups: electron-donating 
groups (Me and OMe) and electron-withdrawing substituents (F, Cl, Br, CN, COMe, CF3 and CO2Et) at 
positions 4- and 5-of the pyridyl ring. Excellent yields were obtained with the non-substituted pyridyl 
ring. The better yields were from compounds bearing strong electron donating groups rather than 
those bearing weak electron-withdrawing or electron-donating groups. The 4,5 disubstituted pyridyl 
yielded the product in low yield.  
 
Scheme 39: Synthesis of pyrano[4,3-a]quinolizine-1,4,6(2H)-trione derivatives from 4- and 5-
substituted pyridyl derivatives. 
 
The continuous development of these kinds of scaffolds and their further biological testing for 
potential new drug development is very attractive for the pharmaceutical industry. 
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Other interesting methodology to assembly heterocyclic compounds is the RCM (Ring-closing 
metathesis) strategy. This strategy has been shown to be a powerful methodology for assembling 
bicyclic heterocyclic systems containing a nitrogen atom at the ring conjunction. In the following 
scheme the different type of heterocycles formed via RCM methodology. 
 
Figure 24: Synthesis of 6,6-fused bicyclic ring system via RCM strategy.67,68,69 
 
However the quinolizinone system has not been synthesized using this methodology so far. Recently, 
Alanine et al. reported the synthesis of 4H-quinolizinones via Ring Closing Metathesis.3 Their work 
started with the N-alkylation of the readily available 2-pyridone 186, followed by Pd-catalysed cross 
coupling to synthesize the essential precursor for the RCM strategy 189. The RCM reaction rendered 
another interesting substrate; the hydroquinolizinone 190 and the desirable quinolizinone 192 was 
obtained after the final dehydrogenation step. The general synthesis and the conditions are 
summarised in Table 14. 
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Table 14 : Synthesis of quinolizinones via Ring Closing Metathesis  strategy. 
 
Entry R1 R2 R3 Product Ratio
d (192:190) Yielde % 
1 H H H 192aa 4:1 68 
2 H H CH3 192b
b 3:2 33 
3 H CH3 CH3 192c
c 10:0 75 
4 H CH3 H 192d
b 3:1 62 
5 H Ph H 192eb 10:1 72 
6 H Ph CH3 192f
c 4:1 36 
7 H CO2Me H 192g
b 3:1 40 
8 H CO2Me CH3 192h
C 3:3:4f 25 
RCM and dehydrogenation steps: 
[a] Condition A: Grubbs 2nd generation catalyst (5 mol-%), CH2Cl2 (substrate concentration 0.1 M), r.t., 2h. 
[b] Conditions B: Grubbs 2nd generation catalyst (5 mol-%), CH2Cl2 (substrate concentration 0.1 M), 50 °C, 2h.  
[c] Grubbs 2nd generation catalyst portionwise (3 X 5 mol-%), CH2Cl2 (substrate concentration 0.1 M), 50 °C, 2h. 
[d] Ratio determined by 1H NMR analysis of crude product mixture. 
[e] Isolated yield of pure material. [f] Ratio of 14h/15h/12h. 
 
A new strategy has been developed for the synthesis of wanted 4H-quinolizin-4-ones bearing a wide 
range of substituents.  
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In 2011 Rosas-Sánchez and coworkers6  reported the synthesis of 3-ferrocenyl-4H-quinolizin-4-one 
199, using acetylferrocene 193 and Fe2(CO)9 196 in order to synthesize  (
4-
ferrocenylvinylketene)Fe(CO)3 complex 197, and a subsequent thermal cyclization reaction furnished 
the 3-ferrocenyl-4H-quinolizin-4-one 199 (Scheme 40).  
 
 
Scheme 40: Synthesis of 3-ferrocenyl-4H-quinolizin-4-one.70 
 
As an extension of this paper in 2014 they reported an efficient route to synthesize 3-substituted 4H-
quinolizin-4-ones, using a (4-vinylketene)Fe(0) 203 complex as key intermediate. 
They heated the (4-vinylketene)Fe(CO)3 203 complexes to synthesize a library of 3-substituted 4H-
quinolizin-4-ones. 
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Scheme 41: Synthetic route of 4H-quinolizi-4-one derivatives using isolable and stable tricarbonyl( 
-vinylketene)iron(0) complex 203.6 
  
α,β-Unsaturated ketones 201a-g were synthesized via aldol-type condensation reaction, and  then 
were exposed to Fe2(CO3)9, to obtain the necessary (η
2-PyCHCHCOR)-Fe(CO)4 complex 202a-g  for 
the carbonylation reaction. (η4-vinylketene)-Fe(CO)3 complex 203a-g  was obtained under 
carbonylation conditions. The majority of the complexes were purified and isolated in moderate to 
good yields. The quinolizinone derivatives 204a-g were obtained in good yields (Scheme 41). 
The literature presents many examples of the synthesis of 4H-quinolizin-4-one scaffolds using ethyl 
or methyl pyridylacetate, 2-picoline or 3,4-dihydropyridones.  In our research, we are interested in a 
straightforward synthesis of desirable 4H-quinolizin-4-one scaffolds by condensation of N-benzyl 6-
methyl 2-pyridones with dicarbonyl compounds, and the formation of the desired quinolizinone 
after the condensation step. 
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Result and discussion 
1- Synthesis of Pyridopyrimidine derivatives. 
 
The pyridopyrimidine ring system has been one of most studied in the literature due to its wide 
ranging biological activities. In particular, the 4H-pyrido[1,2-a]pyrimidin-4-one ring has been found 
as part of the core of many fused heterocyclic compounds. It is a significant scaffold for the synthesis 
of more complex molecules and is thus an important synthetic intermediate. 
The thermal cyclocondensation of 2-aminopyrimidine 12 with different β-keto esters 13 has been 
one of the most reported pathways for the synthesis of  4H-pyrido[1,2-a]pyrimidin-4-ones.24,18,13  
A drawback of this route is that corrosive acids are involved in the reaction, such as polyphosphoric 
acid, sulfuric acid, p-toluenesulfonic acid (p-TsOH) or phosphoryl chlorides (Scheme 42). 24,13,71,72 
 
Scheme 42: Traditional methodology to assembly 4H-pyrido[1,2-a]pyrimidin-4-ones. 
 
This reaction (Scheme 42) is still an effective means for the synthesis of 4H-pyrido[1,2-a]pyrimidin-4-
one derivatives. This is the reason why in our study, we wanted to improve on the traditional 
methodology, to assemble 4H-pyrido[1,2-a]pyrimidin-4-ones 14 from commercially available 2-
aminopyridine 12 and -keto esters 13 under thermal conditions. We wanted to design a more 
environmentally friendly pathway, replacing the corrosive acids with milder reagents. 
Recently, Roslan et al.13 and our research group envisioned the same general idea for the 
improvement of the traditional methodology, to replace the corrosive reagents for mild, available 
and cheap Lewis acids. They decided to study bismuth salts as catalysts. They replaced the corrosive 
Brønsted acid for Bi(OTf)3 or BiCl3. The results of their optimized study are shown in the following 
table: 
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Table 15: Optimization parametres for Bi(III)-catalized synthesis of 4H-pyrido[1,2-a]pyrimidin-4-
one derivatives. 
 
Entry Solvent Catalyst Temp (°C) Time (h) Yield (%)a 
1 Dioxane Bi(OTf)3 100 8 37 
2 MeNO2 Bi(OTf)3 100 8 38 
3 H2O Bi(OTf)3 100 8 41 
4 Toluene Bi(OTf)3 100 8 88 
5 - Bi(OTf)3 100 8 100 
6 - - 100 8 Traces 
7 - Bi(OAc)3 100 8 21 
8 - BiCl3 100 8 100 
9 - InCl3 100 5 Traces 
10 - ZnCl2 100 5 0 
11 - BiCl3 100 5 99 
12 - BiCl3 100 3 97 
13 - BiCl3 100 1 85 
14 - BiCl3 80 3 75 
15 - BiCl3 50 3 52 
aYield determinated by GC analysis. 
 
They investigated different solvents (entries 1-4), obtaining the best yield in entry 4, however the 
highest yield was obtained when the reaction was performed under solvent free conditions (entry 
5); here the product was synthetized in 100% yield.  They tried to perform the reaction without 
catalyst (entry 6), however the reaction did not work efficiently and only traces of product were 
formed. Other Lewis acids, such as InCl3 and ZnCl2 were also used. However, the reaction catalyzed 
by InCl3 (entry 9) only yielded traces of product, and for the reaction catalyzed by ZnCl2, cyclization 
was not achieved (entry 10). 
In addition, other bismuth(III) salts were also tried (entries 7 and 8) and BiCl3 was found to be as 
effective as Bi(OTf)3. Hence, BiCl3 was chosen as the catalyst for the following synthesis of 4H-
pyrido[1,2-a]pyrimidin-4-one derivatives, because BiCl3 is cheaper than Bi(OTf)3.  
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BiCl3 is a mild, moisture and air-stable Lewis acid. Although bismuth is a heavy metal, this element is 
not toxic or carcinogenic.  
They also wanted to optimize other parameters, and shorter reaction times and lower temperatures 
were studied. They were able to decrease the reactions times from 8 h to 3 h, obtaining the same 
good yields.  On the other hand, when they tried to decrease the temperature from 100 °C to 80 °C 
in entry 14 and to 50 °C in entry 15, the yield dropped from 97% to 75% and 52% respectively. As a 
result of the temperature screening, the optimum temperature was found to be 100 °C.   
After the screening of different times and temperatures, for the synthesis of 4H-pyrido[1,2-
a]pyrimidin-4-one derivatives 14a-i the optimized conditions were 2-aminopyrimidine 12 (0.5 
mmol), -oxo ester (1 mmol) and BiCl3 (0.025 mmol) neat at 100 °C for 3 h. The following 
compounds were synthesized (Scheme 43). 
 
 
Scheme 43: Synthesis of 4H-pyrido[1,2-a]pyrimidin-4-ones using BiCl3 as catalyst. 
 
The work described in Roslan and co-workers’ paper was conducted simultaneously with our project 
which is described in the following pages. We had a similar idea to Roslan et al. In our study we 
wanted to find simple, convenient and mild conditions for the synthesis of 4H-pyrido[1,2-
a]pyrimidin-4-ones. As Roslan and co-workers reported in their paper, we also wanted to replace the 
corrosive acid for a mild Lewis acid, or to obtain the product using only the two starting material 
under thermal conditions, avoiding the use of any extra reagent. 
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In the literature the isomer most reported is the 4-oxo isomer 14 (Scheme 42). The fact that the 
reaction of 2-aminopyridine and a -keto ester could deliver two possible isomers 14 and 205 
depends on the site of the first nucleophilic attack and this also needs to be taken into account 
(Scheme 44). 
 
Scheme 44: Two possible isomers from the condensation reaction of 2-aminopyridine and -keto 
esters. 
 
Therefore, we looked into the literature for the synthesis of the two isomers and found many papers 
which report the synthesis of 4-oxo-isomer; however there are few papers reporting the synthesis of 
the 2-oxo isomer.  
The two possible mechanisms for the formation of 2-oxo 205 and 4-oxo 14 isomer starting from 2-
aminopyridine and -ester are shown in the following schemes: 
 
 
Scheme 45: Proposed mechanism for formation of 2-alkyl-4H-pyrido[1,2-a]pyrimidin-4-ones. 
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Scheme 46: Proposed mechanism for formation of 4-alkyl-2H-pyrido[1,2-a]pyrimidin-2-ones. 
 
Suris and co-workers were aware of the same problem: the possibility of the synthesis of two 
different isomers and they carried out a study entitled “An unequivocal synthesis of 4-methyl-2-oxo- 
(2H)-pyrido[1,2-a]pyrimidine 205a”, which reported the following reaction (Scheme 47).71  
 
Scheme 47: An unequivocal synthesis of 4-methyl-2-oxo- (2H)-pyrido[1,2-a]pyrimidine. 71,73 
 
Suri et al. published three papers for the synthesis of the 2- and 4-oxo isomer. The first one reported 
the first step of the total synthesis of 4-methyl-2-oxo-(2H)-pyrido[1,2-a]pyrimidine 205a, the 
acetoacetylation of 2-aminopyridine 12  with ethyl acetoacetate 13b under microwave irradiation to 
afford compound 211a (Scheme 47).73 
The second paper reported the unequivocal synthesis of 4-methyl-2-oxo-(2H)-pyrido[1,2-
a]pyrimidine 205a. Describing the cyclisation of compound 211a under thermal conditions using PPA 
as the catalyst.71 
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They claimed to be the first research group to report the synthesis of 4-methyl-2-oxo-(2H)-
pyrido[1,2a]pyrimidines by the reaction between -oxoesters and 2-aminopyridines.  
They explained that they had problems in the synthesis of these two isomers, because both isomers 
have very similar 1H and 13C NMR data. A number of research groups had claimed the synthesis of 
the 2-oxo-isomer and later on these products were determined to be the 4-oxo-isomer. One of the 
cases discussed in Suris’ paper is the work of Antaki74 who in 1958 reported the synthesis of 2-oxo-
(2H)-pyrido[1,2-a]-pyrimidines by the reaction of 2-amino-4-methyl pyridines with ethyl 
ethoxymethylenecyanoacetate. However, the products were later determined to be the 4-oxo-
isomer.  
The third paper reported by Suri et al. was called “Unequivocal total assignment of 13C and 1H NMR 
spectra of some pyrido[1,2-a]pyrimidine derivatives”, and in the paper the similarity of the NMR 
data of both isomers 14 and 205 was discussed.75  
In this paper they reported a comparison of the 1H and 13C NMR data for the following two isomers 
(Table 16). The synthesis of the 2-oxo isomer has been described (Scheme 47), and for the synthesis 
of the 4-oxo isomer, the data used that reported by Suri and co-workers in previous work in 1993. 
Table 16: Comparison of 1H NMR data for 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one and 2-methyl-
4H-pyrido[1,2-a]pyrimidin-4-one by Suri et al.75 
Compound Data Compound  Data 
 
205a 
2.47 (s, 3H, C4-CH3) 
 
14a 
2.47 (s, 3H, C2-CH3) 
6.35 (s, 1H, H-3) 6.35 (s, 1H, H-3) 
7.13 (dt, 1H, J = 7.12, 1.28 Hz,  
H-7) 
7.13 (dd, 1H, J = 7.12, 7.12 Hz,  
H-7) 
7.60 (bd, 1H, J = 7.12 Hz, H-9) 7.59 (d, 1H, J = 7.12 Hz, H-9) 
7.74 (m, 1H, H-8) 7.74 (m, 1H, H-8) 
9.03 (bd, 1H, J = 7.12 Hz, H-6) 9.04 (d, 1H, J = 7.12 Hz, H-6) 
 
To try to help to clarify the issue we carried out a similar study to Suri and co-workers. We 
synthesized the same two isomers, in order to understand the reaction better, and to obtain 
spectroscopic and X-ray diffraction data.   
Firstly, we synthesized the 4-oxo-isomer (2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one 14a), following 
the procedure  reported by Shifeng et al. in 2008.76 
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Scheme 48: Synthesis of 2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one 14a.76 
 
The reaction was carried out in acetic acid as catalyst and solvent, affording 2-methyl-4-oxo-(4H)-
pyrido[1,2-a]pyrimidine 14a. The compound was fully characterised by 1H and 13C NMR 
spectroscopy, and the structure (as a mono-acetic acid solvate) was confirmed by X-ray 
crystallography unambiguously to be the 4-oxo isomer. This confirmed that this approach led to the 
2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one isomer 14a. 
 
Figure 25: X-ray crystallography structure of 2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one. 
 
Secondly, we followed Suri’s synthesis pathway, pre-forming the amide link. However for the 
synthesis of compound 205 (Scheme 47) we modified the procedure, and instead of carrying out the 
reaction with microwave assistance, we performed the reaction under conventional heating. 
The N-acetoacetylation of 2-aminopyridine 12 by ethyl acetoacetate 13b under thermal conditions 
was carried out using the conditions described in (Table 17).  
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Table 17 : N- acetoacetylation of 2-aminopyridine from ethyl acetoacetate. 
 
Entry 2-aminopyridine 
(mmol) 
Ethylacetoacetate 
(mmol) 
T ° C Solvent  (ml) Time  
 (h) 
Product 
(Yield %) 
1 2.5 2.5 Reflux Xylene  (20ml) 24 - 
2 5 5 91 Xylene  (3ml) 24 - 
3 2.5 2.5 170 No solvent 2 211a (60%) 
4 3 9 110 No solvent 5 211a (62%) 
 
The reaction was carried out in xylene due to its high boiling point (entry 1 and entry 2). The first 
reaction was performed using 2.5 mmol in 20 ml of solvent, but unfortunately the reaction gave only 
the starting material back. For this reason, in entry 2, the quantities of reagents were increased to 5 
mmol and the volume of solvent was decreased to 3 mL of xylene to increase the reaction mixture 
concentration, but the reaction was still unsuccessful. The NMR spectrum showed only starting 
material signals. Taking advantage of one of the reagents (ethyl acetoacetate) being a liquid and 
with a boiling point of 181 °C, the next reaction was carried under solvent-free conditions, and was 
heated at 170 °C over 2 h obtaining the desired product 211a in 60% yield (entry 3). The optimal 
conditions achieved are given in entry 4: reagent ratio was 1:3 equivalents (2-aminopyrimidine: ethyl 
acetoacetate), heated at 110 °C over 5 h to afford the product 211a in 62% yield. 
Having the N-acetoacetylated pyridine in hand, the following step was to effect the cyclisation of 
211a to afford the 4-oxo-isomer, compound 205a. We followed the procedure reported by Suri et 
al.: Cyclisation of N-(1,3-dioxobutyl)-2-aminopyrimidine under thermal condition catalysed by 
polyphosphoric acid (PPA).71  Thus we obtained the 4-oxo isomer. 
 
Scheme 49: Synthesis of 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one. 
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Following the reaction pathway reported by Suri only the synthesis of the 2-oxo isomer 205a was 
possible (assuming the amide remains intact during the second step). We thus could confirm Suri’s 
conclusions, and the chemical shift data for both isomers are very similar, as shown in Table 18. 
 
Scheme 50: Synthesis pathways for the synthesis of 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one and 
2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one. 
 
In the following table is the comparison of the 1H NMR data of 4-methyl-2H-pyrido[1,2-a]pyrimidin-
2-one and 2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, that we synthesized. 
 
Table 18: 1H NMR data for 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one and 2-methyl-4H-pyrido[1,2-
a]pyrimidin-4-one. 
Compound Data Compound  Data 
 
205a 
2.51 (s, C4-CH3) 
 
14a 
2.48 (s, 3H, C2-CH3) 
6.37 (s, 1H, H-3) 6.36 (s, 1H, H-3) 
7.12 - 7.19 (t, J= 6.8 Hz, 1H, H-7) 
7.12 (td, J=6.8, 1.2 Hz, 1H-7) 
 
7.68 (d, J=8.8 Hz, 1H, H-9) 7.60 (bd, J=8.8 Hz, H-9) 
7.77 (ddd, J=8.8, 6.8, 1.5 Hz, 1H, 
H-8) 
7.73 (ddd, J=8.8, 6.8, 1.6 Hz, 1H-
8). 
9.07 (d, J=6.8 Hz, 1H H-6) 9.04 (d, J=6.8 Hz, H-6 
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As can be seen in Table 18 the 1H NMR data are very similar, as are that actual spectra (Figure 26). 
There is only important difference, the doublet at 7.60 in the first spectrum is sharper than the one 
for compound where 205a the doublet is broad. Also the J values are lightly different between both 
spectra; however nothing in the spectra clarified which one is which. 
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Figure 26: Comparision of 2 and 4-oxo isomer spectra. 
 
Taking this information into account, we wanted to introduce a new procedure for the synthesis of 
these two isomers using Lewis acids. We needed to further study the 1H NMR data because we 
wanted to be sure that we reported the correct product (isomer). The study showed that the 
synthesis of the two isomers is possible depending on the pathway that we decided to follow. 
Having the N-acetoacetylated amine 211a in hand, firstly we looked for mild conditions for the 
cyclisation step to afford the pyridopyrymidine 205a. We decide to study the reaction catalyzed by a 
Lewis acid (ZnCl2). 
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 N-acetoacetylated product and ZnCl2 were dissolved in THF and stirred under reflux, Scheme 51. 
The reaction was not successful and only starting material was recovered. It is possible that THF 
competed for the zinc catalyst preventing activation of the carbonyl group by the Lewis acid.   
 
Scheme 51 : Attempted synthesis of 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one. 
 
In the next reaction we started with 2-aminopyridine 12 and ethyl acetoacetate 13b, and the 
reaction mixture was stirred over 5 h, neat and then ZnCl2 was added to the reaction mixture, with 
stirring for a further 30 min. An emulsion was formed after the ZnCl2 was added. The reaction 
mixture was worked-up, adding the same quantities of water and ethyl acetate, and it was left 
overnight to obtain two separate layers, so this procedure was difficult to work with.  
 
Table 19: Synthesis of 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one catalysed by ZnCl2. 
 
Entry Catalyst T ( °C) Time (h) Yield ( % ) a 
1 ZnCl2 (1 eq) 170 6 5  
2 ZnCl2 (1 eq) 170 6 50  
a Reaction conditions: 2-amino pyridine and the ethyl acetoacetate staring over 5.30 h and the ZnCl2 was added to reaction mixture, the 
reaction was stopped after 30 min to afford compound 205a. 
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Isomer 205a was obtained in low yield (entry 1) due to the difficulty in the work-up step, leading to a 
decreased yield for the reaction. The reaction was reproducible and the yield was improved to 50%, 
however, the work-up step was always problematic due to the emulsion that was formed. In order 
to solve this problem, other conditions were tested. We looked for other Lewis acid which might give 
an easier work-up and therefore, a higher yield. Montmorillonite clay was chosen as an ideal Lewis 
acid, due to its properties, inexpensive, strong acidity and non-corrosivity.77 It is used under mild 
reaction conditions and can be recovered from the reaction mixture by simple filtration.  
The synthesis of the 4-oxopyrido[1,2-a]pyrimidine moiety 14 was carried out by direct 
condensation/ cyclization of 2-aminopyridine with substituted β-keto esters catalysed by the clay 
mineral montmorillonite (K-10)77 under solvent-free conditions. It was concluded that the method 
was an effective, clean process and easy to work-up. Also a higher yield was obtained 60% (Scheme 
52).  
 
Scheme 52: Synthesis of 2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one 14a. 
 
The montmorillonite (K-10) was added at the same time than the pyridine 12 and the ester 13b. The 
product yield was calculated from the NMR spectrum of the crude product (Scheme 52). 
In (Figure 27) is summarized the four reactions conducted: reactions 1 and 2 are the method 
following the previous literature procedures. For reaction 1, we obtained confirmation of the 
synthesis of the 4-oxo isomer from its X-ray crystal structure. For reaction 2, we had followed an 
unequivocal synthesis for the 2-oxo isomer. Reaction 3 is the reaction catalysed by montmorillonite, 
which was added at the beginning of the reaction. The final reaction (reaction 4), involved stirring 
the 2-aminopyridine and the -ketoester at 170 °C for 5 h, and then adding the ZnCl2 to the reaction 
mixture.  
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Figure 27: Comparison of the four spectra. 
 
Below is an expansion of Figure 27, where it is possible to see that although there are small 
differences between all spectra (and a minor impurity in entry 3), spectra 1 and 3 are effectively the 
same, and likewise spectra 2 and 4 are the same.  
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Figure 28: Zoom of Figure 27. 
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Following this comparison, between spectra we can conclude that the 1H NMR spectra for the four 
reactions show 1 and 3 are the same, and 2 and 4 are also the same (despite small changes in 
chemical shift which could be due to concentration or temperature). 
This means that the product from reactions 1 and 3 is the 2-methyl-4-oxo isomer 14a as drawn, 
which was confirmed by X-ray diffraction analysis. 
 
Figure 29: 2-methyl-4-oxo isomer (14a) and 4-methyl-2-oxo isomer (205a). 
 
The product of reactions 2 and 4 must therefore be the 4-methyl-2-oxo isomer 205a, which was 
confirmed by the unequivocal synthesis pathway reported by Suri et al. 
We tried to further substantiate these results by nOe experiments with the product of reaction 4, 
believed to be the 2-oxo isomer. The methyl group was therefore irradiated leading to enhancement 
of the singlet at 6.33 (which is H-3) as expected (and this enhancement would be observed in both 
isomers). A weak enhancement of the doublet at 7.6 was also observed, but no enhancement of the 
doublet at 9.0 was seen. This was surprising as enhancement of H-6 was expected, as this proton, 
adjacent to the bridgehead nitrogen, has previously been assigned at  9.0. 
This suggests the doublet at 7.6 could be due H-6, although the weakness of the enhancement is of 
concern. In the 2-methyl-4-oxo isomer, the methyl group appears so far away from H-9, that no nOe 
effect would be expected. 
The nOe study did not help to further substantiate the structure of the product of reaction 4 (which 
we still believe to be the 4-methyl-2-oxo compound). Further nOe studies on both isomers as well as 
C-6 and C-9 substituted analogues would be required to gain a full understanding. 
  
73 
 
 
Figure 30: nOe coupling of 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one (205a). 
 
In conclusion, all the data confirmed that the compound was the 2-oxo isomer. However, the nOe 
experiment conducted was inconclusive. 
 
 
Figure 31: 1H NMR spectrum of 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one (205a). 
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Figure 32: Spectrum of the nOe study of 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one (205a), 
irradiation at 2.46 ppm (CH3). 
 
 
Figure 33: Expansion of Figure 32. 
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We wanted to expand the chemistry, so the optimal reaction conditions (110 -120 °C, solvent free 
and montmorillonite as the Lewis acid) were used with the following -keto esters, obtaining clean 
reactions, easy work-up and good NMR spectra in most cases (Table 20).  
Table 20: Synthesis of 4H-pyrido[1,2-a]pyrimidin-4-one derivatives. 
 
Entry β-ketoester Temperature (°C) Time (h) Product Yield (%) 
1 
 
 
120 7 
 
80 
2 
 
100 7 
 
60 
3 
 
120 5 
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In these reactions (Table 20), the Lewis acid (montmorillonite) was added at the same time as the 2-
aminopyridine and the -ester and the reaction was stirred at 100-120 °C to afford the 4-oxo 
isomers. The cyclic product was formed, because the NMR spectra showed an aromatic proton at 9 
ppm.  
The problem of this method so far was the NMR chemical shifts for the 2-oxo- and 4-oxo- isomers 
were found to be very similar as indicated by Suri 1 and co-workers, and that care was required in 
assigning the structures of these types of compound. 
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2- Synthesis of pyrimidopyrimidine derivatives. 
 
After finding that the synthesis of pyridopyrimidines could be achieved under mild thermal 
conditions, using a protic acid catalyst or Lewis acid, we wanted to then synthesize 
pyrimidopyrimidine derivatives 40 from commercially available 2-aminopyrimidine 39 with different 
β-keto esters 13.  
 
Scheme 53: Optimal conditions for the synthesis of pyridopyrimidines from 2-aminopyridine with 
different β-keto esters. 
 
The same conditions that were studied for the synthesis pyridopyrimidine derivatives in the previous 
section (synthesis of pyridopyrimidine derivatives) were used for the synthesis of 
pyrimidopyrimidines 40a and 40b from the readily available starting material, 2-aminopyrimidine 39 
and two different β-keto esters 13b and 13d (Scheme 54). 
 
Scheme 54: Proposed pathway for the synthesis of pyrimidopyrimidines from 2-aminopyrimidine 
and two different β-keto esters. 
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The study started with the synthesis of pyrimidopyrimidine from 2-aminopyrimidine 39 and ethyl 
acetoacetate 13b, the reaction was catalysed by montmorillonite (Table 21, entry 1). Also, small 
amount of DCM was added to the reaction mixture in order to obtain a homogeneous mixture 
before heating the reaction at 100 °C. Once the reaction mixture reached this temperature, the DCM 
was boiled off, so the reaction was performed solvent free. ii) The reaction was cooled down and 
was stirred at room temperature overnight. The crude product showed signals of the mono addition 
compound 216a instead the expected heterocyclic compound. 
Table 21: Attempted synthesis of 2-methyl-4H-pyrimido[1,2-a]pyrimidin-4-one. 
 
Entry 2-amino 
pyrimidine 
β-ketoester 
13b 
Catalyst 
(mg / eq. ) 
Solvent T °C Time Product 
1 1 1 Montmorillonitea 
 
DCM* 100 7.30h (39:216a) 
(0.39:0.61) r.t 12h 
2 1 1 Neat - 175 3h decomposed 
3 1 1  AcOH Reflux 24 216a (9%) 
4 1 2 Montmorillonitea  - 110 24 216a (20%) 
aMonmorillonite (600 mg) / 2-aminopyrimidine (5 mmol). 
 
In entry 2, Table 21 the reaction was performed as a neat reaction, but the reaction generated a   
complex mixture, not product was isolated. In entry 3, the reaction was performed in acetic acid as 
solvent and catalyst; the compound 216a was synthesized. Also, when the reaction was carried out 
with two equivalents of ethyl acetoacetate (using the ethyl acetoacetate as a solvent) and 
montmorillonite as catalyst, the reaction resulted in formation of enamine 216a in 20% yield (entry 
4, Table 21).  
The conclusion of this screening was that the reactivity of 2-aminopyrimidine is lower than the 2-
aminopyridine, delivering the mono-addition product 216a, and before the second nucleophilic 
attack at the carbonyl group a dehydration occurred, delivering the (Z)-enamine product 216a, 
(Scheme 55). 
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Scheme 55: Proposed mechanisme for the enamine 216a formation. 
 
A similar screening was performed for 2-aminopyrimidine and methyl propionylacetate, and 
surprisingly, the reactivity of methyl propionyl acetate was different from the ethyl acetoacetate, as 
shown in Table 22.  
 
Table 22: Attempt to synthesise 2-ethyl-4H-pyrimido[1,2-a]pyrimidin-4-one 216b. 
 
Entry 2-amino 
Pyrimidine 
(eq) 
β-ketoester 
(13c) 
 (eq) 
Catalyst 
(mg / eq ) 
Solvent T °C Time 
(h) 
Product 
(Yield) 
1 1 1 Montmorillonitea DCMb 120 24 - 
2 1 3 Montmorillonitea - 110 24 - 
3 1 3 - AcOH Reflux 24 - 
4 1 3 Montmorillonitea Xylene 110 5 216b (10%) 
aMonmorillonite (600 mg) / 2-aminopyrimidine (5 mmol). 
bDCM was added in order to mix all the reagent, as soon as the reaction was heat it up, the DCM was boiled off. 
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In entry 1, (Table 22) the reaction was performed using montmorillonite as catalyst. Again a small 
quantity of DCM was used in order to ensure a homogeneous mixture formed before the reaction 
was heated at 120°C for 24 h. Even though the reaction was heated for 24 h, the reaction gave back 
starting material. In entry 2, the amount of ester was increased to 3 eq. hoping that the reaction 
would form product. However, the reaction was again unsuccessful. 
After the experiments using 2-aminopyrimidine 39 and the -ketoesters: ethyl acetoacetate 13b 
(entry 2, Table 21) and methyl propionylacetate 13c (entries 1 and 2, Table 22) under solvent free 
conditions, we arrived at the following conclusion. The 2-aminopyrimidine was subliming during the 
reaction, and the β-ketoester was likely to be reacting with itself to afford polymeric or complex 
products, leading to the NMR spectrum showing only 2-aminopyrimidine signals. 
In entry 3, the reaction was performed in acetic acid as the solvent and catalyst. However, the 
reaction was not successful and the NMR spectrum showed only starting material.  
The reaction did not work under acidic conditions, so we tried again with montmorillonite, but we 
needed to solve the problem of the ester reacting with itself, therefore xylene was chosen as a 
solvent, due to its high boiling point. In entry 4, the reaction was performed in xylene at 110 °C using 
montmorillonite as a catalyst, over 5 h. These conditions delivered the enamine 216b in 66% yield.  
After isolation of compound 216a, the following reactions were conducted to cyclise the enamine 
216a to form compound 40a, using the conditions shown in Scheme 56.  The yield of the reaction 
was very low, and the 1H NMR spectrum signals were very weak. However, the product was 
confirmed by GS-MS and the 1H NMR spectrum showed new aromatic signals at 9.32 ppm, 9.08ppm 
and 7.17 ppm. The symmetry of the pyrimidine ring was lost, giving three different signals for the 
aromatic protons, also the lack of the ester signals confirmed the cyclisation of the enamine.   
 
Scheme 56 : Synthesis of 2-methyl-4H-pyrimido[1,2-a]pyrimidin-4-one under thermal conditions.  
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The reactivity found for 2-aminopyridine was much better than for 2-aminopyrimidine, possibly due 
to the second nitrogen in the aromatic ring removing electron density from the amino substituent, 
lowering its nucleophilicity.  
 
Scheme 57:  Proposed mechanism for the synthesis of 2-methyl-4H-pyrimido[1,2-a]pyrimidin-4-
one. 
 
The mechanism of nucleophilic attack in the N-acylation step involved attack at C-3, and the product 
290a was afforded after dehydration of the presumed aminal intermediate. However, the double 
bond of enamine caused a serious problem in the cyclisation step, because there was limited free 
rotation in the molecule and the probability to cyclise was low.  
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3- Study of 2-pyridones and 4-pyridone derivatives. 
 
Six-membered ring scaffolds containing nitrogen are known to be prominent in medicinal chemistry 
(e.g. pyridines, pyridones, quinolizinones).11 Here we focus on 2- and 4-pyridones, as they have been 
found in different antibacterial agents such as pilicidines, and curlide (ciprofloxacin).11,54  
Herein I report the synthesis of 2-pyridones and 4-pyridone derivatives, from commercially available 
starting materials, and their subsequent metallation reactions. In the synthesis of N-alkylated 6-
methyl 2-pyridones we used 2-methoxy-6-methylpyridine 221 and a number of different alkylating 
reagents (Scheme 58). We employed a 6-methyl substituted pyridine so that we could investigate 
deprotonation of the methyl group for subsequent ring-forming reactions. For the synthesis of N-
alkylated 2-methyl 4-pyridones, 4-chloro-2-methyl pyridine 223 was used as starting material, and 
the desired pyridone was achieved after 3 steps (Scheme 59). 
 
Scheme 58: Synthesis of N-alkylated-6-methyl 2-pyridones. 
 
 
Scheme 59: Synthesis route to N-alkyl 2-pyridone and N-alkyl 4-pyridone. 
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The ring functionalization of 2- and 4-pyridone and analoguous pyridines such as 2-picoline, have 
been studied intensively in the past years. Furthermore, the metallation at the methyl position of 2-
picoline has been studied as an efficient means for the preparation of complex molecules, and 
therefore, has been study intensively. There are studies in this field dating back to 1974. 
Our group has been interested in the regioselective methyl lithiation and subsequent electrophilic 
quenching of N-alkyl-6-methyl-2-pyridone and N-alkyl-2-methyl 4-pyridone. There are only a few 
papers which report the metallation and functionalization of N-alkyl-6-methyl-2-pyridone and N-
alkyl-6-methyl-2-pyridone, at the methyl position. To the best of our knowledge, there is only one 
paper which describes the metallation of 1,6-dimethyl 2-pyridone, which was reported by Sammes 
and co-workers.78  
The metallation at the methyl position of 2- and 4- pyridone has not been reported in detail, and it 
requires a thorough investigation. This scaffold represents an interesting synthetic intermediate for 
the synthesis of larger and more complex molecules, and for this reason we present the selective 
mono-metallation at the 6-methyl position of 1-substituted-6-methyl-2-pyridone and 1-substituted-
2-methyl-4-pyridone with n-BuLi/KHMDS at -78 °C at 6-methyl position and the reactivity of such 
synthetic intermediates towards a wide range of electrophiles (diketones, aldehydes, alkylating 
reagents), (Scheme 60 and Scheme 61). 
 
Scheme 60: Synthesis of 1-substituted-6-methyl-2-pyridones 231a-n and 239a-f by regioselective 
metallation at methyl position. 
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Scheme 61: Synthesis of 1-substituted-2-methyl-4-pyridone (244a-d, and 245a,b). 
 
As shown in Scheme 60 and Scheme 61, firstly the synthesis of 2- and 4-pyridone precursors was 
required. The second part of the study was the metallation at the methyl position of 2-pyridone and 
4-pyridone. 
During the following pages the synthesis of 1-substituted-6-methyl-2-pyridone and 1-substituted-2-
methyl-4-pyridone and the subsequent metallation at the 6-methyl position and at the 2-methyl 
position, respectively, will be discussed in detail. 
 
3.1- Study of 2-pyridone derivatives. 
3.1.1- Synthesis of N-alkylated 2-pyridones. 
 
Our synthesis pathway was based on Bowman’s work.44 We decided to study the synthesis of N-
alkylated 2-pyridones from 2-methoxy-6-methylpyridine and a number of different alkylating 
reagents. Using 2-methoxy-6-methylpyridine 221 as the starting material, we needed to take into 
account the fact that the starting material has an extra methyl group at position 6, therefore the 
reactivity of the nitrogen atom could be different since this position could be less accessible and 
because of this, less reactive.  
 
Figure 34: 2-Methoxy-6-methylpyridine. 
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The 2-methoxy-6-methylpyridine 221 bears a methoxy group on position 2, which during the 
reaction conditions underwent dealkylation to the pyridone derivative, losing a methyl group in the 
process and forming one molecule of methyl bromide which evaporated during the reaction due to 
its low boiling point (Scheme 62). Bearing all this information in mind, we started screening different 
solvents, temperatures and reaction times. 
 
Scheme 62:  Proposed mechanism of the synthesis of N-substituted-6methyl-2-pyridones. 
 
As a first example, ethyl bromoacetate was chosen as good alkylating reagent, to afford ethyl 2-(6-
methyl-2-oxopyridin-1(2H)-yl)acetate 228a.  
Table 23: Screening for the synthesis of ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate. 
 
Entry 
2-methoxy-6-
methylpyridine 
Ethyl-2-
bromoacetate 
Reagent Solvent Temp Time 
Product 
(%) 
1 1 2.5 - EtOAc Reflux 48 h -* 
2 1 2.5 
AgNO3 
(1.5 eq) 
Butanone Reflux 24 h 30% 
3 1 3 
NaI 
(3 eq) 
Butanone Reflux 24 h 40% 
4 1 3 - Neat 150 °C 48 h 30% 
5 1 1 - Neat 120 °C 48 h 40% 
6 1 1 - Neat 
100-110 
°C 
48 h 70% 
7 1 1 - Neat 100 °C 72 h 77% 
*Analysis of the crude product. 
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In entry 1, the reaction was performed in ethyl acetate; and gave only recovered starting material. In 
the following reactions (entries 2 and 3) reagents to speed up the reaction were added, AgNO3 and 
NaI respectively. AgNO3 was used to make the alkyl halide more electrophilic (entry 2), and the 
desired pyridone was afforded in 30% yield. In entry 3, NaI was used to activate the halide, by 
conversion of the bromide into the iodide in situ and the reaction worked in 40% yield (Table 23). 
Using 2-methoxy-6-methylpyridine as the starting material in the synthesis of N-substituted 2-
pyridones, the ambident character problem of 2-pyridone anion was avoided. In trying to remove 
the need for an extra reagent, in entry 4, the reaction was performed solvent free, and only 2-
methoxy-6-methylpyridine and ethyl-2-bromoacetate (3 eq.) were used. These conditions were 
possible due to both reagents being liquids and having high boiling points. The same yield as in entry 
2 was obtained, the reaction working in 30% yield, however some by-product was formed. In entry 
5, we decreased the temperature from 150 to 120 °C, in order to avoid the by-product formation, 
and also the quantity of ethyl-2-bromoacetate, resulting in a yield of 40%. Decreasing the 
temperature further, and increasing the reactions times, improved yields again entries 6 and 7; the 
product was obtained in 70 and 77% yields respectively.  
The advantage of the conditions in entry 6 and 7 was that the reaction was performed solvent free, 
and no extra reagent was needed, so the reaction conditions are more environmental friendly than 
those in entries 2 and 3, where butanone was used as a solvent and an extra reagent was needed to 
speed up the reaction. 
Having the optimized conditions in hand, the reaction was scaled up to 10 mmol, and the ethyl 2-(6-
methyl-2-oxopyridin-1(2H)-yl)acetate 228a was isolated in 70% yield, and also 1,6-dimethyl 2-
pyridine  228b was formed as a by-product in 14 % yield (Scheme 63).  
 
Scheme 63: Scale up the synthesis of ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate at 10 mmol 
scale. 
Continuing on the synthesis of other pyridones, benzyl bromide was chosen as the next alkylating 
reagent, and the reaction was performed on a 4 mmol scale. Pyridone 228c was obtained in 
excellent yield 98% (Scheme 64). 
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Scheme 64 : Synthesis of pyridone 228c. 
 
Performing the reaction on a large scale (24 mmol), 1,6-dimethyl 2-pyridone 228b was also isolated 
as a by-product in 20%  yield (Scheme 65).  
 
Scheme 65: Synthesis of pyridone 228b and 228c at 24 mmol scale. 
 
The formation of 1,6-dimethyl 2-pyridone 228b as a by-product was a constant problem. It was an 
unexpected result initially. Nevertheless, an explanation was given in Ruda and co-workers’ work.45 
The aim of their work was to study the way to avoid the formation of these by-products.   
In contrast of Ruda’s work, we were very interested in 1,6-dimethyl pyridone 228b, because we 
could use this potentially versatile scaffold for further applications. We wanted to find a good 
procedure for the synthesis of 1,6-dimethyl-2-pyridone 228b. 
In the following scheme a proposed mechanism of the formation of 1,6-dimethylpyridine is given. 
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Scheme 66: A proposed mechanism of the synthesis of 1,6-dimethylpyridin-2(1H)-one. 
 
In the synthesis of N-alkylated pyridones, an alkoxypyridine (2-methoxy-6-methylpyridine) 221 is the 
starting material. The nitrogen of the alkoxypyridine 221 attacks the halide and produces a 
pyridinium salt 230a. Then the bromide anion subsequently displaces the methyl group to afford the 
N-alkyl pyridone 228a or 228c, depending on the alkylating reagent 222a or 222c, and generating 
one molecule of methyl bromide 222b. The methyl bromide formed in situ, it is a potential alkylating 
reagent and can also N-alkylate the remaining unreacted alkoxypyridine 221 leading to a mixture of 
ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228a and 1,6-dimethyl pyridone 228b or benzyl 
pyridine 228c and 1,6-dimethyl pyridone 228b correspondingly (Scheme 66). 
Also, it could be possible that the nitrogen of the alkoxypyridine 221 displaces the methyl group to 
afford the N-alkyl pyridone 228a, 228b or 228c, and generated another pyridinium salt 230b 
(Scheme 67). 
 
Scheme 67: Proposed mechanism of the synthesis of 1,6-dimethylpyridin-2(1H)-one, being the 
alkoxypyridine (221) which displace the methyl group. 
88 
 
To continue the study of the synthesis of 1,6-dimethyl 2-pyridone we tried to synthesize the 1,6-
dimethyll pyridone via three different methods: 
Following the work of Tasker, who developed an efficient and inexpensive LiI-promoted O-to N-alkyl 
migration of 2-benzyloxy-, 2-allyloxy-, and 2-propargyloxypyridines,79 we used similar conditions.  
We tried to promote O- to N-methyl migration of 2-methoxy-6-methylpyridines using lithium 
bromide to cleave the C-O bond of the alkoxypyridine follow by methyl migration (Table 24).79 In 
these reaction conditions (entries 1 and 2) acetonitrile was used as a solvent in order to dissolve de 
LiBr and to obtain a homogeneous mixture. In entry 1, the reaction mixture was heating under reflux 
but reaction was not successful, for this reason in entry 2 the reaction was heating in the microwave 
at 150 °C. However, the methyl migration did not occur. In conclusion, we thought that it could be 
necessary to alkylate the pyridine before the bromide ion was able to cleave the C-O bond n (Table 
24). 
Table 24: Synthesis of 1,6-dimethylpyridine-one via LiI-promoted O-to N-alkyl migration. 
 
 
Entry Pyridine LiBr (mmol) Heating Temp Time 221:228b 
1 1eq 1eq Conventional 
heating 
Reflux 20 hours. 1:0 
2 1eq 1eq MW 150 °C 33 min 1:0 
 
We tried to alkylate the pyridone using methyl iodide in a catalytic amount, supposing the pyridine 
could be alkylated and afterwards the iodide anion might cleave the C-O bond. Therefore, the 
reaction could be initiated, and may have delivered the 1,6-dimethyl pyridone. We designed the 
following two reaction conditions: 
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Table 25: Synthesis of 1,6-dimethylpyridine-one via methyl alkylation. 
 
Entry MeI Solvent Temp Time 221:228b 
1 10% neat 100   °C 24h 1:0 
2 10% neat 30   °C 24h 1:0 
 
The first reaction was performed at 100 °C, solvent free, 24 hours, however the reaction did not 
work and all the starting material was recovered. One explanation could be the low boiling point of 
methyl iodide (42-43 °C). The MeI 229 could boil off at this temperature before the lone pair on the 
pyridine nitrogen was able to attack the MeI 229. As a result of this, the second reaction was 
performed at 30 °C, however this reaction also did not work. The information obtained in the last 
reaction demonstrated that the reaction could not be effected with a catalytic amount of alkyl halide 
at ambient temperature. The alkylation of 2-methoxy-6-methylpyridine with methyl iodide had to be 
conducted at 100 °C.  
As shown in the following Scheme 68, the inconvenience of the low boiling point of the MeBr was 
overcome by using benzyl bromide. 
 
Scheme 68: Synthesis of 1,6-dimethyl-2-pyridone in 83% yield. 
 
1,6-Dimethylpyridin-2(1H)-one 228b proved to be more difficult to synthesize than 1-benzyl-6-
methylpyridin-2(1H)-one 228c via the N-alkylation reaction under standard conditions (2-methoxy-6-
methylpyridine (1 eq.), alkylating reagent (1 eq.), 100-110 °C, 48 h). However, we were able to 
synthesize 1,6-dimethylpyridin-2(1H)-one 228b in a good yield.  On increasing the quantity of (2-
methoxy-6-methylpyridine to 2 eq., and using only 1 eq. of benzyl bromide, at 100-110 °C, over 48 h) 
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1,6-dimethylpyridin-2(1H)-one 228b and 1-benzyl-6-methylpyridin-2(1H)-one 228c were obtained  in 
a (1:1) mixture and in excellent yields 83 % and 83 % respectively, which could be separated fairly 
easily by flash chromatography. 
After these excellent results, we continued with the synthesis of a range of pyridones. The following 
reaction was carried out under the different conditions (Table 26): 
Table 26: Synthesis of 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetonitrile. 
 
Entry temperature time Product (%) 
1 100-110 °C 48 h 48 % 
2 100-110 °C (2 h) and at rt (48 h) 50 h 80 % 
 
The synthesis of pyridone 228d was performed under standard conditions (neat reaction, 100-110 
°C, 48 h) in entry 1. However in entry 2, after 2 h the reaction mixture became black. Although the 
reactions normally darkened to a brown colour, this indicated decomposition, so we decided to stop 
the heating and the reaction mixture was stirred for 48 h at room temperature. The yield increased 
to 80%.  
For the synthesis of 6-methyl-1-(4-nitrobenzyl)pyridin-2(1H)-one 228e; 4-nitrobenzyl bromide was 
used as the alkylating agent. The reaction was performed in toluene as a solvent because 4-
nitrobenzyl bromide is a solid reagent, and so the neat conditions could not be used. The reaction 
gave the product in a very low yield, only 18%. 
For the remaining pyridones, the standard conditions were 2-methoxy-6-methylpyridine (1 eq.), 
alkylating reagent (1 eq.), 100-110 °C, 48 h. The two following pyridones were obtained: tert-butyl 2-
(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228f in 63% yield, and 1-(4-fluorobenzyl)-6-methylpyridin-
2(1H)-one 228g in 75% yield. 
To conclude, under our standard conditions the alkylating reagent did not need to be activated with 
NaI. Non-activated halides could be used, and the reaction could be performed in a solvent free 
environment, with only one exception, when 4-nitrobenzyl bromide was used as an alkylating agent. 
Here the reaction was performed in toluene as a solvent. 
In the following scheme there is a summary of the pyridones synthesized using our new conditions. 
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Scheme 69: Library of N-alkylated-2-pyridones. 
 
The synthesis of 2-pyridones derivatives (Scheme 69) via direct alkylation of 2-methoxy-6-
methylpyridine 221 represents a new alternative for the synthesis of 2-pyridone derivatives. The 
reaction could be performed in the absence of solvent and no catalyst was needed, and the reaction 
could be effected in good to excellent yields. Furthermore, using 2-methoxy-6-methylpyridine 221 as 
the starting material, the competition between N and O-alkylation was avoided. As a drawback of 
this pathway, MeBr 222b was formed as by-product, one part of MeBr boiled off during the reaction 
time and did not react with the unreacted pyridine. However, some molecules of MeBr could react 
with the unreacted pyridine and when the reaction was scale up to 10 mmol, the 1,6-dimethyl-2-
pyridone 228b appeared as a by-product. On other hand, this by-product could be separated easily 
by flash chromatography in all the reaction mixtures. 
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3.1.2- Study of metallation of N-benzyl-6-methyl-2-pyridones. 
 
With the 2-pyridone derivatives 228a-g in hand, our study of the synthesis of new N-alkyl-6-
(monosubstituted-methyl)-2-pyridinones focused initially on pyridone 228b and 228c as starting 
materials. 
Our study started with the investigation of the selective methyl lithiation (position 7) of 1-benzyl-6-
methyl-2-pyridone 228c (Figure 35). 
 
Figure 35: 1-benzyl-6-methyl-2-pyridone structure. 
 
A study of reactivity was undertaken and 1-benzyl-6-methyl-2-pyridone 228c was treated with n-
butyllithium (n-BuLi) in tetrahydrofuran (THF) at -78 °C , the reaction mixture being warmed up to 
0°C, and cooled down to -78°C again. This process resulted in an intense blue solution shown to 
contain the 6-methyl-lithiated species by quenching with D2O at -78 °C. This led to recovery of only 
the mono-deuterated pyridone 231a (>98%) at C-7 position. The location of the label was easily 
established by 1H NMR and 13C NMR spectroscopic analysis. 
 
Scheme 70 :  Deuterium study. 
 
The methyl lithiated 1-benzyl-6-methylpyridin-2(1H)-one 228c was then reacted with a variety of 
electrophiles, starting with diketones under the following standard conditions: 
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Scheme 71: Using diketone as electrophiles. 
 
Scheme 71 shows the optimized conditions for several diketones, which are highly reactive 
electrophiles. Only, pyridone 231c was obtained in a poor yield (19 %), because the electrophile 4,4-
dibromobenzil 232b was insoluble in THF. 
The product of methyl lithiation of 1-benzyl-6-methylpyridin-2(1H)-one 228c, was also reacted with a 
range of mono-carbonyl electrophiles. The reactions worked in good yields with again, alkylation 
occurring on the methyl substituent, obtaining compound 231e and 231f (Scheme 72).  
 
 
Scheme 72: Reactivity of 1-benzyl-6-methyl-2-pyridones with ketones. 
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However, careful control of methyl lithiation of 1-benzyl-6-methylpyridin-2(1H)-one was needed in 
this part of the study. The stoichiometry of the base to the pyridone was very important, since an 
excess of base yielded an undesired product, the doubly alkylated pyridone 234 as shown in Scheme 
73. 
 
Scheme 73 : Synthesis of the dialkylated product 234. 
 
Using 1.2 eq. of base (an excess of base), the reaction generated the dialkylated product 234 in 15% 
yield along with a complex mixture of unidentifiable compounds. So, we needed to answer the 
following questions: did we have a double alkylation because the electrophile was less reactive than 
the diketone, and was there a competition between position 7 and 8, or did we have a double 
alkylation due to the excess of base?   
In order to answer these questions, we set up a reaction where the amount of base and the 
electrophile was lower than that of the pyridone, so no double alkylation would be obtained. Only 
the mono-alkylated pyridone 231e (alkylation at methyl position) and the unreacted pyridone 228c 
were obtained. The product 231e and the starting material ran very close on a TLC plate, so they 
were very difficult to separate, so we reported the mixture of compounds, and the ratio was 1:1. In 
conclusion, the more acidic protons are those in the methyl group (position 7).  
Trying to confirm that an excess of base (2 eq.) was the source of the dialkylation product 234a, a 
reaction with 2 eq. of base was performed. As soon as we added more than 1 eq. of base, position 8 
was also deprotonated and the electrophile was added to both positions.  
The comparison of the NMR spectra of products 231e, 234 and the starting material are shown in 
Figure 36:  
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Figure 36: The comparison of NMR spectrum from reaction using 2 eq. of base with starting 
material and mono alkylate product 231e and the dialkylated product 234. 
 
In the NMR spectra shown above, when 2 eq. of n-BuLi were added to 1eq. of pyridone the reaction 
yielded in a complex mixture. Looking at the spectra, it is possible to distinguish the signals of a 
mixture of 3 different compounds (231e, 234 and unknown compound) and unreacted pyridone. 
The reactions showed that careful control over the amount of base was needed, since an excess of 
base led to the unwanted dialkylated product. The standard conditions for further reactions with 
ketones were: 1 eq. of pyridone, 1 eq. of n-BuLi and 1.2 eq. of electrophile. 
The next type of carbonyl compounds investigated were aldehydes, the first being benzaldehyde. 
The reaction was performed under the standard conditions developed for the diketones and 
ketones, giving compound 231g in a good 85% yield. (Entry 1, Table 27).  
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Table 27:Methyl lithiation of 1-benzyl-6-methyl-2-pyridone. 
 
Entry Electrophile Temperature Compound Yield 
1 
 
-78 °C 
 
85% 
2 
 
-78 °C 
 
80% 
3 
 
-78 °C 
 
26% 
4 
 
-78 °C 
 
33% 
 
 
In entry 2, pivaldehyde was next used as an electrophile, and the reaction again worked in excellent 
yield, the new pyridone 231h was isolated pure in 80 % yield. 
On the contrary, an interesting result was found, when propianaldehyde, as shown in entry 3, was 
used as the electrophile. This electrophile was different from the previous ones, since it bears an 
acidic proton in the α-position to the carbonyl. The metalated pyridone reacted in a different way. 
The pyridone anion has several resonance structures as shown in Figure 37. The most reactive 
position is 6-methyl position (position 7, Figure 37). However, there is the possibility of alkylating the 
3- or 5- positions of the ring, or to obtain O-alkylation.  
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Figure 37: Resonance structures of the anion of N-alkylated-6-methyl 2-pyridones. 
 
Using propionaldehyde as the electrophile, the pyridone anion appeared to behave mainly as a base 
and the major compound recovered was the starting 1-benzyl-6-methyl-2-pyridone, presumably 
formed by deprotonation of the α-position of the aldehyde. Some of the anion did react as a 
nucleophile however, and 26% of the pyridone 236 with alkylation at position 3 was obtained. It is 
not clear why this aldehyde behaved differently and gave ring alkylation. Further investigation with 
other aliphatic aldehydes would be desirable. 
 
Scheme 74: Alkylation at position 3 instead of position 7 of 1-benzyl-6-methylpyridin-2(1H)-one. 
 
The compound structure was confirmed by an nOe study. The spectra are shown in the following 
figures.  
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Figure 38: Irradiation at 6.23 ppm (CH) of pyridone 236. 
 
 
Figure 39: Irradiation at 4.99 ppm (CH) of pyridone 236. 
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Figure 40: Irradiation at 2.38 ppm (CH3) of pyridone 236. 
 
Using the nOe study we could confirm that the alkylation was in position 3. The reaction was set up 
again, under the same conditions, to confirm the product obtained by alkylation in position 3 was 
the predictable product. The reaction gave as the same outcome; the alkylation occurred at position 
3 instead of position 7. 
In the following spectra, Figure 41 shows the comparison between the starting material 228c 
spectrum, the pyridone 236 spectrum and the reaction mixture spectrum. Also in the Figure 42 is 
shown the expansion of Figure 41 which shows that the reaction was reproducible: 
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Figure 41: Confirmation of pyridone 236 and reaction mixture. 
 
 
Figure 42: Expansion of Figure 41 . 
 
In entry 4, Table 27, we also investigated the reaction with a conjugated carbonyl compound, (, 
unsaturated carbonyl). The standard conditions were used with cinnamaldehyde as an electrophile. 
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There were two possible additions, either 1,2 or 1,4 nucleophilic addition to cinnammaldehyde.  The 
1,2-additon product was isolated in 33% yield. Also, the reaction mixture showed new peak, that 
could have been the 1,4-addition product, however, only the 1,2-addition product 231i could be 
isolated and fully characterised (Table 27, entry 4). 
In order to finish the study of the carbonyl electrophile set, a Weinreb amide was chosen as an 
electrophile as this would be a useful route to keto substituted pyridones. 
 
Table 28: Attempted synthesize of pyridone 231j. 
 
Entry Time Temperature Conclusion 
1 
 
2 h -78 °C Starting material 
2 
 
3 h 30 min 
2h 30 min 
-78 °C 
0 °C 
Starting material and new product 
3 
 
2h  °  Starting material and new product 
 
In entry 1 (Table 28), the reaction was performed under the previous standard conditions. After 2 
hours at -78 °C, the reaction was quenched and the crude product was isolated and purified, 
obtaining almost all of the starting material back. After this surprising result, the reaction was set up 
again (entry 2). The reaction was monitored by TLC, and after 3h and 30 min, there were only signs 
of starting material, so the temperature was increased to 0 °C, and the reaction stirred at 0°C over 2 
h and 30 min before the work-up. In entry 3 the reaction was performed at 0°C over 2 h. The same 
result than in entry 2 was obtained. The crude product was purified by flash chromatography, 
however the pyridone starting material and the new pyridone had similar polarity and it was not 
possible to isolate the new product.  
Continuing the study of methyl C6-lithiated N-benzyl-2-pyridones, two different halides were chosen 
as electrophiles, in order to show that our standard conditions could also be used in alkylation 
reactions (Scheme 75). 
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Scheme 75: Reaction with halides. 
 
As we can see in Scheme 75, the reactions worked in excellent yields.  
In order to expand the study, we wanted to show that we could add a heteroatom to the pyridone 
scaffold at the methyl position, so the following reaction with the azo compound diethyl 
azodicarboxylate (DEAD) was designed (Scheme 76). The reaction worked in 45% yield. 
 
Scheme 76: Reaction of methyl lithiated N-benzyl-2-pyridone with DEAD reagent. 
 
In summary, the product of C6-methyl lithiation of 1-benzyl-6-methylpyridin-2(1H)-one 296c, reacts 
with a variety of carbonyl electrophiles such as: diketones, ketones and aldehydes, and the reactions 
worked in good to excellent yields. Furthermore, other groups of electrophiles such as the halides, 
benzyl bromide, allyl bromide, or an aza-electrophile such as diethyl azodicarboxylate are also 
compatible with this methodology. 
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3.1.3- Study of metallation of 1,6-dimethyl-2-pyridones. 
 
After the lithiation study of N-benzyl-2-pyridones with a wide range of electrophiles, we decided to 
expand the chemistry, moving onto another N-substituted-2-pyridone. The aim of this part was to 
try the optimised conditions for the new pyridone 1,6-dimethylpyridone 228b. In order to prove that 
the reaction works with a wide range of electrophiles, we chose one representative electrophile for 
each group, diketone, aldehyde, halide, and an aza-electrophile, all of which worked very well in the 
previous study. 
We conducted the following reactions under the newly found optimized conditions. Our first 
electrophile was the diketone 232a, and the results are shown in Table 29. In entry 1, the reaction 
worked in 38% yield, but the NMR spectrum of the crude product showed several by-products, and 
the yield was not very good. Using allyl bromide as an electrophile (entry 2), the reaction did not 
work as we expected. The product 239b was formed, but the NMR spectrum showed some by-
products which were not identified. For this reason, in entry 3 the same reaction was set up, but the 
reaction was stopped after one hour to try to discover when the by-products were formed. After 
only one hour, the reaction was quenched, but the result was the same as that in entry 2. The 
nucleophilic addition to the carbonyl group was achieved, however there were other by-products, 
and it was impossible to isolate or identify them. 
The last experiment under the standard conditions employed pivaldehyde as an electrophile, since it 
had been an excellent reagent in the reaction with lithiated N-benzyl-6-methyl-2-pyridone 228c. The 
excess of pivaldehyde was removed under vacuum, and the NMR spectrum of the crude product 
showed a very clean product, so no further purification was needed. The same result was expected 
when the reaction was performed with 1,6-dimethyl-2-pyridone. However, the reaction worked in 
only 37% yield, (entry 4) and 1H NMR showed that by products had formed. However the by-
products were not isolated. In entry 5, the same reaction conditions as in entry 4 were used, and the 
reaction was stirred for only one hour, trying to avoid the formation of by-products. The same 
results occurred and, the NMR spectra showed some by-products. 
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Table 29: Selective mono-lithiation at the 6-methyl position of 1,6-dimethylpyridin-2(1H)-one. 
 
Entry Electrophile Temperature/time Compound Yield/comments 
1  
232a 
78 °C  +5 °C  -78 °C 
 2h 
 
      239a 
38% 
 
2 
 
222h 
-78 °C  +5 °C -78 °C 
 1h 
 
   239b 
Very complex 
spectrum 
3  
235b 
78 °C  +5 °C -78 °C 
2h 
 
    239c 
37% 
 
 
Because of the low yield obtained and the formation of by-products in the lithiation of 1,6 dimethyl-
2-pyridone 228b using n-BuLi as a base, the following deuteration study using two different bases 
was carried out to gain an understanding of the deprotonation behaviour of 228b. 
Table 30: Deuteration study of 1,6-dimethylpyridin-2(1H)-one. 
 
Entry Base (eq) temperature Compound Yield 
1 n-BuLi (1 eq.) -78 °C Very messy spectrum - 
2 KHMDS (1 eq.) -78 °C 239d 55% 
3 KHMDS (2.5 eq.) 78 °C  +5 °C -78 °C 239d 45% 
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Treatment of 1,6-dimethyl-2-pyridone 228b with 1 eq. of n-BuLi  in THF at -78 °C, (entry 1, Table 30) 
resulted in a light orange solution. The mixture was stirred over 10 min, and then quenched with 
D2O at -78 °C which produced a mixture of starting material and by-products. Analysis of the NMR 
spectrum showed that the use of n-BuLi generated a very complex product mixture (Figure 43, entry 
1). 
For the reaction described in Table 30, entries 2 and 3, KHMDS was then studied as a base, due to its 
non-nucleophilic properties. Figure 43, entry 2 is shown the 1H NMR spectrum of the metallation of 
1,6-dimethyl pyridone 228b using the conditions of entry 2, Table 30, and in entry 3 is shown the 1H 
NMR spectrum of the metallation of 1,6-dimethyl pyridone using the conditions of entry 3, Table 30. 
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Figure 43: Spectra of entries 1 to 3. 
 
As can be seen in Figure 43 the nBuLi generated new unknown peaks at 6.4 ppm and 6.0 ppm, and 
the KHMDS did not generate any new unknown peaks, and the spectrum shows only the pyridone 
peaks for the two products, a mixture of deuterated pyridone 239d and the non-deuterated 
pyridone.  
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Figure 44: Expansion of spectra 6 (7.8 ppm-5.2 ppm). 
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Figure 45: Zoom of spectra 6 (4.0 ppm - 0 ppm). 
In Figure 45 is shown that the use of nBuli in entry 1 generated unknown peaks from 4 to 2.35 ppm. 
And in entry 2 and 3 are shown only the peaks at 2.35 ppm for the deuterated pyridone and 2.34 
ppm for the non-deuterated pyridone  
In entry 3, Table 30, we proved that an excess of KHMDS (2.5 eq.) was not able to deprotonate more 
than one position and the reaction did not show any by-products. KHMDS was only strong enough to 
deprotonate the methyl group at position 6. This is shown in entry 3, the peak at 2.35 ppm 
integrates 2 H for a CH2D, instead of 3H for a CH3 group. 
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After this screening, we could conclude that the n-BuLi generated several by-products, and 
consequently the yield decreased. The problem was solved, using KHMDS, as the optimum base, a 
regioselective deprotonation at the methyl position, the monodeuterated pyridone 239d, was 
obtained. The location of the label was easily established by 1H NMR and 13C NMR spectroscopic 
analysis. In subsequent experiments, we selected to employ KHMDS as the base.  
After the deuterium study, the new standard deprotonation conditions using 1,6-dimethyl-2-
pyridone 228b, and a range of electrophiles afforded products in good yield as shown in Table 31: 
Table 31: Reactions of 1,6-dimethyl-2-pyridone and different electrophiles. 
 
Entry Electrophile Compound Yield (%) 
1 
232a 
       239a 
65% 
2    222h 
239b 
75% 
3 
    235b 239c 
84% 
    
4 
     
238 
239e 
 
70% 
 
 
The pyridone 239e was fully characterised by 1H and 13C NMR spectroscopy and the structure was 
verified by X-ray crystallography (Figure 46). 
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Figure 46: Crystallography structure of compound 239e. 
 
The last experiment we carried out in order to complete the 1,6-dimethyl-2-pyridone 228b study 
was the following set of reactions (Table 32). Sammes had reported in 198278 the synthesis of 6-hex-
5-enyl-1-methyl-2(1H)-pyridone in 6.6% yield by lithiation of a methyl pyridone. We believe this to 
be the only report of this type of lithiation in the literature, and we wished to test our reaction 
conditions to compare yield. 
We first tried to synthesize 6-hex-5-enyl-1-methyl-2(1H)-pyridone using our optimized conditions; 
however the conditions did not work and we recovered all the starting material (entry 1, Table 32).  
In entry 2 double amount of base was added and the reaction was stirred for 1 hour, but the 
reaction again was unsuccessful. In entry 3, the same amount of base was used and the reaction was 
stirred at -78 °C for 3 h and temperature allowed to rise to -35 °C and the reaction was then stirred 
for 1 h. However this method also failed. 
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Table 32: Reactions of 1,6-dimethyl-2-pyridone and 5-bromo-1-pentene. 
 
Entry KHMDS 
Temperature 
addition 
electrophile 
Reaction time and 
Temperature 
Compounds 
1 1 eq. -78 °C 2h at -78 °C Starting material 
2 2 eq. -78 °C 1h at -78 °C Starting material 
3 2 eq. 0 °C 
3h at -78 °C 
1h at -35 °C 
Starting material 
4 2.5 eq. 0 °C 2h at 0 °C 240 (8%) + 241 (8%) + 242 (18%) 
5 1 eq. -10 °C 1h at -10 °C 239f (20%) 
 
In entry 4, 2.5 eq. of base were used and the reaction was performed at 0°C for 2 h. The reaction 
delivered 3 different products 240, 241, 242. The excess of base at -78 °C was able to deprotonate 
only position 7. However, an excess of base at 0°C was able to deprotonate more than one position.  
Taking this information into account, in entry 5, the reaction was performed at -10 °C and the 
desired pyridone 239f was obtained in 13% higher than recorded by Sammes. The formation of the 
products 240, 241 and 242 shows that very subtle effects are in operation in these metallation 
reactions and obtaining high selectivity is very challenging. 
We wanted to expand the chemistry and to control the alkylation at the N-methyl position (8).We 
were able to alkylate the 1,6-dimethyl-2-pyridone 228b at the N-methyl position (position 8) 
depending on the reaction conditions. Using in total 2 eq. of LDA, a regioselective deprotonation at 
the N-methyl position was obtained as shown in Scheme 77. 
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Scheme 77: Synthesis of compound 243. 
 
This regioselective deprotonation at the N-methyl position is under investigation.  
 
3.2- Study of N-substituted-2-methyl-4-pyridones 
 
4-Pyridone compounds are very important as substructures of natural products and they are found 
in several bioactive compounds. For this reason, we wished to continue the metallation study at the 
methyl position of 1-benzyl-2-methylpyridin-4(1H)-one 226a and 1,2-dimethylpyridin-4(1H)-one 
226b, as structural isomers of 1-benzyl-6-methylpyridin-2(1H)-one 228c and 1,6-dimethylpyridin-
2(1H)-one 228b already studied. 
 
Figure 47: 1-benzyl-2-methylpyridin-4(1H)-one and 1,2-dimethylpyridin-4(1H)-one. 
 
In this section, we present firstly the synthesis of 1-benzyl-2-methylpyridin-4(1H)-one and 1,2-
dimethylpyridin-4(1H)-one. Secondly, results of metallation at the methyl position and the products 
of subsequent reactions with different electrophiles are described. 
111 
 
3.2.1- Synthesis of N-alkylated-4-pyridones. 
 
Alkoxy pyridines have been explored as a means of accessing N-alkyl pyridones.11,80 This is a 
particular attractive strategy for the synthesis of N-substituted 4-pyridones over 3 steps. Firstly, 
alkoxy pyridines 224a, 224b can be accessed directly and in high yield from 4-chloro-6-methyl 
pyridine 223 and an appropriate alcohol via nucleophilic aromatic substitution. Secondly, the 
pyridinium salts 225a, 225b and 225c can be accessed by direct N-alkylation of alkoxy pyridines such 
as 224. The pyridinium salts 225a, 225b and 225c were exposed to basic conditions over 3 h leading 
to the desired pyridones 1-benzyl-2-methylpyridin-4(1H)-one 226a and 1,2-dimethyl-4-pyridone 
226b. 
 
Scheme 78: Retrosynthesis of of N-substituted-4-pyridone 226a and 226b from 4-chloropyridines. 
 
3.2.1.1- Synthesis of 1,2-dimethyl-4-pyridone and 1-benzyl-2-methylpyridin-4(1H)-one. 
 
The syntheses of the required alkoxy pyridines 224a and 224b were achieved by treating 4-chloro-2-
methyl pyridine 223 with benzyl alcohol or methanol in presence of NaH.  
 
Scheme 79:Synthesis of O-alkylated pyridines. 
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In order to synthesize the required intermediate pyridinium salts 225a the 4-benzyloxy-pyridine 
224a was alkylated with benzyl bromide in toluene. For the synthesis of piridinium salts 225b and 
225c, the 4-methoxy-pyridine 224b was alkylated with methyl iodide in EtOAc. 
 
Scheme 80: Synthesis of the intermediate pyridinium salts 225a, 225b and 225c. 
 
In the last step in the synthesis of 1,2-dimethyl pyridine-4(1H)-one and 1-benzyl-2-methylpyridin-
4(1H)-one, the pyridinium salts 225a, 225b, 225c were dissolved in THF and exposed to aq NaOH 
solution (2M). The debenzylation reaction was completed over 3 h to give the required 4-pyridones 
226a and 226b in 70 and 25% yields respectively. 
 
Scheme 81: Synthesis of 1-benzyl-2-methylpyridin-4(1H)-one and 1,2-dimethylpyridin-4(1H)-one. 
 
This general methodology allowed for the preparation of a wide range of N-substituted-4-pyridones 
in good yields over 3 steps.  
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3.2.2- Study of the metallation of 2-methyl-4-pyridone derivatives 
 
For the second part of this study, 4-pyridones 226a and 226b were used as starting materials for the 
investigation of the selective methyl metallation of 1-substituted-2-methyl-4-pyridones so that their 
behaviour could be compared with the reactions of the 2-pyridones described earlier. 
 
 
 
 
3.2.2.1- Study of methyl lithiation of 1-benzyl-2-methylpyridin-4(1H)-one. 
 
The product of methyl lithiation of 1-benzyl-2-methylpyridin-4(1H)-one was reacted with a variety of 
electrophiles. As shown in Table 33, the reaction worked under the same standard conditions used 
successfully in the study of methyl lithiation of 1-benzyl-6-methyl-2-pyridone. The yields were 
generally not high as for the 2-pyridones series; mainly due difficulties in the purification step caused 
by the higher polarity of the 4-pyridone derivatives.   
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Table 33: Methyl lithiation of 1-benzyl-2-methyl-4-pyridone. 
 
Entry Electrophile Time Product   Yielda 
1 
 
232a 
2h 
 
244a 
 45 % 
2  
222b 
2h 
 
244b 
 57 % 
3  
235b 
2h 
 
244c 
 40 % 
4 
                   
238 
2h 
 
244d 
 35 % 
 a Isolated product after purification. 
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3.2.2.2- Study of methyl metallation of 1,2-dimethyl-4-pyridone. 
 
Although the studies described in the previous sections showed clearly that efficient metallation of 
1-benzyl-6-methylpyridin-2(1H)-one 228c; 1,6-dimethylpyridin-2(1H)-one 228b and 1-benzyl-2-
methylpyridin-4(1H)-one 226a was possible, considerably less success was achived with the mono-
metallation of the 1,2-dimethylpyridin-4(1H)-one analogue 226b. 
Different reaction conditions were therefore systematically investigated in order to find a set of 
conditions which would favour the monoalkylation. 
The standard conditions were used with 1,2-dimethylpyridin-4(1H)-one 226b, 1 mol eq. of KHMDS at 
-78 °C, increasing the temperature to 0 °C, and quenching with the electrophile after cooling back to 
-78 °C (2 h). Unfortunately no alkylated pyridone was obtained. Screening the quantity of base from 
1 eq. to 2.5 eq. was studied, while the temperature of the electrophile addition (-78 °C) and 2 h as a 
reaction time were maintained as constant conditions. However the reaction was again unsuccessful 
and only starting material was recovered. 
In a final attempt to circumvent the difficulties encountered in the alkylation, the reaction was 
performed with the addition of 2.5 eq. of base to the pyridone at -78 °C and as in the previous 
reactions, warming the mixture to 0°C and at this point adding the electrophile at 0°C (2 h). 
These conditions were used to generate 2-(metallated-methyl)-1-methyl-4-pyridinone which was 
evaluated with carbon electrophiles such as alkyl halides (allyl bromide). The desired alkylated 
pyridone 245a was obtained in 15%. However, the reaction was complicated by the subsequent 
deprotonation of the alkylated-pyridone product 245a again in position 7 and further alkylation at 
this position, delivering the dialkylated compound 246a in 38% yield (Scheme 82). 
 
Scheme 82: Synthesis of 1-methyl-2-substituted-4-pyridones 
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We also evaluated this metallated-methyl pyridone with pivaldehyde and the reaction proceeded 
under the same conditions. The desired pyridone 245b was obtained in 15% yield and once again, 
the reaction was complicated by the subsequence deprotonation in position C-7. At this step an E2 
elimination took place and the unsaturated product 247 was delivered in 17% yield (Scheme 83).  
 
Scheme 83: Conditions for the synthesis of 6-methyl-pyridone. 
 
To conclude, the reaction of 1,2-dimethylpyridin-4(1H)-one with 2.5 eq. of KHMDS and two different 
electrophiles, allyl bromide and pivaldehyde, under the conditions shown in Scheme 82 and Scheme 
83, delivered a mixture of mono (245a,b) and double deprotonated product (246 and 247) in both 
cases. It was impossible to control the second deprotonation, and as by-product pyridones 246 and 
247 were obtained in higher yields. 
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4- Synthesis of quinolizinones. 
 
4H-Quinolizin-4-one 1 and 2H-quinolizin-2-one 2 represent neutral carbonyl-bearing derivatives of 
the quinolizinium ring system 248, a bridgehead azanaphthalene. Such compounds have potential 
applications in drug development as alternatives to quinoline 249 and isoquinoline 250 derivatives, 
which are much exploited in medicinal chemistry. A number of quinolizin-4-one based drug 
candidates have been developed, but considerable scope remains to employ this ring as a central 
building block in drug discovery. 
 
 
Figure 48: Azanaphthalene rings employed in medicinal chemistry. 
 
The synthesis of 2- and 4-oxoquinolizine derivatives as new drug scaffolds is still needed, due to 
increasing bacterial resistance to quinolones. Consequently, new analogues need to be developed 
urgently. 
We wanted to develop new synthetic routes for the synthesis of quinolizinone derivatives, from 
readily available starting materials, (such as 2-picoline, and 2-methoxy-6-methylpyridine). 
In our study, formation of the quinolizinone scaffold was attempted using two different synthetic 
pathways. 
In route A, 2-picoline 141 was used as the starting material and the goal was to build the pyridone 
ring onto the existing pyridine.  On the other hand, in route B 2-methoxy-6-methyl-pyridone 221 was 
used as the starting material, which would become the pyridone ring at an early state of the 
synthesis, and the new pyridine ring would then be built onto the pyridone. 
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Figure 49 : Quinolizinone scaffold.  
 
Route A and Route B will be explained in the following pages. 
 
4.1- From 2-picoline as starting material. 
 
The target was to develop new routes for the synthesis of quinolizinone derivatives from readily 
available starting materials, such as 2-picoline 141. In the quinolizinone synthesis the goal was to 
synthesize compounds based on scaffold 1, such as compound 253. The preparation of the required 
precursor 1-(pyridin-2-yl)pentane-2,4-dione compound 252 was initially planned from 2-picoline 141 
and diketene or 2,2,6-trimethyl-4H-1,3-dioxin-4-one 251 a diketene equivalent (Scheme 84).  
 
 
Scheme 84 : Attempted synthesis of quinolizinone. 
 
Our attempt to synthesize compound 252 was unsuccessful to date. It was, therefore, impossible to 
carry out the second step and attempt to synthesize compound 253, as proposed in Scheme 84.  
In this approach, the goal was to deprotonate the methyl group of 2-picoline and to react the anion 
with diketene 254 (Scheme 85), or its synthetic equivalent 251 (Scheme 86). Thus, the following 
reaction was attempted using the 2-picoline 141 anion and 2,2,6-trimethyl-4H-1,3-dioxin-4-one 251. 
The anion, was assumed to be formed because the intermediate was orange in colour, as reported in 
the literature.81  
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Scheme 85: Proposed mechanism of the reaction with diketene. 
 
Due to the unavailability of diketene, dioxinone 251 was used as substitute. The dioxinone ring was 
expected to be opened by nucleophilic attack to give product 252 and a molecule of acetone. 
 
 
Scheme 86: Proposed mechanism for the synthesis of 1-(pyridin-2-yl)pentane-2,4-dione 252. 
 
However, the reaction did not work in the expected way, and the only product isolated was tertiary 
alcohol 259. The 2-picoline anion reacted with a molecule of acetone, presumably formed by 
breakdown of 251, and no evidence for the formation of 252 was obtained. 
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Scheme 87: Attempted synthesis of 1-(pyridin-2-yl)pentane-2,4-dione. 
 
We decided therefore to synthesize an alternative starting material 261, (Table 34) containing a 
bridging silicon atom. The formation of acetone during the reaction could be avoided which came 
from the decomposition of compound 251. As a result, attempts were made to synthesise 331 by 
treating ethyl acetoacetate with dichlorodimethysilane 260 (Table 34). 
Table 34: Conditions for the attempted synthesis of compound 261. 
 
Entry Base (eq) Catalyst Solvent time (h) T ° C Product 
1 Et3N (2.2eq)  Acetonitrile 2 65 Complex mixture 
2 Et3N (2.2eq)  Acetonitrile 4 65 Complex mixture 
3 NaH(2.2eq)  Acetonitrile 3 55 Complex mixture 
4 - ZnCl2 (10%) Acetonitrile 6 65 Complex mixture 
5 NaH (2.2eq) ZnCl2 (10%) Acetonitrile 5 55 Complex mixture 
 
Disappointingly all of the attempts to synthesize 261 were unsuccessful. Consequently, the following 
reaction was investigated, in order to check the reactivity of reagent 251. 2-Aminopyridine 12 was 
employed as a nucleophile reagent and used to react with compound 251 (Scheme 88). 
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Scheme 88: Attempted synthesis of acetylacetamide. 
 
2-Aminopyridine 12 was chosen because it could act as a bis-nucleophile, although it is less reactive 
than 2-picoline anion. We hope that a thermal reaction would lead to breakdown of the dioxinone 
251 (Scheme 89), and following the mechanism proposed by Basset and co-workers82 this would 
generate acetyl ketene 262, which may possibly react with 2-aminopyridine to form the 
acetylacetamide 211a as shown Scheme 90. 
 
Scheme 89: Retro-cycloaddition 
 
 
Scheme 90: Proposed nucleophilic attack of 2-aminopirimidine on ketene 262. 
 
However, after heating 2-aminopyrimidine 12 and the dioxinone 262 in toluene, the NMR spectrum 
only showed starting material signals. 
Disappointingly, all of the attempts to use 2,2,6-trimethyl-4H-1,3-dioxin-4-one 251 as an 
electrophilic reagent, to be opened by nucleophilic attack as shown in Scheme 87, failed. The 
investigation was then directed towards a new general synthetic approach, as shown in Scheme 91. 
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Scheme 91: New general synthetic route to synthesise quinolizinones. 
 
2-Picoline 141 was retained as the nucleophilic reagent, but, 2,2,6-trimethyl-4H-1,3-dioxin-4-one 251 
was changed for acryloyl chloride 264, because it is more reactive.  
Our work was based on Natarajan and co-workers’ research.57 They reported the synthesis of the 
2H-quinolizin-2-one scaffold 272 from initial deprotonation of 2-picoline 141 with LDA, followed by 
acylation with propynoate electrophiles. In their study, β-TMS-propynoate derivatives 267 and 3-
alkyl or arylpropynoate 273 were used. In the case of β-TMS-propynoate derivatives used as the 
acylating agent, the deprotonation of the triple bond was required to allow a 6-endo-trig-cyclization 
to yield the desired 2H-quinolizinone derivatives 272. However, in the reaction with 3-alkyl or aryl 
propionate derivatives 273a-c, after the initial acylation, ring closure was found to occur 
spontaneously. In other examples the crude reaction mixture had to be heated to 100 °C to 
complete the ring closure reaction.  
 
123 
 
 
Scheme 92: Assembly of 2H-quinolizin-2-one scaffolds.57 
 
 
In our synthetic route, we wanted to study the N-acylation of 2-picoline to synthesize the 
corresponding 4H-quinolizin-4-one scaffold. Hence, a strong base was not required as the lone pair 
on the nitrogen atom was nucleophilic and we hoped that this was sufficient to achieve N-acylation. 
A mild base was required in order to neutralize the hydrogen chloride by-product which would form 
in the reaction mixture. The base chosen was a non-nucleophilic base in order to avoid side reactions 
between the base and the acryloyl chloride. The nitrogen atom in 2-picoline ring was therefore 
employed as the nucleophilic reagent and used to react with carbonyl of acryloyl chloride 264a, to 
afford compound 274. No product was obtained using the reaction conditions in entry 1. In entries 2 
and 3, 10 % of Lewis acid was employed, but not product was obtained in both entries. However, in 
entry 4, no base was used and the addition of the acryloyl chloride 264a was at 0 °C. Under these 
conditions, a molecule of 2-picoline 141 reacted with two molecules of acryloyl chloride 264a to 
afford compound 275 (Table 35). 
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Table 35: Attempt to monoacylation of 2-picoline. 
 
Entry 2-
picoline 
(mmol) 
Acyl 
chloride 
(mmol) 
Solvent 
(mL) 
Base 
(mmol) 
Catalyst Temp. 
addition 
(°C) 
Time 
(h)a 
Product 
(yield %)b 
1 3 3 DCM 
1 mL 
DIPEA 
3mmol 
- -78 48 141 b 
2 3 3 1 mL DIPEA 
 
ZnCl2 
(10%) 
-78 24 141 b  
3 2 2 THF 
6 mL 
DIPEA ZnCl2 
(10%) 
-78 24 141b 
4 2 2 DCM 
10 mL 
- - 0 12 275  
(10%) 
aThe reaction stirred at r.t.  
 
In conclusion the N-acylation of 2-picoline,  the addition of acryloyl chloride was a 0 °C and followed 
by warming up at room temperature, and stirring overnight in order to promote ring closure, only a 
10 % of the diacylation compound 275 was isolated (entry 4). When the addition of the acyl-reagent 
was at -78°C followed by warming up to room temperature and stirring overnight, a black oil was 
obtained. From this complex mixture only 2-picoline was recovered, and no acryloyl signals 
appeared in the NMR spectrum. 
The reason could be that the acryloyl chloride presumably decomposed, due for the black oil 
obtained, and the lone pair of the nitrogen atom did not react with the acryloyl chloride.   
Route A, in Figure 50, has been discussed so far. However the synthesis of 4H-quinolizin-4-one, with 
acryloyl chloride as N-acylating reagent was unsuccessful and the synthesis of 2H-quinolizin-2-one, 
with similar reagents, was reported by Natarajan in 2006.57  
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Figure 50: Pathways to synthesize 4H-quinolizin-4-one scaffold. 
 
The research continued with a different approach, but still with 2-picoline as the starting material. 
The electrophilic reagent however was changed to an alkylating reagent, ethyl bromoacetate. We 
decided to alkylate the 2-picoline instead of acylating it, with the aim of making pyridium salts 
suitable for annelation to quinolizinium derivatives which could, in turn, be converted into 
quinolizinones. 
We devised a new route to synthesize 2- and 4-oxoquinolizinones which involved the Westphal 
reaction followed by the oxidation of the resulting quinolizinium salts with nucleophilic oxidation 
reagents, to convert them into the corresponding quinolizinone derivatives.  
Westphal et al.83 reported in 1961 the condensation of a cycloimmonium salt, such as an N alkyl-
substituted 2-picolinium salt 276, acting as an 1,4-dinucleophile on 1,2-diketones 232 in the 
presence of an organic base, to give the corresponding substituted quinolizinium salts 279.  
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Scheme 93: Intermolecular Westphal reaction. 
 
The Westphal reaction is an efficient and straightforward method for the synthesis of the 
quinolizinium ring system. It involves a condensation between α-methylcycloimmonium salt 276 and 
1,2-diketones 232. The Westphal reaction had usually been carried out with symmetrical 1,2-
diketones, until Diaz and co-workers84 reported in 1994, their study on the regioselectivity of this 
condensation reaction with unsymmetrical 1,2-diketones. 
In 2003, a study of the Westphal reaction on a solid-support was reported by Alvarez-Builla and his 
co-workers.85 They reported the preparation of a library of cycloimonium salts, which were 
synthesized in good to high yields. 
In 2011 Chen and his co-workers reported the synthesis of quinolizinium salts 279a,b86 by the 
Westphal reaction, the procedure being modified from the previously reported solid-phase 
procedure.   
Our synthesis of quinolizinium salts was based on the work of Chen et al,86  however we modified 
the procedure, and changed the solvent and the reaction time as shown in Scheme 94. 
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Scheme 94: Synthesis of quinolizinium salt by Westphal reaction.86 
 
We prepared the pyridinium salt 276a, via a quaternization reaction between 2-picoline 141 and 
ethyl 2-bromoacetate 222a, in ethyl acetate under reflux for 24 h. The quinolizinium salts 279a and 
279b were then synthesized through a Westphal reaction, modified from a previously reported solid-
phase procedure. The best conditions were when the mixture of 1,2-diketone and 1 eq. of 
triethylamine was added dropwise into a THF solution of 1.2 eq. of the pyridinium salt, and the 
mixture heated under reflux for 3 h. This afforded compounds 279a and 279b as solids in good 
yields.  
It was now hoped that the quinolizinium salts could be oxidized in positions (4, 6 or 8) (ortho or para 
to the pyridinium nitrogen) to afford quinolizinone derivatives, potentially isomers 280, 281 or 282 
(Scheme 95). 
 
Scheme 95: Attempted of oxidation of pyridinium salt in position 4, 6 or 8. 
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Starting the oxidation study, the quinolizinium salts were exposed to the oxidising reagents, 
hydrogen peroxide and potassium ferricyanide in the presence of hydroxide and MCPBA as a shown 
in Table 36. 
Table 36: Conditions of the attempt to synthesize quinolizinone derivatives. 
 
Entry Quinolizinium salt  Oxidant Reagents (eq) Solvent Time  T (°C) Product 
1 279a (1eq.) H2O2 29% (2 eq) H2O/MeOH 24 h Rt - 
2 279a (1eq.) H2O2 29% (2 eq) H2O/MeOH 48 h Rt - 
3 279a (1eq.) H2O2 29% (5 eq) H2O/MeOH 48 h Rt - 
4 279a (1eq.) H2O2 29% (5 eq) H2O/MeOH 6 h 50 - 
5 279b (1eq.) H2O2 29% (5 eq) H2O/MeOH 36 h Rt - 
6 279a (1eq.) K3Fe(CN)6 (2eq)/ NaOH (4eq) H2O 24 h Rt 283a* 
7 279b (1eq.) K3Fe(CN)6 (2eq)/ NaOH (4eq) H2O 24 h Rt - 
8 279a (1eq.) K3Fe(CN)6 (2eq)/NaOH (1eq) H2O 48 h Rt 283a* 
9 279a (1eq.) - DMSO 96 h 110-150  - 
10 279b (1eq.) - DMSO 96 h 110-150  - 
11 279a (1eq.) MPCBA (2eq.) H2O/MeOH 48 h Rt - 
12 279a (1eq.) MPCBA (2eq.) H2O/MeOH 48 h Rt - 
* NMR spectrum of compound 12a showed aldehyde signal and alkene signal. 
 
As shown in Table 36, using mild conditions the reaction did not work, however when stronger 
oxidising conditions were used, compound 283a was obtained.  
Ring opening was one of the most important considerations, since there are some examples of 
pyridinium salts, particularly, but not exclusively, those with powerful electron-withdrawing N-
substituents, adding a nucleophile at C-2 and then undergoing a ring opening.87 A typical example of 
ring-opening is the addition of sodium hydroxide to the pyridine sulphur trioxide complex, as shown 
in Scheme 96. 
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Scheme 96: Ring opening mechanism.88 
 
After the difficulty encountered in oxidising the quinolizinium salts in positions 1, 4 or 6, we decided 
to alkylate 2-picoline 141 to afford the pyridinium salt 276 and afterwards to oxidise the pyridinium 
salt at position 6. Finally, the synthesis of the desired quinolizinone scaffold could be achieved via 
double condensation reaction with the diketone (Scheme 97). 
 
Scheme 97: Proposed synthesis pathway. 
  
The proposed synthesis of compound 228c was based on Pasarella’s work89, shown below. 
 
Scheme 98 : Synthesis of pyridone compound 346 reported by Passarella et al. 
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To obtain the 2-pyridone 228c, the picolinium salt 276b was treated with NaOH/KF(CN)6, following 
Passarella’s procedure (Scheme 98). However, this reaction did not generate the desired 2-pyridone 
228c (Scheme 99), and only delivered a complex product mixture. 
 
Scheme 99: Attempted oxidation of compound 276b in position 6. 
 
Due to the lack of success with the oxidation of the pyridinium salt, we decided to change the 
starting material to one with a substituent at position 2 or 4 which could be converted into the 
carbonyl group at a later stage of the synthesis.  
 
4.2- From 2-methoxy-6-methylpyridine. 
 
2-Methoxy-6-methylpyridine 221 was chosen as the starting material, since it bears a methoxy group 
in position 2 which, during the reaction could undergo de-alkylation to give the pyridone derivative, 
once the pyridine was activated by the alkylating agent.  This synthetic approach to 2-pyridone 
derivatives has been discussed in section 3.1.1. 
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Scheme 100:  Comparison of Westphal reaction and our synthetic pathway. 
 
We based our synthesis of quinolizinones on the Westphal reaction, and employed a similar pathway 
to synthesize quinolizinone derivatives, as shown in Scheme 100. We were focussed on the following 
pyridones 228a,b,c,g. Due to its properties, pyridone 228a was chosen because it bears an ester 
group, which can stabilise anion formation at α-position to the carbonyl of the ester group, and 
pyridones 228c and 228g were chosen because the phenyl group can similarly, though to a lesser 
extent, stabilise an anion at the same position. On the other hand, pyridone 228b was also selected 
because it is an interesting building block due to the lack of substituents. 
In the synthesis of 4H-quinolizin-4-one derivatives, a stronger base was used in order to deprotonate 
CH2 position α to the carbonyl (position 8, Scheme 101), in comparison with Westphal reaction, 
where triethylamine was strong enough to deprotonate position 8 in a α-methylcycloimmonium salt, 
to obtain an equilibrium amount of N-ylide intermediate. The anion was stable because it has a 
positive charge on the nitrogen atom close to the negative charge in position 8, and for the ester 
group as shown in the Scheme 101:  
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Scheme 101: Structures of N-ylide intermediate (277a and 278a). 
  
However in ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228a the nitrogen atom has a lone pair, 
reducing the electron withdrawing effect of the carbonyl group, so the anion is less stable (Scheme 
102), and a stronger base was required.  
 
 
Scheme 102 : Equilibrium of N-ylide intermediate. 
 
As shown in the following Table 37, NaH was chosen as a base in order to deprotonate compound 
228a, because NaH is considerably stronger than triethylamine. However, NaH proved not to be 
strong enough to deprotonate positions 8 or 7, and 2-pyridone 228a was recovered (entry 1). 
Considering this result, in entry 2, potassium bis(trimethylsilyl)amide (KHMDS) was next used to 
deprotonate the pyridone compound. This base was chosen due to its strength (pKa= 30), and non-
nucleophilic properties. 
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Table 37: Conditions for the synthesis of 4H-quinolizin-4-one.  
 
Entry 
Pyridone 
296a 
1,2-Dicarbonyl 
(eq.) 
Base 
(eq.) 
Time 
(h) 
Temp 
(°C) 
Product 
Yield (%) 
1 1 eq. a 1.2 eq NaH (4) 24 -78 °C * SM 
2 1 eq. c 1.2 eq. 
KHMDS 
(2.75) 
24 -78 °C * 
Complex 
mixture 
3 1 eq. a 1.2 eq 
KHMDS 
(2.75) 
24 -78 °C * 292c (20%) 
4 1 eq. d 1.2 eq. 
KHMDS 
(2.75) 
24 -78 °C * 293 (12%) 
* The base was added to the mixture of compound 296 and 306 at -78 °C and then the reaction was slowly warmed up to room 
temperature (20 °C). 
 
As a general procedure in all the reactions in Table 37, Ethyl 2-(6-methyl-2-oxopyridin-1(2H)-
yl)acetate 228a and the diketone were dissolved in THF and then the base was added to the reaction 
mixture, an excess of base was needed to deprotonate both positions, the pyridone methyl group (C-
7) and the CH2 of (C-8). In order to generate the dianion in the presence of the electrophile (1,2-
diketone). This way should decrease the probability of pyridone dimerization, and also could 
increase the rate of the reaction. 
In entry 2, 1,2-butanedione 232c was used as electrophile and the reaction led to a complex product 
mixture. The reason could be that both starting materials, 2-pyridone and 1,2-butanedione, were  
susceptible to deprotonation allowing side reactions to occur. 
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The same conditions to generate the dianion were used in entry 3, in order to react with 4,4′-
dimethylbenzil 232a, and pleasingly afforded the expected quinolizinone 292c, albeit in a low 20 % 
yield. The structure was confirmed by 1H NMR spectroscopy and HRMS, however, the sample was 
insufficient to obtain a 13C NMR spectrum. 
 
Scheme 103: Synthesis of 4H-quinolizin-4-one 292c. 
 
The same conditions were used to generate the dianion, and benzil was used as an electrophile for 
the attempted synthesis of 4H-quinolizin-4-one 292b, (entry 4, Table 37). The formation of 
quinazolin-4-one 293 was expected, however the reaction formed a complex mixture of products, 
and none of the expected quinolizinone 292b was obtained after chromatographic separation of the 
crude product mixture. The only compound that could be obtained pure was the fused azetidinone 
293, in which the quinolizin-4-one ring skeleton had formed, but to which was attached a fused 4-
membered lactam ring.  
The presence of a 4-memebered lactam ring in the molecule was suggested by IR spectrum which 
showed absorption at 1776cm-1 indicating the presence of a small ring carbonyl group, and by 1H 
NMR spectroscopy, which showed an broad signal at  10.29 ppm consistent with NH and a CH 
singlet at  5.86 ppm (H-9a). The absence of triplet and quartet signals for an ethyl ester indicated 
that this group had been transformed. The 13C NMR spectrum showed a signal at  68.1 ppm 
consistent with a saturated CH (C-9a) and two carbonyl signals at  164.7 and 160.5 ppm. 
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 The structure of the molecule was confirmed by single crystal X-ray diffraction analysis, which 
confirmed the presence of the 4-membered lactam. The compound was found to exist as a mono-
ethanol solvate 363 (Figure 51).  
  
Figure 51: X-Ray crystal structure of compound 293. 
 
Yellow crystals with a plate morphology were formed by slow evaporation of an ethanolic solution of 
293. Due to their small size and weak diffracting power, data were collected using synchrotron 
radiation at the Advance Light Source in the US. The molecules were found to form head-to-tail 
R44(18) H-bonded pairs via inserted ethanol molecules.  Hydrogen bond geometry is shown in Table 
38. 
Table 38: Hydrogen-bond geometry (Å,°) for 9•EtOH. 
D-H•••A D-H H•••A D•••A D-H•••A 
N1-H1•••O3(A) 0.92 (2) 1.92 (2) 2.8305 (17) 168 (2) 
O3-H3•••O2 0.98 (3) 1.71 (3) 2.6651 (16) 165 (2) 
Symmetry code: (A) –x, -y + 1, -z + 1. 
 
The formation of the fused azetidinone product 293 was unexpected and a number mechanisms for 
generation of the 4-membered lactam ring compound can be imagined. It is not clear how the 
nitrogen atom of the lactam ring was introduced into the molecule, or the order of the ring forming 
steps. The azetidinone nitrogen is most likely to be derived from the hexamethyldisilazane (HMDS) 
formed as a by-product during deprotonation by the KHMDS. The most plausible mechanism 
proposed in Scheme 105 involves formation of the ester enolate 294 by deprotonation of 228a with 
KHMDS, and reaction of the HMDS produced in situ, or the excess KHMDS, with benzil 232d to form 
either the mono-(295a) or bis-imine(295b). Either electrophile could then condense with the anion 
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228a’ to form the azetidinone derivative 296. The reaction of imines with ester enolates is a well 
established method to form 4-membered lactams. Subsequent deprotonation of the 6-methyl group 
of the pyridone ring would generate enolate 297, the cis diastereoisomer of which could undergo 
intramolecular aldol reaction with the ketone (X=O) or silylimine (X=NSiMe3) group forming 298. 
Subsequent elimination would then generate the observed product 293, which was isolated after 
aqueous work-up and extraction. 
 
Scheme 104: Synthesis of 2a,3-diphenyl-2,2a-dihydro-1H-azeto[2,3-c]quinolizine-1,8(9aH)-dione 
(293). 
 
 
Scheme 105: Possible mechanism for formation of azeto[2,3-c]quinolizine (293). 
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The formation of a 4-membered β-lactam ring was unexpected, however, it demonstrated that ethyl 
2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228a was acting as a 1,4-dinucleophile (C-C substrate) in 
the presence of the 1,2-diketones. The quinolizinone scaffold was therefore successfully formed, as 
shown in the Scheme 104.  
When pyridone 228a was used as the starting material, a side reaction took place resulting as 
decarboxylation, so the ethoxy group was lost in the reaction. The NMR spectrum of the crude 
product did not show any ester group signals of the pyridone signals. The pyridone compound 
disappeared in the reaction. However, only a small quantity of desired products 292c and 293 were 
isolated. In order to synthesize 4H-quinolizin-4-one compounds, different conditions were studied, 
such as different temperatures, and numbers of equivalents of base, and the order of the reagent 
addition was altered to investigate changes in the reactivity. However, in all the reactions, poor 
yields and significant quantities of by-products were obtained.  In order to understand the behaviour 
of the pyridone, a deuteration study was undertaken, as outlined below.  
 
4.2.1- Study of selective deprotonation of ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl) 
acetate.  
 
In order to study the deprotonation reactivity of ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl) acetate 
228a, we decided to employ CD3OD as electrophile. Ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 
228a was firstly treated with one equivalent of base at -78 °C. The reaction was stirred over 20 to 30 
min and then quenched with CD3OD, and the reaction mixture was then warmed up to room 
temperature and stirred at room temperature overnight. The solvent was removed under vacuum 
after the quenching, but before the extraction with ethyl acetate. The base was shown to 
deprotonate both position 7 and 8, however also the ester group was cleaved.  
 
 
Scheme 106: Deuterated study of ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl) acetate. 
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In the following figure is the comparison of starting material 228a and the deuterated product 299. 
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Figure 52: 1H NMR spectra comparison of the starting material pyridone (228a) and the deuterated 
derivative (299). 
 
Comparing the starting material 228a with the deuterated product, 1H NMR analysis showed that 
the ethoxy group is fully lost, the quartet signal (CH2, C-10) at 4.15 ppm and the triplet signal (CH3, C-
11) at 1.21 ppm had disappeared.  
The NMR spectrum (Figure 52) showed that when the pyridone was treated only with 1 eq. of base, 
the methyl group and the methylene group of the acetate substituent were deprotonated, but the 
main product had deuterium at position C-8, as the methylene signal was absent and the signal for 
the methyl group at 2.21 ppm still showed. Nevertheless, a new signal at 2.19 ppm appeared in the 
spectrum and this corresponding to a CH2D group at C-7. 
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Figure 53: 13C and DEPT spectra of Ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate (228a) in 
DMSO-d6. 
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Figure 54: 13C and DEPT spectra of the deuterated compound (299). 
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The formation of the deuterated compound was confirmed by 13C NMR spectroscopy. The 13C and 
DEPT spectra for the starting material are shown in Figure 53. The corresponding 13C and DEPT for 
the deuterated material are shown in Figure 54. And also, the disappearance of the ester group was 
confirmed by 13C and DEPT NMR spectra, the CH2 signal at 61 ppm and the CH3 at 14 ppm 
disappeared. 
The peaks at 61 and 45 ppm correspond to C-10 and C-8 in 228a, (Figure 53). In the spectra of the 
deuterated material, the signals at 61 ppm had disappeared, while the C-8 signal showed a positive 
triplet for CHD and reduced negative singlet for the remaining CH2 Figure 54. The lack of signals at 61 
and 13 ppm confirmed that the ester group disappeared. The information in the 13C and DEPT NMR 
spectra confirmed that the ester had hydrolysed to the acid group, because there was a signal at 168 
ppm, which corresponding to C-9.  
Likewise a negative triplet at 19.6 ppm indicated CH2D (C-7) for the partially deuterated methyl 
group. 
Also, in order to confirm that the ester group is hydrolysed to the acid, the following study was 
designed (Scheme 107) where the quenching step was with non-deuterated methanol at -78°C: 
 
 
Scheme 107: Formation of compound 300. 
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Figure 55: 1H spectrum of the non-deuterated compound (300). 
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Figure 56: 13C spectrum of the non-deuterated compound (300). 
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Figure 57: DEPT spectrum of the non-deuterated compound (300). 
 
The conclusion of this reaction was that the ester group was cleaved, as the 1H NMR spectrum shows 
the C-10 (quartet at 4.15) and C-11 (triplet at 1.21) signals of the ester group had disappeared. 
However, the signal at 4.31 ppm of CH2 (C-8) was still present in the 
1H NMR spectrum.  
The last experiment we did to conclude the study was to control the temperature. The pyridone 
228a was dissolved in THF and the solution was cooled at -78 °C. The base, KHMDS, was added at -78 
°C and then the reaction was warmed up to 0 °C, and then cooled down to -78 °C. Then D2O was 
added at -78 °C and the reaction was allowed to proceed for 10 min at -78 °C. NH4Cl(aq) was added 
and the product extracted with ethyl acetate. The solvent was removed under vacuum and the 
mono-deuterated product at C-8 was obtained in 30% yield. 
The mains differences were that the reaction did not reach room temperature, and the THF was not 
removed under vacuum before the extraction, so the work-up was performed directly on the 
reaction mixture. 
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Scheme 108: Deuterated study of ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl) acetate at -78 °C. 
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Figure 58: 1H NMR Spectrum of mono-deuterated ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl) acetate. 
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Figure 59: Expansion of mono-deuterated ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl) acetate. 
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Figure 60: 13C and DEPT NMR spectra of mono-deuterated ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl) 
acetate. 
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Only position C-8 was deprotonated, and the ester group was not cleaved.  
These experiments showed that the ester group was cleaved during the work-up step. Because the 
solvent was removed before the extraction, the residue would become basic due to the 
deuteriomethoxide formed, and the ester group could be hydrolysed on contact with water. 
The studies highlighted the importance of neutralising the reaction mixture before evaporation. 
To continue the study, the following experiment showed that it was possible to alkylate the ester 
pyridone at the C-8 position under the following conditions (Scheme 109). When the work-up was 
carried out at -78 °C, the alkylated product at C-8 position was isolated in 35% yield. 
 
Scheme 109: Synthesis of ethyl 3-hydroxy-2-(6-methyl-2-oxopyridin-1(2H)-yl)-4-oxo-3,4-di-p-
tolylbutanoate. 
 
In conclusion, the temperature was a very important variable, as was the work-up step, as 
demonstrated by the last deuteration experiment and the last synthetic reaction (Scheme 109). Also, 
pyridone 228a and product 302 are highly soluble in water and THF, and during the work-up step it 
was not possible to extract all the product from the aqueous layer and the yield was low. However, 
removing the solvent before the extraction, the ester group would cleave, and side reactions could 
also occur. 
Another possible reason for the by-product formation could be the use of strong base such as LDA or 
KHMDS, allowing a reactive intermediate forming in the reaction mixture could facilitate side 
reactions. This could also account for the low yields obtained so far. 
Continuing the quinolizinone study, another pyridone was investigated. In order to avoid the 
problem of the ester group, 228c pyridone was chosen as the object of the study. 
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Scheme 110: General synthesis of 4H-quinolizinone derivatives 
 
The new pyridone starting material had to have some essential characteristics such as an electron 
withdrawing group on carbon 8, in order to make this H-atom more acid, therefore ensuring easy 
deprotonation. Also, the new pyridones would be less soluble in water which would hopefully allow 
easier isolation. 
Using N-benzyl-6-methyl-2-pyridone 228c we tried to effect the condensation reaction under 
Westphal conditions (Scheme 111), however the reaction did not work. After 5 h under reflux, the 
reaction mixture became black, so the reaction was stopped, and after the work-up, the NMR 
spectrum showed only starting material signals. It was concluded that a stronger base was needed 
and a lower temperature, in order to avoid side reactions. 
 
Scheme 111: Atempt to synthesize 287a using westphal reaction condictions. 
In the following reaction LDA was used as a base due to its strong and non-nucleophilic properties.  
The base used was a commercially available solution and the colour was brown. For this reason it 
was impossible to titrate the base; so, an excess of base was employed. The pyridone and the 
diketone were dissolved in THF and the reaction mixture cooled to -78 °C. The base was then added 
and the reaction stirred at -78°C for 3 h. Later, the reaction was warmed up to r.t. and it was stirred 
overnight. Scheme 112 shows the synthetic pathway used here to attempt to synthesize compound 
287a however the reaction yielded only the intermediate compounds 303 and 304. 
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Scheme 112: Attempt to synthesize quinolizinone 287b. 
 
This experiment confirmed that it was possible to achieve the double alkylation. The compounds 303 
and 304 represent intermediates in the synthesis of compound 287b. Compound 303 was generated 
via mono addition of pyridone anion at C-8 to diketone 303 in 25 % yield after the purification step.  
 
 
Scheme 113: Synthesis of compound 303 and 304. 
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From this intermediate compound 303, another equivalent of base must have reacted to promote a 
further nucleophilic addition to the second carbonyl group, affording compound 304 in 10% yield. 
Intermediates 303 and 304 were isolated in a combined 35 % yield, and characterised by their 1H and 
13C NMR spectra, IR spectra and mass spectra.  The 1H NMR spectrum for 303 showed signals for the 
presence of three methyl groups indicating the pyridone methyl was still present, while the 1H NMR 
spectrum of 304 showed a signal for the new alkene proton. 
Taking into consideration this information led us to make a study of different bases, temperatures, 
and reaction times.  
The double alkylation was possible under the previous conditions. Now, we wanted to control the 
reaction more carefully, in order to better understand the mechanism, and ascertain why the second 
condensation step had not taken place.  One of the reasons could be that the temperature was not 
high enough. 
Following Westphal reaction conditions as a basis to synthesize pyridinium salts, we tried to use a 
similar pathway to synthesize quinolizinone derivatives. In the Westphal reaction a high temperature 
was needed to synthesize the pyridinium salt, in order to effect the dehydration step; however in 
the case of pyridones, when we tried to carry out the reaction at high temperature very messy 
product mixtures resulted.  
The previous reaction (Scheme 112) showed that the C-C bond in the methyl and benzylic position 
could be formed, and at r.t we could obtain one dehydration step. 
We decided to carry out the reaction at lower temperature to avoid the uncharacterized by-product 
formation, and the reaction was attempted under the following conditions. The LDA was prepared 
in-situ, and only 2 eq. of base were used. The reaction was performed at -78 °C, over 2 h and also the 
work-up was conducted at -78 °C. 
Under these conditions, double alkylation was achieved, and no condensation step occurred, as we 
predicted due to the low temperature. The final product achieved was the double alkylation 
product, diol 305.  
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Scheme 114: Synthesis of 2,3-dihydroxy-4-phenyl-2,3-di-p-tolyl-3,4-dihydro-1H-quinolizin-6(2H)-
one. 
 
The yield obtained was only 14%, and a large number of uncharacterised by-products appeared in 
the reaction mixture. 
Considering this information, the reaction was carried out in a step-wise manner. Because the yield 
was low, and a large number of by-products were formed, we needed to know which step was the 
problematic one.  The reaction was broken down in further steps. The carbonyl addition was done in 
two further steps and also a dehydration step was added to the total synthesis. Scheme 115 shows 
the new synthesis pathway. 
 
Scheme 115: Total synthesis pathway of quinolizinone derivatives. 
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In the new synthesis pathway, 2-pyridone was treated with 1 eq. of base at 78 °C over 2 h and the 
work-up was also at -78 °C. The results are shown in Table 39. 
Table 39: Second step in the synthesis of quinolizinone derivatives (mono addition of the diketone 
to the pyridone scaffold). 
 
Entry R1 R2 Base Yield 
1 H CH3 LDA 80 % 
2 H CH3 n-BuLi 89 % 
3 F CH3 LDA 94 % 
4 F Br LDA 19 % 
 
The addition of different diketones to the mono-metallated 1-benzyl-6-methyl-2-pyridinone, was 
performed successfully, and in very good yield, except for the case of 4,4′-dibromobenzil which is 
not very soluble in THF and therefore, gave a reduced yield of 19%. 
The mono-alkylation at -78°C went smoothly to the methyl position C-7 in all cases, and no signals 
corresponding to alkylation in position C-8 appeared. Under these reaction conditions, we obtained 
a selective alkylation. 
Knowing the excellent yield for the mono-alkylation, the second alkylation step was then studied 
with compounds 231b and 231d. 
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Table 40: Third step in the synthesis of quinolizinone derivatives (second alkylation). 
 
Entry R Base Time Yield 
1 H n-BuLi 3 h 13% 
2 F n-BuLi 3 h 10 % 
3 H n-BuLi 1 h 30 % 
 
In this reaction, 2 eq. of base were needed, the first equivalent to deprotonate the alcohol and the 
second one was needed to deprotonate C-8. The diol was achieved, however a large number of by-
products appeared during the reaction. The reaction time was an important factor. In entries 1 and 
2, the reaction was stirred for 3 h, and the reaction delivered many by-products. In entry 3, the 
reaction was stirred for only 1 hour at -78°C and yielded the product 305b in 30%. 
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In the following scheme, there is the comparison between the one-pot reaction and the stepwise of 
compound 305a. 
 
Scheme 116: Comparison between one pot reaction and stepwise reaction. 
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The yield was higher when the reaction was performed stepwise. Having the diol 305a in hand, the 
final step (dehydration step) was then performed Scheme 117. 
 
Scheme 117: Fourth step in the synthesis of quinolizinone derivatives (dehydration step). 
 
The total synthesis of compound 287a was achieved in 10% yield, but for the compound 305b, only 
partial dehydration occurred, and one further dehydration step would be needed to form the fully 
unsaturated quinolizinone 287b. 
In summary, the total synthesis of 4H-quinolizinone 287a and the synthesis of 4-(4-fluorophenyl)-3-
hydroxy-2,3-di-p-tolyl-3H-quinolizin-6(4H)-one 304b are shown in Scheme 118 and Scheme 119 
respectively. 
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Scheme 118: Synthesis of 6-phenyl-7,8-di-p-tolyl-4H-quinolizin-4-one.  
 
 
 
Scheme 119: Synthesis of 4-(4-fluorophenyl)-3-hydroxy-2,3-di-p-tolyl-3H-quinolizin-6(4H)-one. 
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Continuing the study, the keto-ester electrophile 306 was investigated as another way to synthesize 
quinolizinone scaffolds.  
We chose this new electrophile, due to it being an unsymmetrical dicarbonyl compound, and it was 
less hindered than the previous diaryl diketones. Also this interesting new scaffold 308 possess a 
new carbonyl position, which could be a key position for further transformations in drug 
development. 
The two-step alkylation-acylation (compound 307) was achieved in 21%. The dehydration step has 
not been achieved so far, and the starting material was recovered after heating in the presence of 
acid. However, this scaffold 307 bears a ketone group which could be very useful for further 
reactions. 
 
Scheme 120: Synthesis of 4-phenyl-2-(p-tolyl)-3H-quinolizine-3,6(4H)-dione. 
 
These synthesis pathways represent an interesting method to deliver quinolizinone derivatives with 
different substituents in positions 8, 9 and 10. 
In conclusion we developed a straightforward synthesis of the desirable 4H-quinolizin-4-one 
scaffold, albeit in low yield. Further investigation is required to improve the yield in the second ring-
closing step at position 8. 
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Conclusions 
We have developed an efficient, new methodology for the synthesis of 4H-pyrido[1,2-a]pyrimidin-4-
one derivatives from commercially available 2-aminopyridines and -oxoesters. We designed a more 
environmentally friendly pathway, replacing the corrosive acids conventionally used with milder 
reagents. In this investigation, the synthesis of 4H-pyrido[1,2-a]pyrimidin-4-one derivatives were 
carried out by direct condensation/cyclization of 2-aminopyridine 12 with substituted β-keto esters 
13, catalysed by the clay mineral montmorillonite (K-10) under solvent-free conditions. It was found 
that the method was an effective, clean process with easy work-up, and also good yields were 
obtained (Scheme 121). 
 
Scheme 121: Synthesis of 4H-pyrido[1,2-a]pyrimidin-4-one derivatives. 
 
This methodology was expanded for the synthesis of 4H-pyrimido[1,2-a]pyrimidin-4-one derivatives 
from 2-aminopyrimidine with different β-keto esters, however only mono-addition products, the 
enamines 216a and 216b, were obtained. The synthesis of the 2-methyl-4H-pyrimido[1,2-
a]pyrimidin-4-one 40a required an extra condensation reaction, to cyclise the enamine which 
occurred only in low yield (Scheme 122). 
 
Scheme 122: Synthesis of a 4H-pyrimido[1,2-a]pyrimidin-4-one derivative. 
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We developed new methodology for the synthesis of N-alkylated 6-methyl 2-pyridones 228 and N-
alkylated 2-methyl 4-pyridones 226, from commercially available starting materials. Selective mono-
metallation of the methyl substituent of N-alkylated 6-methyl 2-pyridones and N-alkylated 2-methyl 
4-pyridones with n-BuLi/KHMDS at -78 °C proceded smoothly, and the resulting lithiated 
intermediates were shown to react with a wide range of electrophiles (diketones, aldehydes, 
alkylating reagents and azo-compounds) to give novel sidechain functionalised pyridones. 
In the synthesis of N-alkylated 6-methyl 2-pyridones 228, 2-methoxy-6-methyl pyridine 221 and a 
number of different alkylating reagents were used (Scheme 123) to successfully generate a series of 
pyridone building blocks.  
 
Scheme 123: Synthesis of N-alkylated-6-methyl 2-pyridones. 
 
For the synthesis of N-alkylated 2-methyl 4-pyridones 226, 4-chloro-2-methyl pyridine 223 was used 
as the starting material, and the desired pyridone was obtained in 3 steps by SNAr substitution, N-
alkylation and concomitant O-dealkylation (Scheme 124). 
 
 
Scheme 124: Synthesis route of N-alkyl 2-pyridone and N-alkyl 4-pyridone. 
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The product of methyl lithiation of 1-benzyl-6-methylpyridin-2(1H)-one 228c, was found to react 
with a variety of carbonyl electrophiles such as diketones, ketones and aldehydes, and the reactions 
worked in good to excellent yields. Furthermore, other groups of electrophiles including the halides, 
benzyl bromide, and allyl bromide, and an aza-electrophile, diethyl azodicarboxylate, reacted 
successfully (Scheme 125). 
 
Scheme 125: Synthesis of 1-benzyl-6-alkylated-2-pyridones 231a-n by regioselective metallation at 
the methyl substituent. 
 
In the study of the highly selective methyl lithiation of 1,6-dimethylpyridin-2(1H)-one 228b, 
metallation was shown to take place very efficiently when KHMDS was used as the base. In this 
study ketones, aldehydes, and alkyl halides were used successfully as electrophiles to trap the 6-
(metallated-methyl)-1-methyl-2-pyridinone intermediate. All the reactions took place in good yield, 
except when 5-bromo-1-pentene was used as the electrophile. In this case an increase in the 
temperature of the electrophile addition from -78 °C to 0 °C was needed in order to obtain the 
desired product 239f in a moderate 20% yield (Scheme 126). 
 
Scheme 126: Synthesis of 1-methyl-6-alkylated-2-pyridones 239a-f by regioselective metallation at 
methyl position. 
 
The product of methyl lithiation of 1-benzyl-2-methylpyridin-4(1H)-one 226a reacted successfully 
with a variety of electrophiles. The reactions worked under the same standard conditions used 
successfully in the study of methyl lithiation of 1-benzyl-6-methyl-2-pyridone 228c. The yields were 
generally not high as for the 2-pyridones series, and this is believed to be due to the difficulty in the 
purification due to the higher polarity of the 4-pyridone derivatives.   
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Scheme 127: Synthesis of 1-benzyl-2-alkylated-4-pyridone (244a-d). 
 
The reaction of 1,2-dimethylpyridin-4(1H)-one 226b  was evaluated with two different electrophiles 
(allyl bromide and pivaldehyde) under the conditions shown in Scheme 128. However, the reaction 
was complicated by the subsequent deprotonation of the alkylated-pyridone product 245a,b again 
in position 7. The desired alkylated pyridones 245a,b were both obtained in only 10% yield.    
 
Scheme 128 : Synthesis of 1-methyl-2-alkylated-4-pyridones (245a,b) 
 
A straightforward synthesis of the desired 4H-quinolizin-4-one 287 scaffold by condensation of the 
N-benzyl 6-methyl 2-pyridones 228 with dicarbonyl compounds, and the formation of the desired 
quinolizinone after the condensation step was also developed. A number of novel quinolizinone 
derivatives, representing potential new scaffolds for medicinal chemistry, were successfully 
synthesized and characterized. 
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Scheme 129: Synthesis of the desired 4H-quinolizin-4-one. 
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Future work 
To continue the study into the investigation of the synthesis of 4H-pyrido[1,2-a]pyrimidin-4-one 
derivatives direct condensation/cyclization of 2-aminopyridine 12 with substituted β-keto esters 13, 
catalysed by the clay mineral montmorillonite (K-10) under solvent-free conditions should be 
attempted (Scheme 130).  
 
Scheme 130: Synthesis of 4H-pyrido[1,2-a]pyrimidin-4-one derivatives using K-10. 
 
It will be very interesting to show that the clay mineral montmorillonite (K-10), could be filtered off 
after the reaction and used again in another reaction. It will prove that montmorillonite (K-10) can 
be recycled and this characteristic will add value as a green catalyst. 
The synthesis of 4H-pyrimido[1,2-a]pyrimidin-4-one derivatives from 2-aminopyrimidine with 
different β-keto esters could be studied as a two-step synthesis.  Development of the conditions for 
the new steps, and optimisation of the yield in each step, and synthesis of a new library of 4H-
pyrimido[1,2-a]pyrimidin-4-one derivative in good yields will be an excellent extension of the work 
(Scheme 131). 
 
Scheme 131: New conditions for the synthesis of a 4H-pyrimido[1,2-a]pyrimidin-4-one derivative. 
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After the excellent work developed in the regioselective methyllithiation and subsequent 
electrophilic quenching of N-alkyl-6 methyl-2-pyridones, it will be desirable to study the selective 
alkylation at the N-methyl position (8). 
 
Scheme 132: Regioselective methyllithiation and subsequent electrophilic quenching of N-aklkyl-6 
methyl-2-pyridones. 
 
Scheme 133 shows that we were able to alkylate the 1,6-dimethyl-2-pyridone 228b at the N-methyl 
position (position 8) by appropriate choice of reaction conditions. Using in total 2 eq. of LDA, a 
regioselective deprotonation at the N-methyl position was obtained. 
 
Scheme 133: First example of N-methyl alkylation of 1,6-dimethyl-2-pyridone. 
 
It would be important to continue the study of the regioselective deprotonation at the N-methyl 
position of 2-pyridones and to obtain alkylation of several 2-pyridones at the N-methyl position (8). 
This scaffold will represent an interesting synthetic intermediate for the synthesis of more complex 
molecules. 
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To continue the research on the synthesis of 4-H-quinolizinones would be an exciting development 
to find the optimum third step of the total synthesis conditions in order to avoid the side reactions 
and therefore to improve the yield and synthesize of other examples of this important and emerging 
scaffold. 
 
 
Scheme 134: Third step of the total synthesis of 4H-quinolizin-4-one. 
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Experimental 
General information 
 
Commercially available solvents were used and not subjected to further purification, except 
Tetrahydrofuran (THF) which was distilled from sodium using benzophenone as an indicator.   DMSO 
was purchased dry from commercial suppliers.  Light petroleum ether refers to the fraction with a 
boiling point between 40-60°C.  All chemicals were acquired from Alfa-Aesar or Sigma-Aldrich and 
used as recived. Sodium hydride was a 60% w/w dispersion in mineral oil. 
Anhydrous reactions were carried out in oven-dried glassware (or flame-dried under nitrogen) and 
under an atmosphere of nitrogen and dry solvents were used. 
All the reactions and columns were monitored by thin layer chromatography (TLC) using silica gel 
(Merk TLC Silica gel 60 F214)  as the absorbent on aluminium-backed plates and were visualized by UV 
light at 254nm using a UVP chromato-vue cabinet model CC-60 or via staining with a solution of 
phosphomolybdic acid (PMA).  
The reactions were purified by flash column chromatography on silica gel (Merck Kieselgel 60H silica) 
as the absorbent or by recrystallization.  
Melting points were recorded using a Stuart Scientific SMP3 melting points apparatus.  
A Pelkin-Elmer spectrum 65 FT-IR spectrophotometer was used to obtain infrared spectra.  Liquid 
samples were acquired using a thin film on a sodium chloride disc.  Solid samples were prepared and 
measured in a KBr disc. 
1H and 13C NMR spectra were obtained either from a Bruker 400MHz or a JEOL 400 MHz (1H: 400 
MHz, 13C: 101 MHz), NMR spectrometer; 500 MHz (1H: 500 MHz, 13C: 126MHz) or 700 MHz (1H: 700 
MHz, 13C: 176MHz) spectrometer. 1H and 13C shifts are given in parts per million (ppm), and are 
measured relative to residual protonated (or deuterated as appropriate) solvent. Chemical shifts 
were quoted in ppm, relative to tetramethylsilane (TMS) and referenced to the proper solvent peak. 
Multiplicity is denoted as singlet (s), doublet (d), triplet (t), quartet (q), doublet of doublets (dd), 
doublet of triplets (dt), multiplet (m), or broad (b). Coupling constant (J) values are giving in hertz 
(Hz). 
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Diffraction data for compound 388EtOH were collected at the Advanced Light Source Station 11.3.1 
using silicon 111 monochromated, synchrotron X-radiation on a Bruker Apex 2 CCD diffractometer. 
The crystal structures were resolved using Bruker APEX 2 CCD diffractometer with Oxford 
Cryosystems low temperature device. High-resolution mass spectrometry was obtained on a Thermo 
Exactive Benchtop Orbitrap MS coupled to Advion TriVersa NanoMate injection system. The GC-MS 
was carried out in the Fisons GC 8000 series (AS 800). 
 
Accurate mass and MSMS fragmentation data were obtained using a Thermo Scientific hybrid LTQ-
FT Mass Spectrometer with an Agilent 1100 Quaternary pump with PDA and Autosampler.  5L of 
sample dissolved in 50:50 Acetonitrile:water 0.1% formic acid was injected onto a Thermo Scientific 
Hypersil Gold 50 x 2.1mm 5m particle LC Column. The gradient was 5 to 100% B over 17 min with 3 
min re-equilibration time at 5% B. The flow rate is 0.5 mL/min with A being 0.1% formic acid in water 
and B 0.1% formic acid in acetonitrile. The MS and MSMS spectra were obtained in  ESI +ve mode in 
both the ion trap and Ion Cyclotron Resonance (ICR) cell using helium as the collision gas at a 
normalised collision energy of 35eV. The ICR cell was run at resolution settings of 25000 in MS mode 
and 12500 in MSMS mode. 
A Thermofisher Exactive (orbi) mass spectrometer was used to obtain high resolution mass spectra, 
with ESI as the ionisation mode.  The solvent used for all samples was methanol/acetic acid. 
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1-  Pyridopyrimidine. 
 
Preparation of ethyl 2-acetylpent-4-enoate (13e). 
 
To a suspension of NaH (60% dispersion in mineral oil) (0.40 g, 10 mmol) in THF (25 mL) in THF under 
an N2 atmosphere, was added drop-wise ethyl acetoacetate 13a (1.4 mL, 11 mmol) at 0 °C. The 
reaction mixture was warmed to room temperature and stirred for 1 h. Allyl bromide (0.87 mL, 10 
mmol) was added to the resulting solution. The reaction was allowed to proceed for 16 h at room 
temperature, before quenching with H2O (5 mL). EtOAc (10 mL) was added and the phases were 
separated. The aqueous layer was re-extracted with EtOAc (3 x 10 mL). The combined organic layers 
were washed with brine, dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude product was purified by silica chromatography with elution gradient 0 to 100% EtOAc in 
petroleum ether (40-60°) to afford ethyl 2-acetylpent-4-enoate 13e as colourless oil, (0.88 g, 50%). 
IR (Neat) 2983, 1742 (C=O), 1717 (C=O), 1643 (C=C) cm-1. 1H NMR (CDCl3, 400MHz):  (ppm)  5.73 
(ddt, J=17.1, 10.2, 6.8 Hz, 1H), 5.00 - 5.12 (m, 2H), 4.18 (qd, J=7.2, 0.8 Hz, 2H), 3.50 (t, J=7.2 Hz, 1H), 
2.58 (t, J=7.2 Hz, 2H), 2.22 (s, 3H), 1.25 (t, J=7.2 Hz, 3H). GC-MS : (m/z) 170 (M+). 
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Synthesis of 2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one using different reagents (205a). 
Using ZnCl2. 
 
A mixture of 2-aminopyridine 12 (0.94 g, 10 mmol) and ethyl acetoacetate 13b (1.30 mL, 10 mmol) 
was stirred at 170 °C for 5.30 h, and then ZnCl2 (1.40 g, 10 mmol) was added to the reaction mixture 
which was then stirred for 30 min. The reaction mixture was diluted H2O (10 mL), and extracted with 
EtOAc (3 x 25 mL). The combined extracted were dried over MgSO4 and concentrated under reduced 
pressure. The crude product was the crude product was recrystallized from diethyl ether to afford 2-
methyl-4H-pyrido[1,2-a]pyrimidin-4-one 205a as white solid (0.34 g, 50%). m.p. 80-82 °C. IR (Neat) 
1710 (C=O), 1632.73 (C=N) cm-1. 1H NMR (CDCl3, 400MHz):  (ppm) 9.06 (d, J=6.8 Hz, 1H), 7.76 (ddd, 
J=8.8, 6.8, 1.6 Hz, 1H), 7.65 (d, J=8.8 Hz, 1H), 7.15 (td, J=6.8, 1.4 Hz, 1H), 6.37 (s, 1H), 2.50 (s, 3H). 13C 
NMR (CDCl3, 101MHz):  (ppm) 165.1 (C=O), 157.8 (C), 150.7 (C), 136.4 (CH), 127.3 (CH), 125.7 (CH), 
115.1 (CH), 103.4 (CH), 24.6 (CH3). GC-MS : (m/z) 160 (M
+). 
Using acetic acid. 
 
A mixture of 2-aminopyridine 12 (0.58 g, 6.2 mmol) and ethyl acetoactetate 13b (0.73 mL, 5.0 mmol) 
in acetic acid (3.0 mL) was stirred under reflux for 5 h. After cooling the reaction, the reaction 
mixture was extracted with EtOAc (3 x 10 mL). The combined organic phases were dried over MgSO4, 
filtered and concentrated under reduced pressure and the crude product was recrystallized from 
diethyl ether to afford 2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one 14a as colourless crystals, (0.33 g, 
42%). m.p. 75-77 °C. IR (Neat) 1711 (C=O), 1632 (C=N) cm-1. 1H NMR (CDCl3, 400MHz):  (ppm) 9.04 
(d, J=6.8 Hz, 1H), 7.73 (ddd, J=8.8, 6.8, 1.6 Hz, 1H), 7.60 (d, J=8.8 Hz, 1H), 7.12 (td, J=6.8, 1.2 Hz, 1H), 
6.36 (s, 1H), 2.48 (s, 3H). 13C NMR (CDCl3, 101MHz):  (ppm) 165.3 (C=O), 157.9 (C), 150.7 (C), 136.3 
(CH), 127.3 (CH), 125.8 (CH), 115.0 (CH), 103.4 (CH), 24.7 (CH3). GC-MS : (m/z) 160 (M
+). 
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Synthesis of 2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one stepwise. 
Synthesis of 3-oxo-N-(pyridin-2-yl)butanamide (211a).73 
 
A solution of 2-aminopyridine (0.28 g, 3.0 mmol) and ethyl acetoacetate (1.1 mL, 9.0 mmol) was 
stirred at 110 °C for 5 h. The resulting brown oil was recrystallized from dichloromethane/petrol to 
afford 3-oxo-N-(pyridin-2-yl)butanamide as a white solid, (0.33 g, 62%). m.p.111-113 °C. IR (Neat) 
1720 (C=O), 1686 (CONH) cm-1. 1H NMR (CDCl3, 400MHz):  (ppm) 9.29 (br. s., 1H), 8.32 (dd, J=4.9, 
1.0 Hz, 1H), 8.16 (d, J=8.0 Hz, 1H), 7.67 - 7.74 (m, 1H), 7.06 (ddd, J=7.4, 4.9, 1.0 Hz, 1H), 3.61 (s, 2H), 
2.34 (s, 3H). 
Literature data: m.p.109-110 °C. 1H NMR (CDCl3, 400MHz):  (ppm) 9.68 (br. s., 1H), 8.32 (dt, J=8.32, 
J=2.36 Hz, 1H), 8.21 (bd, J=8.32 Hz, 1H), 7.71 (dt,  J=8.32, J=2.36 Hz, 1H), 7.07 (dt, J=8.32, 2.36 Hz, 
1H), 3.61 (s, 2H), 2.31 (s, 3H).73 
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Synthesis of 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one(205a). 
 
A solution of N-acetoacetylated 211a (0.1 g, 0.56 mmol) and polyphosphoric acid (PPA) in the ratio 
1:10 w:w (0.1 g: 1.0 g) was placed in a round bottomed flask fitted with a reflux condenser and a 
drying tube. The reaction mixture was heated at 100 °C with frequent shaking. The progress of the 
reaction was monitored on TLC and after 3 h the reaction was completed. The reaction mixture was 
diluted with distilled H2O (10 mL), basified with ammonia solution (10 mL) and then extracted with 
EtOAc (3 x 25 mL). The organic layer was dried over MgSO4 and concentrated under reduced 
pressure. The crude product was purified by filtration through a small silica gel column using petrol: 
EtOAc (1:1) to afford 4-methyl-2H-pyrido[1,2-a]pyrimidin-2-one as a yellow solid, (17 mg, 20%). m.p. 
85-87 °C. IR (Neat) 1709 (C=O), 1632 (C=N) cm-1. 1H NMR (CDCl3, 400MHz):  (ppm) 9.07 (d, J=6.8 Hz, 
1H), 7.77 (ddd, J=8.8, 6.8, 1.5 Hz, 1H), 7.68 (d, J=8.8 Hz, 1H), 7.12 - 7.19 (t, J= 6.8 Hz, 1H), 6.37 (s, 1H), 
2.51 (s, 3H). 13C NMR (CDCl3, 101 MHz)  (ppm) 165.28 (C=O), 157.7 (C), 150.6 (C), 136.5 (CH, C-8), 
127.3 (CH, C-6), 125.6 (CH, C-9), 115.2 (CH, C-7), 103.3 (CH, C-3), 24.5 (CH3, C-11). GS-MS : (m/z) 160 
(M+). 
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General procedure (B): Synthesis of Substituted Pyrido[1,2]pyrimidin-4-one. 
 
 A mixture of 2-aminopyridine (5.0 mmol, 1 eq.) and β-keto ester (5.0 mmol, 1 eq.) and 
montmorillonite (600 mg) was stirred at 110 °C for 5 or 7 h. After cooling, the catalyst was removed 
by filtration through a pad of celite and the catalyst was washed with ethyl acetate. The solvent was 
evaporated under reduced pressure. The crude product was purified by silica chromatography with 
elution gradient 0 to 100% EtOAc in petroleum ether (40-60°). 
 
Synthesis of 2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (14a). 
 
Following general procedure (B) 2-aminopyridine was added to ethyl acetoacetate and the reaction 
mixture was stirred at 110 °C for 5 h. The crude was recrystallized from diethyl ether to afford 2-
methyl-4H-pyrido[1,2-a]pyrimidin-4-one as a pale yellow solid, (0.45g, 60%). m.p. 98-100 °C. IR 
(Neat) 1708 (C=O), 1630 (C=N) cm-1. 1H NMR (CDCl3, 400MHz):  (ppm) 9.04 (d, J=7.1 Hz, 1H), 7.68 - 
7.76 (m, 1H), 7.59 (d, J=9.0 Hz, 1H), 7.05 - 7.15 (m, 1H), 6.35 (s, 1H), 2.46 (s, 3H).  
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Synthesis of 3,4-dihydro-1H-pyrido[2,1-b]quinazolin-11(2H)-one (14i).13 
 
Following general procedure (B): 2-aminopiridine (5.8 mmol, 0.54 g) was added to ethyl 2-
oxocyclohexanecarboxylate (5.8 mmol, 0.92 mL) and the reaction mixture was stirred at 110 °C for 7 
h. The crude was recrystallized from diethyl ether, to give pale yellow solid (0.80 g, 80%) m.p. 115-
117 °C. IR (Neat) 2934 (CHsp3), 1676 (C=O), 1634 (C=N) cm-1.  1H NMR (CDCl3, 400MHz):  (ppm) 8.97 
(d, J=7.2 Hz, 1H), 7.57 - 7.64 (m, 1H), 7.51 (d, J=8.8 Hz, 1H), 6.97 - 7.06 (m, 1H), 2.82 (t, J=6.0 Hz, 2H), 
2.73 (t, J=6.0 Hz, 2H), 1.79 - 1.95 (m, 4H). GC-MS: (m/z) 200 (M+). 
Literature data: 1H NMR (CDCl3, 300MHz):  (ppm) 8.90 (d, J=7.2 Hz, 1H), 7.60 (t, J=7.7 Hz, 1H), 
7.52 (d, J=8.7 Hz, 1H), 7.02 (t, J=6.8 Hz, 1H), 2.79 (t, J=5.7 Hz, 2H), 2.70 (t, J=5.7 Hz, 2H) 1.90-1.77 
(m, 4H). 
Synthesis of 2-ethyl-4H-pyrido[1,2-a]pyrimidin-4-one (14j). 
 
Following general procedure (B): 2-aminopyridine was added to methyl propionyl acetate and the 
reaction mixture was stirred at 110 °C for 7 h. This afforded 2-ethyl-4H-pyrido[1,2-a]pyrimidin-4-one 
as a red oil, (0.54g, 60 %).  1H NMR (CDCl3, 400 MHz):  (ppm) 9.02 (d, J=7.2 Hz, 1H), 7.71 (dd, J=7.6, 
6.8 Hz, 1H), 7.62 (d, J=9.2 Hz, 1H), 7.10 (t, J=6.8 Hz, 1H), 6.35 (s, 1H), 2.72 (q, J=7.6 Hz, 2H), 1.31 (t, 
J=7.6, 3H). 13C NMR (CDCl3, 101 MHz):  (ppm) 170.1 (C=O), 158.3 (C), 150.8 (C), 136.3 (CH), 127.3 
(CH), 125.9 (CH), 115.1 (CH), 102.1 (CH), 31.4 (CH2), 12.9 (CH3). 
 
 
 
 
172 
 
Synthesis of 3-allyl-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (14k). 
 
Following general procedure (B): 2-aminopyridine was added to ethyl 2-acetylpent-4-enoate and the 
reaction mixture was stirred at 110 °C for 5 h. This afforded 3-allyl-2-methyl-4H-pyrido[1,2-
a]pyrimidin-4-one as a brown oil, (0.67 g, 66%). IR (Neat) 1670 (C=O), 1636 (C=N), 1569 (C=C) cm-1. 
1H NMR (CDCl3, 400MHz):  (ppm) 8.99 (d, J=7.2 Hz, 1H), 7.60 - 7.67 (m, 1H), 7.55 (d, J=8.7 Hz, 1H), 
7.07 (t, J=7.2 Hz, 1H), 5.94 (dd, J=17.1, 10.1 Hz, 1H), 4.99 - 5.15 (m, 2H),  3.49 (d, J=6.1 Hz, 2H), 2.49 
(s, 3H). GC-MS : (m/z) 200 (M+). 
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2-  Pyrimidopyrimidine. 
 
Synthesis of ethyl 3-(pyrimidin-2-ylamino)but-2-enoate (216a). 
 
 
A mixture of 2-aminopyrimidine (0.47 g, 5 mmol) and ethyl acetoacetate (0.63 mL, 5 mmol) and 
montmorillonite (600 mg) was stirred at 110 °C for 24 h. After cooling, the catalyst was removed by 
filtration and washed with diethyl ether. The solvent was evaporated under reduced pressure and 
the crude product was purified by silica chromatography with elution gradient 0 to 100% EtOAc in 
petroleum ether 40-60° to afford ethyl 3-(pyrimidin-2-ylamino)but-2-enoate 216a, as pale yellow 
crystals (0.2 g, 20%). m.p. 81-83°C. 1H NMR (CDCl3, 400MHz):  (ppm) 11.27 (br. s., 1H), 8.42 (d, 
J=4.8 Hz, 2H), 6.80 (t, J=4.8 Hz, 1H), 4.85 (s, 1H), 4.18 (q, J=7.1 Hz, 2H), 2.50 (s, 3H), 1.23 - 1.33 (m, 
3H). 13C NMR (CDCl3, 101 MHz) 169.2 (C-3), 159.3 (C-5), 157.9 (CH, C-8), 157.8 (CH, C-10), 156.0 (C-7), 
114.3 (C-9), 93.0 (C-4), 59.3 (C-2), 22.9 (C-6), 14.4 (C-1). GC-MS: (m/z) 207 (M+).  

Synthesis of (E)-methyl 3-(pyrimidin-2-ylamino)pent-2-enoate (E-216b). 
 
 
A mixture of 2-aminopyrimidine (0.24 g, 2.5 mmol,) and ethyl acetoacetate (0.97 g, 5 mmol) and 
montmorillonite (600 mg) in xylene was stirred at 110 °C for 5 h. After cooling, the catalyst was 
removed by filtration and washed with EtOAc. The solvent was evaporated under reduced pressure 
and the crude product was purified by silica chromatography with elution gradient 0 to 100% EtOAc 
in petroleum ether 40-60° to afford methyl 3-(pyrimidin-2-ylamino)pent-2-enoate 216b as a yellow 
oil, (60 mg, 10%). 1H NMR (CDCl3, 400MHz):  (ppm) Z isomer 11.21 (s, 1 H), 8.44 (d, J=4.8 Hz, 2H), 
6.80 (t, J= 4.8 Hz, 1H), 4.92 (d, J= 0.9 Hz, 1H), 3.72 (s, 3H), 2.99 (qd, J=7.4, 0.9 Hz, 2H), 1.17 ( t, J=7.4 
Hz, 3H).  
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Synthesis of 2-methyl-4H-pyrimido[1,2-a]pyrimidin-4-one (40a). 
 
Ethyl 3-(pyrimidin-2-ylamino)but-2-enoate (25 mg, 0.12 mmol) was heated at 120 °C for 15 min. The 
reaction mixture was purified by prepTLC (petrol : EtOAc; 1 : 1), to afford 2-methyl-4H-pyrimido[1,2-
a]pyrimidin-4-one as white solid, (8 mg, 41%). 1H NMR (CDCl3, 400MHz):  (ppm) 9.32 – 9.24 (m, 1H), 
9.08 – 9.01 (m, 1H), 7.17 – 7.11 (m, 1H), 6.40 (s, 1H), 2.54 (s, 3H). GC-MS : (m/z) 161 (M+). 
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3- Synthesis of 2- and 4-pyridone derivatives. 
 
Ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate (296a) and 1,6-dimethylpyridin-2(1H)-one (228b). 
 
A mixture of 2-methoxy-6-methylpyridine (1.2 mL, 10 mmol) and ethyl 2-bromoacetate (1.1 mL, 10 
mmol) was stirred at 100-110 °C for 48 h, to afford a brown oil. The crude product was purified by 
silica chromatography with elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford 
ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228a as white crystals (1.3 g, 70%), and 1,6-
dimethylpyridin-2(1H)-one 228b a pale brown oil (0.17 g, 14%). 
Ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228a: m.p. 80-82 °C. IR (KBr) 3068 (CHsp2), 2987 
(CHsp3), 1742 (C=O), 1661 (C=O), 1575 (C=C), 1552 (C=C), 1219 (C-O) cm-1. 1H NMR (DMSO-d6, 
400MHz):  (ppm) 7.58 (dd, J=9.2, 6.8 Hz, 1H, H-4), 6.51 (d, J=9.2 Hz, 1H, H-3), 6.38 (d, J=6.8 Hz, 1H, 
H-5), 5.01 (s, 2H, H-8), 4.38 (q, J=7.2 Hz, 2H, H-10), 2.51 (s, 3H, H-7), 1.44 (t, J=7.2 Hz, 3H, H-11). 13C 
NMR (DMSO-d6, 101MHz):  (ppm) 168.2 (C=O, C-2), 162.3 (C=O, C-9), 147.2 (C, C-6), 139.9 (CH, C-
4), 116.1 (CH, C-3), 105.9 (CH, C-5), 61.0 (CH2, C-10), 45.3 (CH2, C-8), 19.9 (CH3), 14.0 (CH3). HRMS 
[ES]: calcd. for C10H14NO3
+ (M-H)+: 196.0974, found: 196.0964. UPLC, MS, r.t: 0.55 min, m/z: ES+ 
[M+H]+ 196. 
 
 
 
 
176 
 
1,6-dimethylpyridin-2(1H)-one (228b) and N-benzyl-6-methyl-2-pyridone (228c).90,45 
 
A mixture of 2-methoxy-6-methylpyridine (2.4 mL, 20 mmol,) and benzyl bromide (1.2 mL, 10 mmol) 
was heated at 100-110 °C for 48 h to afford a brown oil. The crude product was purified by silica 
chromatography with elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford 1,6-
dimethylpyridin-2(1H)-one 228b as white crystals in 83% yield (1.0 g, 8.3 mmol) and N-benzyl-6-
methyl-2-pyridone 228c in 83% yield (1.6 g, 8.3 mmol).  
1,6-Dimethylpyridin-2(1H)-one 228b: IR (neat) 2994 (CHsp3), 2959 (CHsp3), 1652 (C=O) cm-1. 1H NMR 
(DMSO-d6, 400MHz):  (ppm) 7.28 (dd, J=8.8, 6.8 Hz, 1H, H-4), 6.25 (d, J=8.8 Hz, 1H, H-3), 6.12 (d, J= 
6.8 Hz, 1H, H-5), 3.41 (s, 3H, H-8), 2.34 (s, 3H, H-7). 13C NMR (DMSO-d6, 101MHz):  (ppm) 162.5 
(C=O, C-2), 147.7 (C, C-6), 138.8 (CH, C-4), 115.7 (CH, C-3), 105.5 (CH, C-5), 30.4 (CH3, C-8), 20.3 (CH3, 
C-7). HRMS [ES] (M+H)+ required C7H10NO
+: 124.0762; found: 124.0763. 
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N-Benzyl-6-methyl-2-pyridone (228c).90,45,47
 
A mixture of 2-methoxy-6-methylpyridine (0.49 mL, 4.0 mmol) and benzyl bromide (0.48 mL, 4.0 
mmol) was heated at 100 °C for 48 h to afford a brown oil. The product precipitated out with the 
addition of petrol, and the solid was filtered off to afford N-benzyl-6-methyl-2-pyridone 228c (0.78 g, 
98%) as white crystals. m.p. 110-112 °C. IR (KBr) 3086 (CHsp2), 2991 (CHsp3), 1656 (C=O), 1572(C=C), 
1651 (C=C), 790-732 (CAr) cm
-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 7.30 - 7.42 (m, 3H), 7.21 - 7.30 
(m, 1H), 7.11 (d, J=7.2 Hz, 2H), 6.37 (d, J=9.2 Hz, 1H), 6.16 (d, J=6.8 Hz, 1H), 5.29 (s, 2H), 2.25 (s, 3H). 
13C NMR (DMSO-d6, 101MHz):  (ppm) 162.7 (C=O, C-2), 147.4 (C, C-6), 139.6 (CH, C-4), 137.0 (C, C-
9), 128.6 (CHx2, C-11), 127.0 (CH, C-12), 126.1 (CHx2, C-10), 116.5 (CH, C-3), 106.2 (CH, C-5), 46.1 
(CH2, C-8), 19.9 (CH3, C-7).
90 HRMS [ES] (M+Na+), C13H13NONa
+ required 222.0895, found 222.0889.  
Literature data: m.p. 103−105 °C;  1H NMR (CDCl3, 400MHz):  (ppm) 7.18− 7.31 (m, 4H), 7.12 (d, J = 
7.1 Hz, 2H), 6.52 (d, J = 9.0 Hz, 1H), 6.00 (d, J = 6.9 Hz, 1H), 5.33 (s, 2H), 2.24 (s, 3H); HRMS (ESI-TOF) 
m/z 222.0888 [222.0895 calcd for C13H13NONa (M + Na)+].47 
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2-(6-methyl-2-oxopyridin-1(2H)-yl)acetonitrile (228d).
 
A mixture of 2-methoxy-6-methylpyridine (0.60 mL, 4.9 mmol) and bromoacetonitrile (0.34 mL, 4.9 
mmol) was stirred at 100-110°C for 2h, and then for 48 h at room temperature to afford a brown oil. 
The crude product was purified by silica chromatography with elution gradient 0 to 100% EtOAc in 
petroleum ether 40-60° to afford 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetonitrile 228d as a white 
solid, (0.57 g, 80 %). m.p. 105 °C. IR (Neat) 2249 (-CN), 1661 (C=O), 1572 (C=C), 1553(C=C) cm-1. 1H 
NMR (DMSO-d6, 400MHz):  (ppm) 7.41 (dd, J=9.2, 6.8 Hz, 1H, H-4), 6.38 (d, J=9.2 Hz, 1H, H-3), 6.24 
(d, J=6.8 Hz, 1H, H-5), 5.11 (s, 2H, C-8), 2.44 (s, 3H, C-7). 13C NMR (DMSO-d6, 101MHz):  (ppm) 
162.5 (C=O, C-2), 147.3 (C, C-6), 141.4 (CH, C-4), 117.1 (C-H, C-3), 116.8 (C, C-9), 107.5 (CH, C-5), 32.5 
(CH2, C-8), 20.5 (CH3, C-7). HRMS [ES] (M+H
+), C8H9N2O
+ required 149.0708 found 149.0709. 
 
6-methyl-1-(4-nitrobenzyl)pyridin-2(1H)-one (228e).91
 
1-(Bromomethyl)-4-nitrobenzene (1.1 g, 5.0 mmol) was added to a solution of 2-methoxy-6-
methylpyridine (0.61 mL, 5.0 mmol) in toluene (2.0 mL), and the reaction mixture was heated at 110 
°C over a period of 40 h to afford a brown oil. The crude product was purified by flash silica 
chromatography, with elution gradient 0 to 100% EtOAc in heptane to afford 6-methyl-1-(4-
nitrobenzyl)pyridin-2(1H)-one 228e (0.21 g, 18%) as a colourless solid. m.p. 163 °C. IR (KBr) 3075 
(CHsp2), 3066 (CHsp2), 1659 (C=O), 1578 (C=C), 1550 (C-NO), 1510 (C=C), 1340 (C-NO), 803 (CHAr) cm
-
1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 8.20 (d, J=8.8, 2H), 7.33 - 7.42 (m, 3H), 6.37 (d, J=8.4 1H), 
6.19 (d, J=6.6 Hz, 1H), 5.40 (s, 2H), 2.24 (s, 3H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 162.5 (C=O), 
147.1 (C), 146.6 (C), 145.0 (C), 139.9 (CH), 127.4 (CHx2), 123.8 (CHx2), 116.6 (CH), 106.4 (CH), 46.0 
(CH2), 19.9 (CH3). UPLC, MS, r.t: 0.76 min, m/z: ES
+ [M+H]+ 245. HRMS (ES): calcd. for C13H12N2O3 
(M)+: 244.0848, found 244.0864. 
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Tert-butyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate (228f).
 
2-methoxy-6-methylpyridine (0.79 mL, 6.5 mmol) was added in one portion to tert-butyl 2-
bromoacetate (0.96 mL, 6.5 mmol). The resulting solution was stirred at 110 °C for 22 h. The crude 
product was purified by flash silica chromatography, with elution gradient 5 to 100% EtOAc in 
heptane to afford tert-butyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228f (0.91 mg, 63%) as a 
white solid. m.p. 110-111 °C. IR (KBr) 3046 (CHsp2), 2965 (CHsp3), 1737 (C=O), 1662 (C=O), 1581 
(C=C), 1552 (C=C), 1457 (CHsp3), 1381 (CHsp3), 1367 (CHsp3) cm-1. 1H NMR (DMSO-d6, 400MHz):  
(ppm) 7.32 (dd, J=9.0, 6.8 Hz, 1H, H-4), 6.26 (d, J=9.0 Hz, 1H, H-3), 6.12 (d, J=6.8 Hz, 1H, H-5), 4.69 (s, 
2H, H-8), 2.25 (s, 3H, H-7), 1.41 (s, 9H, H-11). 13C NMR (DMSO-d6, 101MHz): δ (ppm) 167.3 (C=O, C-
2), 162.2 (C=O, C-9), 147.1 (C, C-6), 139.7 (CH, C-4), 116.0 (CH, C-3), 105.7 (CH, C-5), 81.6 (C, C-10), 
45.7 (CH2, C-8), 27.6 (CH3, C-7), 19.8 (CH3, C-11). UPLC, MS, r.t: 0.73 min, m/z: ES
+ [M+H]+ 224. HRMS 
(ESI): calcd. for C12H18NO3 (M+H)
+: 224.1281, found 224.1281. 
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1-(4-fluorobenzyl)-6-methylpyridin-2(1H)-one (228g). 
 
1-(Bromomethyl)-4-fluorobenzene (1.2 ml, 10 mmol) was added in one portion to 2-methoxy-6-
methylpyridine (1.2 ml, 10 mmol). The reaction mixture was stirred at 100-110 °C for 48 h. The crude 
product was purified by flash silica chromatography, with elution gradient 0 to 100% EtOAc in 
heptane to afford 1-(4-fluorobenzyl)-6-methylpyridin-2(1H)-one (1.6 g, 75 %) as a white solid. m.p. 
102 °C. IR (KBr) 3072 (CHsp2), 2995 (CHsp3), 1655 (C=O), 1569 (C=C), 1655 (C=C), 811-794 (CAr) cm
-1. 
1H NMR (DMSO-d6, 700MHz):  (ppm) 7.33 (dd, J=9.1, 6.8 Hz, 1H, H-4), 7.12 - 7.19 (m, 4H), 6.34 (d, 
J=9.1 Hz, 1H, H-3), 6.12 (d, J=6.8 Hz, 1H, H-5), 5.25 (s, 2H), 2.24 (s, 3H). 13C NMR (DMSO-d6, 
176MHz):   (ppm) 162.6 (C=O, C-2), 161.0(C, d, JF = 243 Hz, C-12), 147.2 (C, C-6), 139.5 (CH, C-4), 
133.2 (C, C-9), 128.4 (CHx2, C-10), 116.5 (CH, C-3), 115.4 (CHx2, C-11), 106.2 (CH, C-5), 45.5 (CH2), 
19.8 (CH3). UPLC, MS, r.t. 0.77min, m/z: ES+ [M+H]
+ 218. HRMS [ES]: calcd for C13H12FNO (M+): 
217.0903; found: 217.0898. 
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Methyl alkylation of N-benzyl-2-pyridones. 
 
General experimental procedure for the deprotonation of 1-benzyl-6-methylpyridin-2(1H)-one and 
nucleophilic addition to several electrophiles. 
 
 
 
General procedure I: 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with 2-pyridone 228c or 228g (1 eq.) and dissolved in dry THF. 
The flask was cooled to -78 °C by immersion in a bath of dry ice/acetone. Base (n-butyllithium / LDA) 
(1 eq.) was added to the pale transparent yellow solution dropwise over 5 min and the reaction 
become an intense blue colour. The reaction mixture was warmed up to 0 °C and changed to an 
intense dark red colour, and then the reaction was cooled to -78 °C. Concurrently, an additional 
oven-dried flask was purged with N2 and then was charged with the electrophile (1.2 eq.) which was 
then dissolved in dry THF. The electrophile solution was added dropwise to the pyridone solution at -
78 °C via syringe over 5 min. The reaction was allowed to proceed for 2 h at -78 °C, before quenching 
with  saturated NH4Cl(aq). EtOAc (10 mL) was added and the phases were separated. The aqueous 
layer was re-extracted with EtOAc (3 x 10 mL). The combined organic layers were washed with brine.  
The combined organic phases were then dried over MgSO4, filtered and concentrated under reduced 
pressure and the crude product was purified by flash silica chromatography. 
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Methyl deuterated N-benzyl-6-methyl-2-pyridone (231a). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.16 
g, 0.82 mmol), in THF (6.0 mL), n-butyllithium (0.61 mL, 0.82 mmol) and then D2O (20 μL, 1.6 mmol) 
was carried out. The reaction mixture was stirred for 30 min to afford compound 231a as a pale 
yellow solid (0.14 g, 87%). 1H NMR (DMSO-d6, 400MHz):  (ppm) 7.30 - 7.40 (m, 3H), 7.23 - 7.30 (m, 
1H), 7.11 (d, J=7.0 Hz, 2H), 6.37 (d, J=9.2 Hz, 1H), 6.16 (d, J=6.8 Hz, 1H), 5.30 (s, 2H), 2.23 (s, CH2D). 
13C NMR (DMSO-d6, 101MHz):  (ppm) 162.7 (C=O), 147.3 (C), 139.6 (CH), 137.0 (C), 128.6 (CHx2), 
127.0 (CH), 126.1 (CHx2), 116.5 (CH), 106.2 (CH), 46.1 (CH2), 19.6 (t, JC-D=20,CH2D). 
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1-(4-fluorobenzyl)-6-(2-hydroxy-3-oxo-2,3-di-p-tolylpropyl)pyridin-2(1H)-one (231b). 
 
Following general procedure I, the reaction between 1-(4-fluorobenzyl)-6-methylpyridin-2(1H)-one 
228g (0.53 g, 2.5 mmol) in THF (8.8 mL), LDA (3.1 mL, 2.5 mmol) and 1,2-di-p-tolylethane-1,2-dione 
232a (0.70 g, 2.9 mmol) in THF (5 mL) was performed. The crude product was purified by silica 
chromatography with elution gradient 0 to 100% EtOAc in heptane to afford compound 231b as a 
white solid (1.0 g, 94%). m.p. 203-204 °C. IR (KBr) 3269 (OH), 3038 (CHsp2Ar), 2920 (CHsp
3), 
1664(C=O), 1649 (C=O), 1560 (C=C), 1546 (C=C), 1509(C=C), 1158 (CO), 1140 (C-F), 809-720 (CHArom) 
cm-1. 1H NMR (DMSO-d6, 700MHz):  (ppm) 7.79 (d, J=8.1 Hz, 2H), 7.21 (d, J=8.1 Hz, 2H), 7.18 (dd, 
J=9.1, 7.0 Hz, 1H), 7.09 - 7.14 (m, 6H), 7.03 - 7.07 (m, 2H), 6.71 (br. s., 1H), 6.26 (d, J=9.1 Hz, 1H), 5.92 
(d, J=7.0 Hz, 1H), 5.28 (d, J=15.8 Hz, 1H), 5.03 (d, J=15.8 Hz, 1H), 3.40 (d, J=15.4 Hz, 1H), 3.31 (d, 
J=15.4 Hz, 1H), 2.27 (s, 3H), 2.25 (s, 3H). 13C NMR (DMSO-d6, 176MHz):  (ppm) 196.5 (C=O), 160.2 
(C=O), 158.8 (C, d, JF = 242.8 Hz), 143.9 (C), 140.4 (C), 136.1 (CH), 135.9 (C), 134.4 (C), 131.2 (C), 
129.8 (C), 128.0 (2 x CH), 127.6 (CH), 127.1 (CH), 126.6 (CHx2), 125.8 (2xCH), 122.5 (CHx2), 114.6 
(CH), 113.0 (CHx2), 106.3 (CH), 80.1 (C), 42.8 (CH2), 39.9 (CH2), 18.6 (CH3), 18.1 (CH3). UPLC, MS, r.t: 
1.19 min, m/z: ES+ [M+H]+ 456. HRMS (ESI): calcd. for C29H27NO3F (M+H)
+: 456.1969, found 456.1970. 
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6-(2,3-bis(4-bromophenyl)-2-hydroxy-3-oxopropyl)-1-(4-fluorobenzyl)pyridin-2(1H)-one (231c). 
 
Following general procedure I, the reaction between 1-(4-fluorobenzyl)-6-methylpyridin-2(1H)-one 
228g (0.53 g, 2.5 mmol),  in THF (14 mL), LDA (3.1 mL, 2.5 mmol) and 1,2-bis(4-bromophenyl)ethane-
1,2-dione 232b (1.1 g, 2.9 mmol) in THF (3 mL) was performed. The crude product was purified by 
silica chromatography with elution gradient 0 to 100% EtOAc in heptane to afford compound 231c as 
a white solid (0.27 g, 19%). m.p. 215-216 °C.  IR (KBr) 3187 (OH), 2965 (CHsp2Ar), 2843 (CHsp
3), 1677 
(C=O), 1648 (C=O), 1581 (C=C), 1544 (C=C), 1507 (C=C), 1228 (C-F), 1146 (CO), 1073 (C-Br), 819-809 
(CHArom) cm
-1. 1H NMR (DMSO-d6, 700MHz):  (ppm) 7.77 (d, J=9.1 Hz, 2H, H-12), 7.57 (d, J=9.1 Hz, 
2H, H-13), 7.51 (d, J=8.4 Hz, 2H, H-16), 7.27 (d, J=9.1 Hz, 2H, H-17), 7.19 (dd, J=9.1, 6.8 Hz, 1H, H-4), 
7.09 - 7.15 (m, 2H, H-22), 7.02 - 7.09 (m, 3H, H-21, H-9), 6.27 (dd, J=9.1, 1H, H-3), 5.87 (d, J=6.8 Hz, 
1H, H-5), 5.28 (d, J=16.1 Hz, 1H, H-19), 5.13 (d, J=16.1 Hz, 1H, H-19’), 3.41 (d, J=15.4 Hz, 1H, H-7), 
3.34 (d, J=15.4 Hz, 1H, H-7’). 13C NMR (DMSO-d6, 176MHz):  (ppm) 197.8 (C=O, C-10), 162.2 (C=O, 
C-2), 161 (C, d, JF = 246 Hz, C-23), 145.1 (C, C-6), 139.7 (C, C-15), 138.1 (CH, C-4), 133.2 (C, C-11), 
133.1 (C, C-20), 131.7 (CHx2, C-12), 131.1 (CHx2, C-16), 130.8 (CHx2, C-13), 127.9 (CHx2, C-21), 126.9 
(CHx2, C-17), 126.4 (C, C-14), 120.8 (C, C-18), 117.0 (CH, C-3), 115.0 (CHx2, C-22), 108.3 (CH, C-5), 
82.1 (C, C-8), 44.9 (CH2, C-19), 41.5 (CH2, C-7). UPLC, MS, r.t: 1.26 min, m/z: ES
+ [M+H]+ 584. HRMS 
(ESI): calcd. for C27H21
79Br2FNO3 (M+H)
+: 583.9867, found 583.9868. 
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1-Benzyl-6-(2-hydroxy-3-oxo-2,3-di-p-tolylpropyl)pyridin-2(1H)-one (231d). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.56 
mg, 2.8 mmol) in THF (15 mL), n-BuLi (1.8 mL, 2.8 mmol) and 1,2-di-p-tolylethane-1,2-dione 232a 
(0.74 g, 3.1 mmol) in THF (5.0 mL) was performed. The crude product was purified by silica 
chromatography with elution gradient 0 to 100% EtOAc in heptane to afford compound 231d as a 
pale yellow solid (1.1 g, 89%). m.p. 197-198 °C. IR (KBr) 3267 (OH), 3057 (CHsp2Ar), 3027 (CHsp
2), 
2963 (CHsp3), 1667 (C=O), 1646 (C=O), 1562 (C=C), 1545 (C=C), 1142 (CO), 812-720 (CHArom) cm
-1. 1H 
NMR (DMSO-d6, 500 MHz): (ppm) 7.74 - 7.78 (m, 2H), 7.27 - 7.32 (m, 2H), 7.20 - 7.25 (m, 3H), 7.17 
(dd, J=9.1, 7.1 Hz, 1H), 7.11 (d, J=7.9 Hz, 4H), 7.02 (d, J=7.3 Hz, 2H), 6.48 (s, OH), 6.26 (dd, J=9.1, 1.3 
Hz, 1H), 5.97 (dd, J=7.1, 1.3 Hz, 1H), 5.32 (d, J=16.1 Hz, 1H), 5.07 (d, J=16.1 Hz, 1H), 3.44 (d, J=15.3 
Hz, 1H), 3.33 (d, J=15.3 Hz, 1H), 2.28 (s, 3H), 2.26 (s, 3H). 13C NMR (DMSO-d6, 101 MHz): (ppm)  
198.6 (C=O), 162.5 (C=O), 146.1 (C), 142.9 (C), 138.5 (CH), 138.1 (C), 137.3 (C), 136.7 (C), 131.7 (C), 
130.5 (CHx2), 129.0 (CHx2), 128.5 (CHx2), 128.4 (CHx2), 126.8 (CHx2), 125.9 (CHx2), 124.7 (CH), 
116.8 (CH), 108.7 (CH), 82.2 (C), 45.4 (CH2), 42.2 (CH2), 21.0 (CH3), 20.5 (CH3). UPLC, MS, r.t: 1.17 
min, m/z: ES+ [M+H]+ 438. HRMS (ESI): calcd. for C29H28NO3 (M+H)
+: 438.2064, found 438.2063. 
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1-benzyl-6-(2,2-bis(4-chlorophenyl)-2-hydroxyethyl)pyridin-2(1H)-one (231e). 
 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.29 
g, 1.5 mmol), in THF (17 mL), n-BuLi (1.0 mL, 1.5 mmol) and 4,4'-dichlorobenzophenone 233a (0.45 g, 
1.8 mmol) in THF (3 mL) was performed. The crude product was purified by silica chromatography 
with elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 231e as a 
white solid (0.35 g, 52%). m.p. 212 °C. IR (KBr) 3323 (OH), 3057 (CHsp2Ar), 3030 (CHsp
2), 2965 
(CHsp3), 1651 (C=O), 1567 (C=C), 1552 (C=C), 1364 (C-OH), 1142 (C-OH), 1086 (CO), 815-794 (CHArom) 
cm-1. 1H NMR (DMSO-d6, 400MHz): (ppm) 7.30 - 7.38 (m, 10H), 7.24 - 7.30 (m, 1H), 7.18 (dd, J=9.2, 
7.2 Hz, 1H), 7.04 (d, J=7.2 Hz, 2H), 6.46 (s, 1H), 6.3 (d, J=9.2 1H), 5.78 (d, J=7.2 Hz, 1H), 5.43 (br. s., 
2H), 3.55 (s, 2H). 13C NMR (DMSO-d6, 101MHz):(ppm) 162.7 (C=O), 146.2 (Cx2), 145.8 (Cx2), 138.6 
(CH), 137.8 (C), 137.5 (C), 131.5 (CHx2), 128.8 (CH), 128.7 (CHx2), 127.9 (CHx4), 127.1 (CHx2), 126.1 
(CHx2), 116.9 (CH), 108.7 (CH), 76.8 (C), 45.8 (CH2), 42.5 (CH2). HRMS (ESI): calcd. for C26H21NO2
35Cl2 
(M+H)+: 450.1022 found 450.1012. 
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1-benzyl-6-(2-hydroxy-2,2-bis(4-methoxyphenyl)ethyl)pyridin-2(1H)-one (231f). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.33 
g, 1.7 mmol), in THF (15 mL), n-BuLi (1.2 mL, 1.7 mmol) and 4,4'-dimethoxybenzophenone 233b 
(0.48 mg, 2.1 mmol) in THF (5 mL) was performed. The crude product was purified by silica 
chromatography with elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford 
compound 231f as a white solid (0.39 g, 54%). m.p. 180-181 °C. IR (KBr) 3392 (OH), 3034 (CHsp2), 
3002 (CHsp2Ar), 2943 (CHsp
3), 1649 (C=O), 1565 (C=C), 1507 (C=C), 1302 (C-OH), 1081 (CO), 833-797 
(CHArom) cm
-1. 1H NMR (DMSO-d6, 400 MHz):  (ppm) 7.30 (t, J=7.2 Hz, 2H, H-10,H-10’), 7.21 (t, J=7.2 
Hz, 1H, H-11), 7.15 - 7.11 (m, 1H, H-4), 7.14 (d, J=8.8 Hz, 4H), 6.97 (d, J=7.2 Hz, 2H, H-9,H-9’), 6.77 (d, 
J=8.6 Hz, 4H), 6.23 (dd, J=8.8, 1.0 Hz, 1H, H-3), 5.99 (s, 1H, OH), 5.76 (dd, J=7.0, 1.0 Hz, 1H, H-5), 5.31 
(br. s., 2H, H-7, H-7´), 3.66 (s, 6H), 3.41 ( s, 2H, H-12, H-12´). 13C NMR (DMSO-d6, 101 MHz):  (ppm) 
162.7 (C=O, C-2), 157.8 (C), 146.9 (C), 139.5 (C), 138.6 (CH, C-4), 137.5 (C), 128.7 (CHx2), 127.2 
(CHx2), 127.0 (CH, C-11), 126.0 (CH), 116.6 (CH, C-3), 113.1 (CHx4, C-16, C-21), 108.9 (CH, C-5), 76.8 
(C, C-13), 55.0 (2 x CH3, C-19, C-24), 45.7 (CH2, C-7), 43.4 (CH2, C-12). HRMS (ESI): calcd. for C28H28NO4 
(M+H)+: 442.2013 found 442.1997. 
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1-benzyl-6-(2-hydroxy-2-phenylethyl)pyridin-2(1H)-one (301g). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.11 
g, 0.55 mmol), in THF (9.0 mL), n-BuLi (0.40 mL, 0.55 mmol) and benzaldehyde 235a (60 μL, 0.66 
mmol) in THF (3.0 mL) was performed. The crude product was purified by silica chromatography with 
elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 231g as a 
colourless solid (0.14 g, 85%). m.p. 130-131 °C. IR (Neat) 3320 (OH), 3062 (CHsp2), 3030 (CHsp2Ar), 
2960 (CHsp3), 1651 (C=O), 1567 (C=C), 1550 (C=C)Ar, 1402 (C-OH), 1145 (CO), 715-699 (CHArom) cm
-1. 
1H NMR (DMSO-d6, 400 MHz):  (ppm) 7.40 (dd, J=9.0, 6.8 Hz, 1H), 7.28 - 7.36 (m, 6H), 7.22 - 7.27 
(m, 2H), 7.02 - 7.09 (m, J=7.2 Hz, 2H), 6.38 (dd, J=9.0, 1.0 Hz, 1H), 6.20 (dd, J=6.8, 1.0 Hz, 1H), 5.67 (d, 
J=4.4 Hz, 1H), 5.41 (br. s., 2H), 4.75 - 4.85 (m, 1H), 2.81 (d, J=6.6 Hz, 2H). 13C NMR (DMSO-d6, 101 
MHz):  (ppm) 163.2 (C=O), 148.6 (C), 145.3 (C), 139.8 (CH), 137.8 (C), 129.2 (CHx2), 128.6 (CHx2), 
127.7 (CH), 127.5 (CH), 126.5 (CHx2), 126.2 (CHx2), 117.4 (CH), 107.9 (CH), 72.5 (CH), 46.4 (CH2), 42.8 
(CH2). HRMS (ESI): calcd. for C20H20NO2 (M+H)
+: 306.1489 found 306.1488.  
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1-benzyl-6-(2-hydroxy-3,3-dimethylbutyl)pyridin-2(1H)-one (231h). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.16 
g, 0.79 mmol), in THF (8.0 mL), n-BuLi (0.58 mL, 0.79 mmol) and trimethylacetaldehyde 235b (0.10 
mL, 0.95 mmol) in THF (2.0 mL)  gave compound 231h as a pale yellow solid (0.18 g, 80%). m.p. 130 
°C. IR (KBr) 3265 (OH), 3062 (CHsp2), 3026 (CHsp2Ar), 2956 (CHsp
3), 1652 (C=O), 1567 (C=C), 1552 
(C=C)Ar, 1289 (C-OH), 1081 (CO), 732-697 (CHArom) cm
-1. 1H NMR (DMSO-d6, 400 MHz):  (ppm) 7.42 
(dd, J=9.0, 6.8 Hz, 1H), 7.31 - 7.37 (m, 2H), 7.23 - 7.28 (m, 1H), 7.05 (d, J=7.0 Hz, 2H), 6.37 (dd, J=9.0, 
1.2 Hz, 1H), 6.23 (dd, J=6.8, 1.2 Hz, 1H), 5.43 (br. s., 2H), 4.94 (d, J=6.2 Hz, 1H), 3.33 (ddd, J=10.4, 6.2, 
2.0 Hz, 1H), 2.57 - 2.63 (m, 1H), 2.40 (dd, J=14.6, 10.4 Hz, 1H), 0.82 (s, 9H). 13C NMR (DMSO-d6, 101 
MHz):  (ppm) 162.8 (C=O), 150.2 (C), 139.4 (CH), 137.3 (C), 128.6 (2 x CH), 126.9 (CH), 125.9 (2 x 
CH), 116.3 (CH), 107.0 (CH), 77.4 (CH), 45.8 (CH2), 35.2 (CH2), 34.8 (C), 25.5 (3 x CH3). HRMS (ESI): 
calcd. for C18H24O2N (M+H)
+: 286.1802 found 286.1798. 
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(E)-1-benzyl-6-(2-hydroxy-4-phenylbut-3-en-1-yl)pyridin-2(1H)-one (231i). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.16 
g, 0.82 mmol), in THF (8.0 mL), n-BuLi (0.60 mL, 0.82 mmol) and cinnamaldehyde 235d (0.12 mL, 
0.98 mmol) in THF (2.0 mL) was performed. The crude product was purified by silica chromatography 
with elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 231i as a pale 
yellow solid (89 mg, 33%). m.p. 78-79 °C. IR (KBr) 3339 (OH), 3029 (CHsp2), 1650 (C=O), 1566 (C=C), 
1550 (C=C)Ar, 1145 (CO), 732-694 (CHArom) cm
-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 7.38 - 7.44 (m, 
3H), 7.30 - 7.36 (m, 4H), 7.21 - 7.28 (m, 2H), 7.09 (d, J=7.0 Hz, 2H), 6.47 - 6.54 (m, 1H), 6.38 (dd, 
J=9.0, 1.2 Hz, 1H), 6.24 - 6.35 (m, 2H), 5.37 - 5.50 (m, 2H), 5.41 (d, J=4.8, 1H),  4.33 - 4.42 (m, 1H), 
2.67 - 2.86 (m, 2H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 162.7 (C=O, C-2), 148.1 (C, C-6), 139.4 
(CH, C-4), 137.4 (C), 136.5 (C), 132.8 (CH), 128.9 (CH), 128.7 (CHx4), 127.5 (CH), 127.0 (CH), 126.3 
(CHx2), 126.1 (CHx2), 116.9 (CH, C-3), 107.4 (CH, C-5), 70.5 (CH, C-8), 46.0 (CH2, C-16), 40.4 (CH2, C-
7). HRMS (ESI): calcd. for C22H22NO2 (M+H)
+: 332.1645 found 332.1639. HRMS (ESI): calcd. for 
C22H21NO2Na (M+Na)
+: 354.1465 found 354.1459. 
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1-benzyl-6-phenethylpyridin-2(1H)-one (231k). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.14 
g, 0.73 mmol) in THF (7.0 mL), n-BuLi (0.54 mL, 0.73 mmol) and benzyl bromide 222c (0.10 mL, 0.87 
mmol) in THF (2.0 mL) was performed. The crude product was purified by silica chromatography with 
elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 231k as a white 
solid (0.18 g, 86%). m.p. 83 °C. IR (KBr) 3057 (CHsp2), 2930 (CHsp3), 1654 (C=O), 1573 (C=C), 1547 
(C=C)Ar, 789-702 (CHArom). 
1H NMR (DMSO-d6, 400 MHz):  (ppm) 7.42 (dd, J=9.0, 6.0 Hz, 1H), 7.30 - 
7.37 (m, 2H), 7.22 - 7.29 (m, 3H), 7.16 - 7.21 (m, 1H), 7.11 - 7.16 (m, 2H), 7.08 (d, J=7.2 Hz, 2H), 6.40 
(d, J=9.0 Hz, 1H), 6.20 (d, J=6.0 Hz, 1H), 5.36 (br. s., 2H), 2.73 - 2.88 (m, 4H). 13C NMR (DMSO-d6, 
101MHz):  (ppm) 162.6 (C=O), 149.9 (C), 140.1 (C), 139.4 (CH), 137.1 (C), 128.6 (CHx2), 128.2 
(CHx2), 128.1 (CHx2), 126.9 (CH), 126.1 (CH), 125.9 (CHx2), 116.7 (CH), 105.4 (CH), 45.4 (CH2), 33.7 
(CH2), 33.6 (CH2). HRMS (ESI): calcd. for C20H20NO (M+H)
+: 290.1539 found 290.1536. 
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1-benzyl-6-(but-3-en-1-yl)pyridin-2(1H)-one (231l). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.16 
g, 0.81 mmol) in THF (8.0 mL), n-BuLi (0.60 mL, 0.81 mmol) and allyl bromide 222h (84 μL, 0.98 
mmol) in THF (2.0 mL) was performed. The crude product was purified by silica chromatography with 
elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 231l as pale brown 
oil (0.14 g, 74%). IR (Neat) 3064 (CHsp2), 3031 (CHsp2), 3003 (CHsp2Arm), 1659 (C=O), 1580 (C=C), 1550 
(C=C)Ar, 731-696 (CHArom) cm
-1. 1H NMR (DMSO-d6, 400 MHz):  (ppm) 7.42 (dd, J=9.2, 6.8 Hz, 1H), 
7.31 - 7.36 (m, 2H), 7.23 - 7.28 (m, 1H), 7.07 - 7.11 (m, 2H), 6.39 (d, J=9.2 Hz, 1H), 6.16 (d, J=6.8 Hz, 
1H), 5.76 (ddt, J=17.0, 10.4, 6.5 Hz, 1H), 5.33 (br. s., 2H), 4.94 - 5.02 (m, 2H), 2.60 - 2.67 (m, 2H), 2.18 
- 2.28 (m, 2H). 13C NMR (DMSO-d6, 101 MHz):  (ppm) 162.7 (C=O), 150.0 (C), 139.5 (CH), 137.3 (C), 
136.8 (CH), 128.7 (CHx2), 127.0 (CH), 126.1 (CHx2), 116.8 (CH), 115.9 (CH2), 105.3 (CH), 45.6 (CH2), 
31.5 (CH2), 31.2 (CH2). HRMS (ESI): calcd. for C16H18NO (M+H)
+: 240.1383 found 240.1382. HRMS 
(ESI): calcd. for C16H17NONa (M+Na)
+: 262.1202 found 262.1202. 
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Diethyl 1-((1-benzyl-6-oxo-1,6-dihydropyridin-2-yl)methyl)hydrazine-1,2-dicarboxylate (231m). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.10 
g, 0.5 mmol) in THF (5.0 mL), n-BuLi (0.4 mL, 0.5 mmol) and diethyl azodicarboxylate 238 (94 μL, 0.60 
mmol) in THF (2.0 mL) was performed. The crude product was purified by silica chromatography with 
elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 231m as yellow oil 
(83 mg, 45%). IR (Neat) 3430 (NH), 3063 (CHsp2), 2983 (CHsp3), 1723 (C=O), 1657 (C=O), 1577 (C=C), 
1267 (C-O), 1223 (CO), 770-735 (CHArom) cm
-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 9.12 (br. s., 1H), 
7.36 (dd, J=9.0, 7.2 Hz, 1H), 7.28 (t, J=7.5 Hz, 2H), 7.21 (t, J=7.2 Hz, 1H), 7.08 (d, J=7.2 Hz, 2H), 6.41 (d, 
J=9.0 Hz, 1H), 6.20 (d, J=7.2 Hz, 1H), 5.26 (s, 2H), 4.45 (s, 2H), 3.92 - 4.09 (m, 4H), 1.06 - 1.16 (m, 6H). 
13C NMR (DMSO-d6, 101 MHz):  (ppm) 163.0 (C=Ox2), 139.8 (CH), 129.1 (CHx3), 127.6 (CH), 126.5 
(CH), 119.8 (CH), 107.9 (CH), 62.78 (CH2), 61.5 (CH2x2), 45.8 (CH2), 14.9 (CH3x2). HRMS (ESI): calcd. 
for C19H24N3O5 (M+H)
+: 374.1710 found 374.1705. 
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Methyl 3-(1-benzyl-6-oxo-1,6-dihydropyridin-2-yl)-2-hydroxy-2-phenylpropanoate (231n). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.50 
g, 2.5 mmol) in THF (15 mL), n-BuLi (1.6 mL, 2.5 mmol) and methyl 2-oxo-2-phenylacetate 306 (0.43 
mL, 3.0 mmol) was performed. The resulting solution was stirred at -78 °C for 45 min. The crude 
product was purified by silica chromatography with elution gradient 0 to 100% EtOAc in heptane to 
afford compound 231n as a white solid (0.71 g, 78%). m.p. 158-159 °C. IR (KBr) 3144 (OH), 3061 
(CHsp2), 3026 (CHsp2Ar), 2969 (CHsp
3), 1727(C=O), 1648 (C=O), 1565 (C=C), 1384 (OH), 1070 (C-O), 
726-648 (CHArom) cm
-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 7.38 - 7.43 (m, 2H), 7.26 - 7.37 (m, 6H), 
7.20 - 7.26 (m, 1H), 6.99 (d, J=7.1 Hz, 2H), 6.61 (s, 1H), 6.35 (dd, J=9.0, 1.1 Hz, 1H), 6.02 (d, J=6.8 Hz, 
1H), 5.52 (d, J=16.2 Hz, 1H), 5.30 (d, J=16.2 Hz, 1H), 3.65 (s, 3H), 3.45 (d, J=15.2 Hz, 1H), 3.13 (d, 
J=15.2 Hz, 1H). 13C NMR (DMSO-d6, 101 MHz): (ppm) 173.2 (C=O), 162.5 (C=O), 145.9 (C), 141.7 
(C), 138.9 (CH), 137.2 (C), 128.6 (2xCH), 128.2 (2xCH), 127.8 (CH), 126.9 (CH), 125.9 (2xCH), 125.1 
(2xCH), 117.4 (CH), 107.3 (CH), 78.7 (C), 52.5 (CH3), 45.9 (CH2), 40.1 (CH2). UPLC, MS, r.t: 0.93 min, 
m/z: ES+ [M+H]+ 364. HRMS (ESI): calcd. for C22H22NO4 (M+H)
+: 364.1543, found 364.1545. 
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Alkylation of N-benzyl-2-pyridone. 
 
Synthesis of 1-benzyl-3-(1-hydroxypropyl)-6-methylpyridin-2(1H)-one(236). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.15 
g, 0.73 mmol) in THF (5.0 mL), n-BuLi (0.54 mL, 0.73 mmol) and propionaldehyde 235c (62 μL, 0.87 
mmol) in THF (2.0 mL) was performed. The crude product was purified by silica chromatography with 
elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 236 as a colourless 
oil (49 mg, 26%). 1H NMR (DMSO-d6, 400MHz):  (ppm) 7.40 (d, J=7.0 Hz, 1H. H-4), 7.30 - 7.37 (m, 
2H, H-11), 7.23 - 7.28 (m, 1H, H-12), 7.09 (d, J=7.1 Hz, 2H, H-10), 6.19 (d, J=7.0 Hz, 1H, H-5), 5.37 (d, 
J=15.7 Hz, 1H, H-8), 5.27 (d, J=15.7 Hz, 1H, H-8’), 4.99 (d, J=5.0 Hz, 1H, H-14), 4.55 - 4.62 (m, 1H, H-
13), 2.24 (s, 3H, H-7), 1.72 (ddd, J=13.4, 7.4, 3.9 Hz, 1H, H-15), 1.45 (dt, J=13.4, 7.4 Hz, 1H, H-15’), 
0.87 (t, J=7.4 Hz, 3H, H-16). 13C NMR (DMSO-d6, 101MHz):  (ppm) 161.5 (C=O), 144.5 (C), 137.3 (C), 
133.9 (C), 132.4 (CH), 128.7 (CHx2), 127.0 (CH), 126.2 (CHx2), 105.8 (CH), 68.6 (CH), 46.2 (CH2), 29.1 
(CH2), 19.9 (CH3), 10.0 (CH3). HRMS (ESI): calcd. for C16H20NO2 (M+H)
+: 258.1489 found 258.1487. 
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Synthesis of 1-(2,2-bis(4-chlorophenyl)-2-hydroxy-1-phenylethyl)-6-(2,2-bis(4-chlorophenyl)-2-
hydroxyethyl)pyridin-2(1H)-one (234). 
 
Following general procedure I, the reaction between 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.22 
g, 1.12 mmol) in THF (13 mL), n-BuLi (0.84 mL, 1.34 mmol), 4,4'-Dichlorobenzophenone 233a (0.34 g, 
1.34 mmol) in THF (2.0 mL) was performed. The crude product was purified by silica chromatography 
with elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 234 as a white 
solid (0.11 g, 15%). 1H NMR (DMSO-d6, 400MHz):  (ppm) 8.93 (s, 1H), 7.63 (d, J=8.0 Hz, 2H), 7.53 (d, 
J=8.0 Hz, 2H), 7.43 (d, J=8.0 Hz, 2H), 7.38 (d, J=8.0 Hz, 2H), 7.33 (d, J=8.0 Hz, 2H), 7.28 (d, J=8.4 Hz, 
2H), 7.20 - 7.26 (m, 5H), 7.13 - 7.20 (m, 3H), 7.02 - 7.08 (m, 1H), 7.00 (s, 1H), 6.79 - 6.86 (d, J=7.6 Hz, 
2H), 6.08 (d, J=8.8 Hz, 1H), 5.62 (d, J=7.2 Hz, 1H), 3.58 (d, J=15.3 Hz, 1H), 3.43 (d, J=15.3 Hz, 1H). 13C 
NMR (DMSO-d6, 101MHz):  (ppm) 166.3 (C, C-2), 147.6 (C), 146.4 (C), 146.3 (C), 144.9 (C), 144.8 (C), 
139.9 (CH), 137.3 (C), 132.5 (C), 132.3 (C), 132.1 (C), 131.8 (C), 129.4 (CH), 129.0 (CH), 128.7 (CH), 
128.54 (CH), 128.50 (CH), 128.4 (CH), 128.3 (CH), 128.2 (CH), 128.01 (CH), 127.96 (CH), 119.7 (CH), 
113.3 (CH), 79.2 (C), 78.8 (C), 73.1 (CH), 43.4 (CH2).  
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Methyl alkylation of 1,6-dimethyl-2-pyridone 
 
Experimental section 
General experimental procedure for the deprotonation of 1,6-dimethylpyridin-2(1H)-one and 
nucleophilic addition to several electrophiles. 
 
 
 
General procedure II: 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with 1,6-dimethylpyridin-2(1H)-one 228b (1 eq.) and dissolved in 
dry THF. The flask was cooled to -78 °C by immersion in a bath of dry ice/acetone. KHMDS (1 eq.) 
was added to the pale transparent yellow solution dropwise over 5 min and the reaction became 
orange in colour. The reaction mixture was warmed up to 0 °C and changed to a dark brown/green 
colour, and was then cooled to -78 °C. Concurrently, an additional oven-dried flask was purged with 
N2 and then was charged with the electrophile (1.2 eq.) which was then dissolved in dry THF. The 
electrophile solution was added dropwise to the pyridone solution at -78 °C via syringe over 5 min. 
The reaction was allowed to proceed for 2 h at -78 °C, before quenching with saturated NH4Cl (aq). 
EtOAc (10 mL) was added and the phases were separated. The aqueous layer was re-extracted with 
EtOAc (3 x 10 mL), and the combined organic layers were washed with brine.  The combined organic 
phases were dried over MgSO4, filtered and concentrated under reduced pressure and the crude 
product was purified by flash silica chromatography. 
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Synthesis of 1-methyl-2-methyl-deuterated-pyridin-4(1H)-one (239d). 
 
Following general set up of procedure II, 1,6-dimethylpyridin-2(1H)-one 228b (90 mg, 0.73 mmol) 
was dissolved in THF (6.0 mL). KHMDS (1.5 mL, 0.73 mmol) was added at -78 °C, and the reaction 
was stirred for 10 min at -78°C. D2O was added to the solution at -78°C, the reaction was stirred for 5 
min and quenched at -78°C to give compound 239d as a white solid (49 mg, 55%).  
Following general procedure II, reaction between 1,6-dimethylpyridin-2(1H)-one 228b (43 mg, 0.35 
mmol) in THF (12 mL), KHMDS (1.7 mL, 0.87 mmol) and quenching with D2O gave compound 239d as 
a white solid (22 mg, 51%).  1H NMR (CDCl3, 400MHz):  (ppm) 7.21 (dd, J=9.2, 6.8 Hz, 1H), 6.47 (d, 
J=9.2 Hz, 1H), 6.04 (d, J=6.8 Hz, 1H), 3.54 (s, 3H), 2.33 - 2.37 (m, 2H). 13C NMR (CDCl3, 101MHz):  
(ppm) 164.0 (C=O), 146.4 (C), 138.7 (CH), 117.3 (CH), 106.5 (CH), 31.2 (CH3), 20.75 (t, JC-D=19.6,CH2D). 
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6-(2-hydroxy-3-oxo-2,3-di-p-tolylpropyl)-1-methylpyridin-2(1H)-one (239a). 
 
Following general procedure II, the reaction between 1,6-dimethylpyridin-2(1H)-one 228b (61 mg, 
0.50 mmol) in THF (6.0 mL), KHMDS (1.0 mL, 0.50 mmol) and 1,2-di-p-tolylethane-1,2-dione 232a 
(0.145 g, 0.60 mmol) in THF (8.0 mL) was performed. The crude product was purified by silica 
chromatography with elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford 
compound 239a as a white solid (0.11 g, 65%). m.p. 174-175 °C. IR (KBr) 3071 (OH), 3030 (CHsp2), 
2918 (CHsp3), 1672 (C=O), 1644 (C=O), 1605 (C=C), 1559 (C=C), 1509 (C=C), 1379(C-OH), 1096 (CO), 
826, 804 (CHArom) cm
-1. 1H NMR (CDCl3, 400 MHz):  (ppm) 7.67 - 7.71 (m, 2H), 7.31 - 7.36 (m, 2H), 
7.19 (d, J=8.0 Hz, 2H), 7.12 (d, J=8.0 Hz, 2H), 7.02 (dd, J=9.0, 6.8 Hz, 1H), 6.32 (dd, J=9.0, 1.2 Hz, 1H), 
5.70 (dd, J=6.8, 1.2 Hz, 1H), 5.08 (s, 1H), 3.64 - 3.77 (m, 2H), 3.44 (s, 3H), 2.35 (s, 3H), 2.35 (s, 3H). 13C 
NMR (CDCl3, 101MHz):  (ppm) 199.3 (C=O), 164.1 (C=O), 145.2 (C), 144.1 (C), 138.4 (C), 138.3 (C), 
137.9 (CH), 131.2 (C), 130.5 (CHx2), 129.8 (CHx2), 129.2 (CHx2), 125.2 (CHx2), 118.1 (CH), 108.9 (CH), 
82.2 (C), 41.6 (CH2), 32.4 (CH3), 21.6 (CH3), 21.1 (CH3). HRMS (ESI): calcd. for C23H24NO3 (M+H)
+: 
362.1751 found 362.1751. HRMS (ESI): calcd. for C23H23NO3Na (M+Na)
+: 384.1570 found 384.1565. 
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6-(But-3-en-1-yl)-1-methylpyridin-2(1H)-on (239b). 
   
Following general procedure II, the reaction between 1,6-dimethylpyridin-2(1H)-one 228b (0.11 g, 
0.85 mmol) in THF (8.0 mL), KHMDS (1.7 mL, 0.85 mmol) and allylbromide 222h (80 μL, 1.0 mmol) in 
THF (2.0 mL) was performed. The crude product was purified by silica chromatography with elution 
gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 239b as light brown oil 
(0.10 g, 75%). IR (Neat) 3077 (CHsp2), 2976 (CHsp3), 2923 (CHsp3), 1656 (C=O), 1571 (C=C), 1554 
(C=C) cm-1. 1H NMR (CDCl3, 400MHz):  (ppm) 7.25 (dd, J=9.2, 6.8 Hz, 1H), 6.48 (d, J=9.2 Hz, 1H), 6.04 
(d, J=6.8 Hz, 1H), 5.86 (ddt, J=17.0, 10.2, 6.5 Hz, 1H), 5.07 - 5.16 (m, 2H), 3.57 (s, 3H), 2.69 - 2.75 (m, 
2H), 2.34 - 2.46 (m, 2H). 13C NMR (CDCl3, 101MHz):  (ppm) 164.1 (C=O), 149.2 (C), 138.5 (CH), 136.0 
(CH), 117.5 (CH), 116.4 (CH2), 105.7 (CH), 32.9 (CH2), 31.9 (CH2), 30.9 (CH3). HRMS (ESI): calcd. for 
C10H14NO (M+H)
+: 164.1070 found 164.1065. 
6-(2-hydroxy-3,3-dimethylbutyl)-1-methylpyridin-2(1H)-one (239c). 
 
Following general procedure II, the reaction between 1,6-dimethylpyridin-2(1H)-one 228b (99 mg, 
0.80 mmol) in THF (8.0 mL), KHMDS (1.6 mL, 0.80 mmol) and trimethylacetaldehyde 235b (0.10 mL, 
0.96 mmol) in THF (2.0 mL) gave compound 239c as a pale yellow solid (0.14 g, 84%). m.p. 93-94 °C. 
IR (KBr) 3391 (OH), 2958 (CHsp3), 2867 (CHsp3), 1647 (C=O), 1570 (C=C), 1384 (OH), 1148 (CO) cm-1. 
1H NMR (CDCl3, 400 MHz): δ (ppm) 7.23 (dd, J=9.0, 6.8 Hz, 1H, H-4), 6.42 (dd, J=9.0, 1.2 Hz, 1H, H-3), 
6.14 (dd, J=6.8, 1.2 Hz, 1H, H-5), 3.55 (s, 3H, CH3, H-7), 3.53 (m, 1H, H-9), 2.89 (dd, J=14.6, 1.8 Hz, 1H, 
H-8), 2.61 (dd, J=14.6, 10.4 Hz, 1H, H-8´), 1.03 (s, 9H, 3xCH3, H-11). 
13C NMR (CDCl3, 101MHz):  
(ppm) 164.2 (C=O, C2), 148.7 (C, C-6), 138.6 (CH, C-4), 117.4 (CH, C-3), 107.8 (CH, C-5), 77.7 (CH, C-9), 
36.2 (CH2, C-8), 35.4 (C, C-10), 31.5 (CH3, C-7), 25.6 (CH3, C-11). HRMS (ESI): calcd. for C12H20NO2 
(M+H)+: 210.1489 found 210.1484. HRMS (ESI): calcd. for C12H19NO2Na (M+Na)
+: 232.1308 found 
232.1305. 
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Diethyl 1-((1-methyl-6-oxo-1,6-dihydropyridin-2-yl)methyl)hydrazine-1,2-dicarboxylate (239e). 
 
Following general procedure II, the reaction between 1,6-dimethylpyridin-2(1H)-one 228b (59 mg, 
0.48 mmol) in THF (6.0 mL), KHMDS (0.96 mL, 0.48 mmol) and diethyl azodicarboxylate 238 (90 μL, 
0.57 mmol) in THF (2.0 mL) was performed. The crude product was purified by silica chromatography 
with elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 239e as white 
oil (0.10 g, 70%). IR (Neat) 3210 (N-H), 2983 (CHsp3), 2933 (CHsp3), 1730 (C=O), 1655 (C=O), 1266-
1238 (RCO-O-C) cm-1. 1H NMR (CDCl3, 400 MHz):  (ppm) 7.60 (br. s., 1H), 7.16 (dd, J=9.0, 6.6 Hz, 
1H), 6.44 (d, J=9.0 Hz, 1H), 6.07 (d, J=6.6 Hz, 1H), 4.64 (br. s., 2H), 4.22 (q, J=7.0 Hz, 2H), 4.14 (q, J=7.0 
Hz, 2H), 3.47 (s, 3H), 1.15 - 1.29 (m, 6H). 13C NMR (CDCl3, 101MHz):  (ppm) 163.8 (CO), 156.1 (CO), 
155.9 (CO), 143.5 (C), 138.2 (CH), 138.1 (CH), 119.6 (CH), 108.6 (CH), 63.2 (CH2), 62.1 (CH2), 51.5 
(CH2), 31.0 (N-CH3), 14.44 (CH3), 14.42 (CH3). HRMS (ESI): calcd. for C13H20N3O5 (M+H)
+: 298.1397 
found 298.1407. HRMS (ESI): calcd. for C13H19N3O5Na (M+Na)
+: 320.1217 found 320.1226. 
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6-(hex-5-en-1-yl)-1-methylpyridin-2(1H)-one (239f).78 
 
1,6-Didimethylpyridin-2(1H)-one 228b (0.11 g, 0.88 mmol) was dissolved in THF (6.0 mL) and the 
resulting solution was cooled to -78 °C. KHMDS (1.7 mL, 0.88 mmol) was added to the pyridone 
solution at -78 °C, the reaction mixture was warmed up to 0 °C. The reaction was cooled again to -78 
°C and 5-bromopent-1-ene 222j (0.12 mL, 1.1 mmol) in THF (2.0 mL) was added to the solution over 
5 min. The reaction was allowed to proceed for 1 h. at -10 °C, before quenching with saturated 
NH4Cl(aq). EtOAc (10 mL) was added and the phases were separated. The aqueous layer was re-
extracted with EtOAc (3 x 10 mL). The combined organic layers were washed with brine.  The 
combined organic phases were dried over MgSO4, filtered and concentrated under reduced pressure 
and the crude product was purified by flash silica chromatography, with elution gradient 0 to 100 % 
EtOAc in petroleum ether 40-60° to afford compound 239f as a light colorless oil (34 mg, 20%). 1H 
NMR (CDCl3, 400MHz):  (ppm) 7.23 (dd, J=8.8, 7.0 Hz, 1H), 6.46 (d, J=8.8 Hz, 1H), 6.02 (d, J=7.0 Hz, 
1H), 5.80 (ddt, J=17.0, 10.2, 6.5 Hz, 1H), 4.96 - 5.07 (m, 2H), 3.54 (s, 3H), 2.58 - 2.65 (m, 2H), 2.12 (q, 
J=7.0 Hz, 2H), 1.59 - 1.70 (m, 2H), 1.51 (dt, J=15.0, 7.4 Hz, 2H). 13C NMR (CDCl3, 101MHz):  (ppm) 
164.2 (C=O), 150.1 (C), 138.7 (CH), 138.2 (CH), 117.4 (CH), 115.2 (CH2), 105.7 (CH), 33.6 (CH2), 33.4 
(CH2), 31.0 (CH3), 28.4 (CH2), 27.4 (CH2). HRMS (ESI): calcd. for C12H17NO (M+H)
+: 192.1383 found 
192.1381. HRMS (ESI): calcd. for C12H17NONa (M+Na)
+: 214.1202 found 214.1202. 
Literature reference: 1H NMR (CDCl3, 400MHz):  (ppm) 7.26 (dd, J=7.9 Hz, 1H), 6.47 (d, J=10 Hz, 
1H), 6.07 (d, J=7.0 Hz, 1H), 5.63-6.08 (m, 1H), 4.83 - 5.18 (m, 2H), 3.56 (s, 3H), 2.64 (t, J= 7 Hz, 2H), 
1.91-2.33 (m, 2H), 1.41 - 1.84 (m, 4H).78 
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Alkylation of 1,6-dimethyl-2-pyridone.  
 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with 1,6-dimethylpyridin-2(1H)-one 228b (69 mg, 0.56 mmol) in  
dry THF (6.0 mL). The flask was cooled to -78 °C by immersion in a bath of dry ice/acetone. KHMDS 
(2.8 mL, 1.4 mmol) was added to the flask dropwise over 5 min. The reaction mixture was warmed 
up to 0 °C. Concurrently, an additional oven-dried flask was purged with N2 and then was charged 
with 5-bromo-1-pentane 222j (79 μL, 0.67 mmol) which was then dissolved in dry THF (2.0 mL). The 
electrophile solution was added dropwise to the pyridone solution at 0 °C via syringe over 5 min. The 
reaction was allowed to proceed for 2 h at 0 °C by immersion in an ice bath, before quenching with 
saturated NH4Cl(aq). EtOAc (10 mL) was added and the phases were separated. The aqueous layer 
was re-extracted with EtOAc (3 x 10 mL). The combined organic layers were washed with brine.  The 
combined organic phases were dried over MgSO4, filtered and concentrated under reduced pressure 
and the crude product was purified by flash silica chromatography, with elution gradient 0 to 100 % 
EtOAc in petroleum ether 40-60°. To afford compound 240 colourless oil, (12 mg, 8%); compound 
241 colourless oil, (8 mg, 8%) and 242 as a colourless oil, (26 mg, 18%).  
 
 
 
 
 
 
204 
 
6-(hex-5-en-1-yl)-1-methyl-3-(pent-4-en-1-yl)pyridin-2(1H)-one (240). 
 
IR (Neat) 3075 (CHsp2), 2978 (CHsp3), 2928 (CHsp3), 1648 (C=O), 1597 (C=C), 1569 (C=C) cm-1. 1H NMR 
(CDCl3, 400MHz):  (ppm) 7.05 (d, J=7.0 Hz, 1H), 5.94 (d, J=7.2 Hz, 1H), 5.69 - 5.89 (m, 2H), 4.87 - 
5.06 (m, 4H), 3.51 (s, 3H), 2.52 - 2.60 (m, 2H), 2.44 - 2.52 (m, 2H), 2.08 (q, J=6.9 Hz, 4H), 1.53 - 1.71 
(m, 4H), 1.43 - 1.53 (m, 2H). 13C NMR (CDCl3, 101MHz):  (ppm) 164.0 (C), 147.1 (C), 138.8 (CH), 
138.2 (CH), 135.5 (CH), 129.7 (C), 115.1 (CH2), 114.6 (CH2), 105.1 (CH), 33.6 (CH2), 33.5 (CH2), 33.4 
(CH2), 31.1 (CH3), 30.5 (CH2), 28.5 (CH2), 27.6 (CH2), 27.5 (CH2). HRMS (ESI): calcd. for C17H25NONa 
(M+Na)+: 282.1828 found 282.1830. 
1,6-dimethyl-3-(pent-4-en-1-yl)pyridin-2(1H)-one (241). 
 
 
IR (Neat) 3075 (CHsp2), 2924 (CHsp3), 2923 (CHsp3), 1648 (C=O), 1594 (C=C), 1570 (C=C) cm-1. 1H NMR 
(CDCl3, 400MHz):  (ppm) 7.04 (d, J=6.8 Hz, 1H), 5.96 (d, J=6.8 Hz, 1H), 5.74 - 5.90 (m, 1H), 4.87 - 
5.06 (m, 2H), 3.52 (s, 3H), 2.50 (t, J=7.6 Hz, 2H), 2.30 (s, 3H), 2.09 (q, J=7.0 Hz, 2H), 1.65 (m, 2H). 13C 
NMR (CDCl3, 101MHz):  (ppm) 163.8 (C), 143.4 (C), 138.8 (CH), 135.5 (CH), 129.8 (C), 114.6 (CH2), 
105.9 (CH), 33.6 (CH2), 31.4 (CH3), 30.5 (CH2), 27.6 (CH2), 20.9 (CH3). HRMS (ESI): calcd. for C12H18NO 
(M+H)+: 192.1383 found 192.1382. 
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1-methyl-6-(undeca-1,10-dien-6-yl)pyridin-2(1H)-one (242). 
 
IR (Neat) 3075 (CHsp2), 2975 (CHsp3), 2931 (CHsp3), 1661 (C=O), 1583 (C=C), 1549 (C=C) cm-1. 1H NMR 
(CDCl3, 400MHz):  (ppm) 7.19 - 7.31 (m, 1H), 6.37 - 6.47 (m, 1H), 6.01 (d, J=6.9 Hz, 1H), 5.70 (ddt, 
J=17.0, 10.2, 6.5 Hz, 2H), 4.88 - 5.01 (m, 4H), 3.56 (s, 3H), 2.76 - 2.90 (m, 1H), 1.93 - 2.04 (m, 4H), 
1.46 - 1.70 (m, 4H), 1.23 - 1.39 (m, 4H). 13C NMR (CDCl3, 101MHz):  (ppm) 164.3 (C), 154.5 (C), 138.7 
(CH), 138.1 (CHx2), 117.0 (CH), 115.1 (CH2x2), 103.6 (CH), 40.9 (CH), 34.7 (CH2x2), 33.7 (CH2x2), 30.8 
(CH3), 26.4 (CH2x2). HRMS (ESI): calcd. for C17H26NO (M+H)
+: 260.2009 found 260.2010. HRMS (ESI): 
calcd. for C17H25NONa (M+Na)
+: 282.1828 found 282.1829. 
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Synthesis of 1-(2-hydroxy-3-oxo-2,3-di-p-tolylpropyl)-6-methylpyridin-2(1H)-one (243). 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with 1,6-dimethylpyridin-2(1H)-one 228b (0.31 g, 2.5 mmol) 
which was then dissolved in dry THF (15 mL). The flask was cooled to -78 °C by immersion in a bath 
of dry ice/acetone. LDA (3.1 ml, 2.5 mmol, 0.8 M) was added to the solution dropwise.  After 10 min, 
the resulting solution was warmed up and stirred at 0 °C over 2 min and then was then cooled to -78 
°C. A solution of 1,2-di-p-tolylethane-1,2-dione 232a (0.60 g, 2.50 mmol) in THF (5 mL) was added to 
a stirred solution. The resulting solution was stirred at -78°C, for 30 min under N2. A solution of LDA 
(3.1 mL, 2.50 mmol, 0.8 M) was added to reaction mixture. The resulting solution was stirred at -78 
°C for 1 h. The reaction mixture was quenched with saturated NH4Cl(aq) (10 mL), extracted with EtOAc 
(3 x 15 mL), the organic layer was dried over MgSO4, filtered and evaporated to afford a yellow oil. 
The crude product was purified by flash silica chromatography, elution gradient 0 to 100% EtOAc in 
heptane. Pure fractions were evaporated to dryness to afford 1-(2-hydroxy-3-oxo-2,3-di-p-
tolylpropyl)-6-methylpyridin-2(1H)-one 243 (0.27 g, 30%) as a colourless crystalline solid. m.p. 148 
°C. IR (KBr) 3137 (OH), 3032(CHsp2), 2950, 2920, 2855 (CHsp3), 1664 (C=O), 1650 (C=O), 1606 (C=C), 
1560 (C=C), 1509 (C=C), 1403(C-OH), 1109(C-OH), 800 (CHArom) cm
-1. m.p. 148 °C. 1H NMR (DMSO-d6, 
700MHz):  (ppm) 8.23 (s, 1H), 7.71 (d, J=8.4 Hz, 2H), 7.36 (dd, J=9.1, 8.4 Hz, 1H), 7.18 (d, J=8.4 Hz, 
2H), 7.09 - 7.14 (m, 4H), 6.40 (d, J=9.1 Hz, 1H), 6.11 (d, J=6.3 Hz, 1H), 4.80 (d, J=14.7 Hz, 1H), 4.62 (d, 
J=14.7 Hz, 1H), 2.26 (s, 3H), 2.23 (s, 3H), 1.87 (s, 3H). 13C NMR (DMSO-d6, 176MHz):  (ppm) 198.3 
(C=O, C-11), 166.0 (C=O, C-2), 148.5 (C, C-6), 143.0 (C, C-15), 140.7 (CH, C-4), 137.5 (C, C-17), 137.2 
(C, C-20), 131.4 (C, C-12), 130.5 (CHx2, C-13), 129.1 (CHx2, C-19), 128.4 (CHx2, C-14), 124.8 (CHx2, C-
18), 116.1 (CH, C-3), 108.4 (CH, C-5), 82.8 (C, C-9), 54.4 (CH2, C-8), 21.0 (CH3, C-16), 20.5 (CH3, C-21), 
20.1 (CH3, C-7). LCMS r.t. 1.15 min. m/z: ES+ [M+H]+ 362. 
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Synthesis of 4-pyridone derivatives. 
 
4-(benzyloxy)-2-methylpyridine (224a).92 
 
Sodium hydride (60% dispersion in mineral oil) (0.24 g, 6.0 mmol) was added to dry DMSO (6.9 mL) 
under N2 atmosphere and benzyl alcohol 38c (0.50 mL, 4.8 mmol) was added dropwise to the 
reaction mixture. The reaction mixture stirred at room temperature over 10 min. 4-Chloro-2-
methylpyridine 223 (0.44 mL, 4.0 mmol) was added dropwise to the reaction mixture. The reaction 
mixture was stirred at r.t for 3 h and saturated NH4Cl(aq) was added slowly. CH2Cl2 (10 mL) was added 
and the phases were separated. The aqueous layer was re-extracted with CH2Cl2 (3 x 10 mL). The 
combined organic phases were dried over MgSO4, filtered and concentrated under reduced pressure 
to afford a yellow solid. The crude product was purified by flash silica chromatography, with elution 
gradient 0 to 100 % EtOAc in petroleum ether 40-60°, to give 4-(benzyloxy)-2-methylpyridine 224a as 
a white solid (0.60 g, 75%). m.p. 99 °C. IR (KBr) 3034 (CHsp2), 3027 (CHsp2), 2945 (CHsp3), 1599 (C=C), 
1566 (C=C), 743-700 (CHArom) cm
-1. 1H NMR (DMSO-d6, 400 MHz): (ppm) 8.25 (d, J=5.8 Hz, 1H), 7.32 
- 7.49 (m, 5H), 6.92 (d, J=2.4 Hz, 1H), 6.85 (dd, J=5.8, 2.4 Hz, 1H), 5.17 (s, 2H), 2.41 (s, 3H). 13C NMR 
(DMSO-d6, 101 MHz):  (ppm) 165.0 (C), 160.0 (C), 150.6 (CH), 136.7 (C), 129.0 (CHx2), 128.6 (CH), 
128.3 (CHx2), 110.0 (CH), 108.5 (CH), 69.5 (CH2), 24.6 (CH3). HRMS (ESI): calcd. for C13H13NO (M+H)
+: 
200.1070 found 200.1065. HRMS (ESI): calcd. for C13H13NONa (M+Na)
+: 222.0889 found 222.0885. 
Literature reference: 1H NMR (CDCl3, 400 MHz): (ppm)  8.31 (d, J= 5.7 Hz, 1H) 7.40-7.32 (m, 5H) 
6.75-6.74 (m, 1H) 6.71-6.69 (m, 1H) 5.08 (s, 2H) 2.50 (s, 3H).92 
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Synthesis of 1-benzyl-4-(benzyloxy)-2-methylpyridin-1-ium bromide (225a). 
 
 4-(Benzyloxy)-2-methylpyridine 224a (0.42 mg, 2.0 mmol) was suspended in toluene (2.0 mL). 
Benzyl bromide 222c (0.25 mL, 2.0 mmol) was added, the reaction was stirred under reflux 
overnight.  The white precipitate formed was filtered off, and was washed with cold diethyl ether to 
afford 1-benzyl-4-(benzyloxy)-2-methylpyridin-1-ium bromide 225a as a white solid (0.56 mg, 76%). 
m.p. 168°C. IR (KBr) 3267 (OH), 3057 (CHsp2Ar), 3027 (CHsp
2), 2963 (CHsp3), 1667 (C=O), 1646 (C=O), 
1562 (C=C), 1545 (C=C), 1142 (CO), 812-720 (CHArom) cm
-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 
8.97 (d, J=7.2 Hz, 1H), 7.77 (d, J=3.0 Hz, 1H), 7.68 (dd, J=7.2, 3.0 Hz, 1H), 7.51 - 7.56 (m, 2H), 7.37 - 
7.50 (m, 6H), 7.21 - 7.26 (m, 2H), 5.76 (s, 2H), 5.47 (s, 2H), 2.65 (s, 3H). 13C NMR (DMSO-d6, 101 
MHz):  (ppm) 169.6 (C), 156.4 (C), 147.5 (CH), 134.4 (C), 133.9 (C), 129.2 (CHx2), 128.9 (CH), 128.7 
(CHx2), 128.6 (CH), 128.5 (CHx2), 127.1 (CHx2), 115.2 (CH), 112.5 (CH), 72.0 (CH2), 58.4 (CH2), 19.8 
(CH3). HRMS (ESI): calcd. for C20H20NO
+ (M-Br)+: 290.1539 found 290.1536. HRMS (ESI): calcd. for 
C40H40
79BrN2O2 (2M+Br)
+: 659.2268 found 659.2253. 
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Synthesis of 4-(benzyloxy)-1,2-dimethylpyridin-1-ium iodide (225b). 
 
4-(Benzyloxy)-2-methylpyridine 224a (0.44 g, 2.2 mmol) was dissolved in EtOAc (6.0 mL). 
Iodomethane (0.14 mL, 2.2 mmol) was added to the reaction mixture which was then stirred at 40 °C 
overnight.  The white precipitate product was filtered off and was washed with cold EtOAc to afford 
4-(benzyloxy)-1,2-dimethylpyridin-1-ium iodide 225b as a white solid (0.75 g, 100%). m.p. 160 °C. IR 
(KBr) 3031 (CHsp2), 2946 (CHsp3), 1643 (C=C), 1572 (C=C), 1516 (C=C), 1145 (CO), 773-706 (CHArom) 
cm-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 8.72 (d, J=7.2 Hz, 1H), 7.65 (br. s., 1H), 7.44 - 7.53 (m, 
3H), 7.32 - 7.44 (m, 3H), 5.40 (s, 2H), 4.01 (s, 3H), 2.64 (s, 3H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 
169.6 (C), 157.4 (C), 147.9 (CH), 135.0 (C), 129.3 (CH), 129.2 (CHx2), 128.9 (CHx2), 114.6 (CH), 112.3 
(CH), 72.2 (CH2), 44.2 (CH3), 20.5 (CH3). HRMS (ESI): calcd. for C14H16NO (M-I)
+: 214.1226 found 
214.1221. HRMS (ESI): calcd. for C28H32IN2O2 (2M+I)
+: 555.1503 found 555.1484. 
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Synthesis of 4-methoxy-2-methylpyridine (224b). 
 
Sodium hydride 60% dispersion (0.48 g, 12 mmol) was added to dry DMSO (12 mL) under N2 
atmosphere; dry methanol 38b (0.38 mL, 9.6 mmol) was added dropwise to the reaction mixture. 
The reaction mixture stirred at r.t. for 10 min, and 4-chloro-2-methylpyridine 233 (0.89 mL, 8.0 
mmol) was added dropwise to the reaction mixture. The reaction mixture was stirred at r.t. for 3 h 
and saturated NH4Cl(aq) was added slowly. CH2Cl2 (10 mL) was added and the phases were separated. 
The aqueous layer was re-extracted with CH2Cl2 (3 x 10 mL). The combined organic phases were 
dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was 
purified by flash silica chromatography, with elution gradient 0 to 100% EtOAc in petroleum ether 
40-60°, to give 4-methoxy-2-methylpyridine 224b as colourless oil (0.32 g, 30%). 1H NMR (CDCl3, 
400MHz):  (ppm) 8.23 (d, J=5.6 Hz, 1H), 6.61 (d, J=1.6 Hz, 1H), 6.58 (d, J=5.6 Hz, 1H), 3.77 (s, 3H), 
2.44 (s, 3H). 13C (CDCl3): 166.0 (C), 159.9 (C), 150.2 (CH), 109.0 (CH), 107.3 (CH), 55.0 (CH3), 24.5 
(CH3). 
Synthesis of 4-methoxy-1,2-dimethylpyridin-1-ium iodide (225c). 
 
4-methoxy-2-methylpyridine 224b (0.32 g, 2.6 mmol) was dissolved in EtOAc (6.0 mL). Iodomethane 
(0.16 mL, 2.6 mmol) was added to the reaction mixture which was then stirred at r.t. for 48 h.  The 
white precipitate product was filtered off and was washed with cold EtOAc to afford 4-methoxy-1,2-
dimethylpyridin-1-ium iodide 225c as a white solid (0.44 g, 63%). m.p. 165 °C. IR (KBr) 3013 (CHsp2), 
2990 (CHsp3), 1637 (C=C), 1434 (CHsp3), 1197 (C-O-C), cm-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 
8.75 (d, J=7.2 Hz, 1H), 7.60 (d, J=3.0 Hz, 1H), 7.47 (dd, J=7.2, 3.0 Hz, 1H), 4.05 (s, 6H), 2.68 (s, 3H). 13C 
NMR (DMSO-d6, 101MHz):  (ppm) 170.5 (C), 157.4 (C), 147.8 (CH), 114.0 (CH), 111.9 (CH), 58.3 
(CH3), 44.1 (CH3), 20.4 (CH3). HRMS (ESI): calcd. for C8H12NO (M-I)
+: 138.0913 found 138.0908. HRMS 
(ESI): calcd. for C16H24IN2O2 (2M+I)
+: 403.0877 found 403.0864. 
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Synthesis of 1-benzyl-2-methylpyridin-4(1H)-one (226a). 
 
1-Benzyl-4-(benzyloxy)-2-methylpyridin-1-ium bromide 225a (0.72 g, 2.0 mmol) was dissolved in 
THF:H2O (23 mL : 5.7 mL) and 2M aqueous NaOH (2.9 mL, 5.8 mmol) was added. The mixture was 
stirred at r.t. and monitored by TLC, (CH2Cl2 : MeOH 9:1), the reaction was complete in 3 h. The 
mixture was diluted with CH2Cl2 (20 mL), and the phases were separated, and then the aqueous 
layer was re-extracted with CH2Cl2 (2 x 15 mL). The combined organic phases were washed with 
aqueous NaOH 2M. The organic phase was dried over MgSO4 to afford crude product as orange oil. 
The crude product was purified by flash silica chromatography (CH2Cl2 : MeOH 9:1) to give 1-benzyl-
2-methylpyridin-4(1H)-one 226a as a colourless crystals (0.28 g, 70%). m.p. 99 °C. IR (KBr) 3063 
(CHsp2), 2927 (CHsp3), 1637 (C=O), 1543(C=C), 1496 (C=C), 736 (CAr) cm
-1. 1H NMR (CDCl3, 400MHz): 
(ppm) 7.27 - 7.40 (m, 4H), 7.03 (d, J=6.8 Hz, 2H), 6.34 (dd, J=7.4, 2.2 Hz, 1H), 6.28 (d, J=2.2 Hz, 1H), 
5.03 (s, 2H), 2.19 (s, 3H). 13C NMR (CDCl3, 101MHz):  (ppm) 178.5 (CO), 147.4 (C), 140.8 (CH), 134.3 
(C), 128.3 (2 x CHAr), 127.4 (CHAr), 124.9 (2 x CHAr), 118.5 (CH, C3), 116.7 (CH, C5), 55.3 (CH2), 18.7 
(CH3).  
1H NMR (DMSO-d6, 400MHz):  (ppm) 7.79 (d, J=7.6 Hz, 1H), 7.40 (dd, J= 7.2, 7.6 Hz, 2H), 
7.324 (t, J=7.2 Hz, 1H), 7.11 (d, J=7.2 Hz, 2H), 6.06 - 6.12 (m, 2H), 5.19 (s, 2H), 2.15 (s, 3H). 13C NMR 
(DMSO-d6, 101MHz):  (ppm) 177.8 (C=O), 148.8 (C), 142.9 (CH), 137.0 (C), 129.0 (CHx2), 127.8 (CH), 
126.2 (CHx2), 118.4 (CH), 116.4 (CH), 55.0 (CH2), 18.9 (CH3). HRMS (ESI): calcd. for C13H14NO (M+H)
+: 
200.1070 found 200.1065. 
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Synthesis of 1,2-dimethylpyridin-4(1H)-one (226b). 
 
4-(Benzyloxy)-1,2-dimethylpyridin-1-ium iodide 225b (1.2 g, 3.6 mmol) was dissolved in THF : H2O 
(5.3 mL : 2.6 mL) and 2M aqueous NaOH (5.3 mL, 11 mmol) was added. The mixture was stirred at 
r.t. and monitored by TLC, (CH2Cl2 : MeOH 9 : 1), the reaction was complete in 4 h. The mixture was 
diluted with CH2Cl2 (20 mL), and the phases were separated, and then the aqueous layer was re-
extracted with CH2Cl2 (4 x 20 mL). The organic phase was dried over Na2SO4 to afford crude product 
as an orange oil. The crude product was purified by flash silica chromatography (CH2Cl2 : MeOH 9 : 1) 
which gave 1,2-dimethylpyridin-4(1H)-one 226b as a colourless crystals (0.44 g, 25%). m.p. 46 °C. 
IR(Neat) 3072 (CHsp2), 2959 (CHsp3), 1639 (C=O), 1543(C=C) cm-1. 1H NMR (DMSO-d6, 400 MHz): δ 
(ppm) 7.56 (d, J=7.2 Hz, 1H), 5.99 (d, J=2.6 Hz, 1H), 5.93 (dd, J=7.2, 2.6 Hz, 1H), 3.50 (s, 3H), 2.19 (s, 
3H). 1H NMR (CDCl3, 400MHz):  (ppm) 7.27 - 7.29 (m, 1H), 6.29 - 6.30 (m, 2H), 3.59 (s, 3H), 2.30 (s, 
3H). 13C NMR (CDCl3, 101 MHz): δ (ppm) 178.4 (C=O, C-4), 149.5 (C, C-6), 142.8 (CH, C-2), 118.4 (CH, 
C-5), 116.9 (CH, C-3), 41.3 (CH3, C-8), 20.1 (CH3, C-7).  
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Methyl alkylation of N-benzyl-4-pyridones. 
General procedure III: 
 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with 1-benzyl-2-methylpyridin-4(1H)-one 226a (1eq.) and 
dissolved in dry THF. The flask was cooled to -78 °C by submerging in a bath of dry ice/acetone. n-
Butyllithium (1eq.) was added to the pale transparent yellow solution dropwise over 5 min and the 
reaction became an intense purple colour. The reaction mixture was warmed up to 0°C and showed 
a red colour, and then the reaction was cooled to -78 °C. Concurrently, an additional oven-dried flask 
was purged with N2 and then was charged with the electrophile (1.2 eq.) dissolved/ diluted in dry 
THF. The electrophile solution was added dropwise to the pyridone solution at -78 °C via syringe 
over 5 min. The reaction was allowed to proceed for 2 h at -78 °C, before quenching with saturated 
NH4Cl(aq) EtOAc (10 mL) was added and the phases were separated. The aqueous layer was re-
extracted with EtOAc (3 x 15 mL). The combined organic layers were washed with brine and dried 
with MgSO4, filtered and concentrated under reduced pressure and the crude product was purified 
by flash silica chromatography (95 : 5 CH2Cl2 : MeOH). 
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1-benzyl-2-(2-hydroxy-3-oxo-2,3-di-p-tolylpropyl)pyridin-4(1H)-one (244a). 
 
Following general procedure III, the reaction between 1-benzyl-2-methylpyridin-4(1H)-one 226a (80 
mg, 0.40 mmol) in THF (8.0 mL), n-butyllithium (0.40 ml, 0.40 mmol) and 1,2-di-p-tolylethane-1,2-
dione 232a (0.11 g,  0.48 mmol) in THF (3.0 mL) was carried out. The crude product was purified by 
silica chromatography (95 : 5 CH2Cl2 : MeOH) to afford compound 244a as a yellow solid (81 mg, 45 
%). m.p. 188 °C. IR (KBr) 3428 (C-OH), 3063 (CHsp2), 2923 (CHsp3), 1673 (C=O), 1631 (C=O), 1539 
(C=C), 732 (CAr) cm
-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 7.77 (d, J=7.9 Hz, 2H), 7.58 (d, J=7.5 Hz, 
1H), 7.32 - 7.37 (m, 2H), 7.27 (d, J=7.5 Hz, 1H), 7.08 - 7.16 (m, 6H), 6.93 (d, J=7.5 Hz, 2H), 6.91 (s, 1H), 
5.94 (dd, J=7.5, 2.8 Hz, 1H), 5.74 (d, J=2.4 Hz, 1H), 5.08 (d, J=16.7 Hz, 1H), 4.75 (d, J=16.7 Hz, 1H), 
3.04 - 3.17 (m, 2H), 2.22 (d, J=5.6 Hz, 6H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 199.0 (C=O), 177.5 
(C=O), 147.8 (C), 143.7 (CH), 143.6 (C), 138.4 (C), 137.7 (C), 137.3 (C), 132.1 (C), 131.1 (CHx2), 129.7 
(CHx2), 129.5 (CHx2), 129.1 (CHx2), 128.2 (CH), 126.4 (CHx2), 125.3 (CHx2), 122.0 (CH), 116.9 (CH), 
82.5 (C), 55.6 (CH2), 41.7 (CH2), 21.6 (CH3), 21.2 (CH3). HRMS (ESI): calcd. for C29H28NO3 (M+H)
+: 
438.2064 found 438.2054. HRMS (ESI): calcd. for C29H27NO3Na (M+Na)
+: 460.1883 found 460.1871. 
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Synthesis of 1-benzyl-2-(2-hydroxy-3,3-dimethylbutyl)pyridin-4(1H)-one (244c). 
  
Following general procedure III, the reaction between 1-benzyl-2-methylpyridin-4(1H)-one 226a (83 
mg, 0.42 mmol) in THF (6.0 mL), n-butyllithium (0.40 ml, 0.42 mmol) and trimethylacetaldehyde (52 
µL, 0.50 mmol) in THF (2.0 mL) was carried out. The crude product was purified by silica 
chromatography (95 : 5 CH2Cl2 : MeOH) to afford compound 244c as a pale orange solid (46 mg, 
40%). 1H NMR (DMSO-d6, 400MHz):  (ppm) 7.78 (d, J=7.6 Hz, 1H), 7.36 - 7.42 (m, 2H), 7.29 - 7.35 
(m, 1H), 7.07 (d, J=7.2 Hz, 2H), 6.16 (d, J=2.8 Hz, 1H), 6.10 (dd, J=7.6, 2.8 Hz, 1H), 5.44 (d, J=16.8 Hz, 
1H), 5.13 (d, J=16.8 Hz, 1H), 4.99 (d, J=6.4 Hz, 1H), 3.26 - 3.34 (m, 1H), 2.45 - 2.49 (m, 1H), 2.28 (dd, 
J=14.6, 10.6 Hz, 1H), 0.81 (s, 9H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 177.8 (C=O), 151.7 (C, C-6), 
143.3 (CH, C-2), 137.3 (C, C-8), 129.1 (CHArx2), 127.7 (CHArx2), 125.9 (CH, C-11), 119.2 (CH, C-5), 116.3 
(CH, C-3), 77.6 (CH, C-13), 55.4 (CH2, C-7), 35.3 (C, C-14), 33.8 (CH2, C-12), 25.6 (CH3x3, C-15). HRMS 
(ESI): calcd. for C18H24NO2 (M+H)
+: 286.1802 found 286.1800. HRMS (ESI): calcd. for C18H23NO2Na 
(M+Na)+: 308.1621 found 308.1620. 
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1-Benzyl-2-(but-3-en-1-yl)pyridin-4(1H)-one (244b). 
 
Following general procedure III, the reaction between 1-benzyl-2-methylpyridin-4(1H)-one 226a (74 
mg, 0.37 mmol) in THF (6.0 mL), n-butyllithium (0.37 ml, 0.37 mmol) and allylbromide 222h (38 µL, 
0.44 mmol) in THF (2.0 mL) was carried out. The crude product was purified by silica 
chromatography (95 : 5 CH2Cl2 : MeOH) to afford compound 244b as pale brown oil (50 mg, 57%). IR
 
(KBr) 3079 (CHsp2), 2920 (CHsp3), 2850 (CHsp3), 1634 (C=O), 1543 (C=C), 1496 (C=CArm), 733-696 (CAr) 
cm-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 7.79 (d, J=7.2 Hz, 1H), 7.40 (dd, J=7.2, 7.6 Hz, 2H), 7.32 
(dd, J=7.2, 7.6 Hz, 1H), 7.10 (d, J=7.2 Hz, 2H), 6.07 - 6.12 (m, 2H), 5.75 (ddt, J=16.8, 10.4, 6.4 Hz, 1H), 
5.23 (s, 2H), 4.91 - 5.04 (m, 2H), 2.55 (m, , 2H), 2.15 - 2.24 (m, 2H).13C NMR (DMSO-d6, 101MHz):  
(ppm) 177.8 (C=O), 151.5 (C, C-6), 143.4 (CH, C-3), 137.2 (C, C-12), 136.8 (CH), 129.0 (CHx2, C-14), 
127.8 (CH, C-15), 126.1 (CHx2, C-13), 117.6 (CH, C-5), 116.3 (CH, C-4), 116.0 (CH2), 54.9 (CH2, C-11), 
31.4 (CH2), 30.1 (CH2). HRMS (ESI): calcd. for C16H18NO (M+H)
+: 240.1383 found 240.1381. HRMS 
(ESI): calcd. for C16H17NONa (M+Na)
+: 262.1202 found 262.1200. 
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Synthesis of diethyl 1-((1-benzyl-4-oxo-1,4-dihydropyridin-2-yl)methyl)hydrazine-1,2-dicarboxylate 
(244d). 
 
Following general procedure III, the reaction between 1-benzyl-2-methylpyridin-4(1H)-one 226a (85 
mg, 0.43 mmol) in THF (8.0 mL), n-butyllithium (0.41 ml, 0.43 mmol) and diethyl azodicarboxylate 
238 (80 µL, 0.51 mmol) in THF (2.0 mL) was carried out. The crude product was purified by silica 
chromatography (95 : 5 CH2Cl2 : MeOH) to afford compound 244d as white solid (56 mg, 35%). IR
 
(Neat) 3284 (NH), 2982 (CHsp3), 2937 (CHsp3), 1714 (C=O), 1637 (C=O), 1556 (C=C), 1217 (RCO-O-C), 
734 (CAr) cm
-1. 1H NMR (CDCl3, 400MHz):  (ppm) 7.34 - 7.38 (m, 4H), 7.07 - 7.11 (m, 2H), 6.43 (m, 
1H), 6.33 (br. s., 1H), 5.18 (s, 2H), 4.54 (br. s., 2H), 4.12 - 4. 91 (m, 4H), 1.98 (br. s., 1H), 1.20 - 1.25 
(m, 6H). 13C NMR (CDCl3, 101MHz):  (ppm) 179.4 (C), 156.3 (C), 155.9 (C), 146.1 (C), 142.9 (CHx2), 
135.5 (C), 129.4 (CHx2), 128.5 (CHx2), 126.3 (CH), 118.1 (CH), 63.3 (CH2), 62.1 (CH2), 56.2 (CH2x2), 
14.6 (CH3), 14.5 (CH3). HRMS (ESI): calcd. for C19H24O5N3 (M+H)
+: 374.1710 found 374.1705. HRMS 
(ESI): calcd. for C19H23O5N3Na (M+Na)
+: 396.1530 found 396.1522. 
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Methyl alkylation of 1,6-dimethyl-4-pyridone 
 
General procedure IV: General experimental procedure for the deprotonation of 1,2-
dimethylpyridin-4(1H)-one and nucleophilic addition to several electrophiles. 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with 1,2-dimethylpyridin-4(1H)-one 226b (1eq.) and was 
dissolved in dry THF. The flask was cooled to -78 °C by submerging in a bath of dry ice/acetone. 
KHMDS (2.5 eq.) was added to the transparent pale yellow solution dropwise over 5 min. The 
reaction mixture was warmed up at 0 °C and the reaction changed colour from yellow to bright pink. 
Concurrently, an additional oven-dried flask was purged with N2 and then was charged with the 
electrophile (1.2 eq.) which was then dissolved/ diluted in dry THF. The electrophile solution was 
added to the pyridone solution at 0 °C by dropwise addition via syringe over 5 min. The reaction was 
allowed to proceed for 2 h at 0 °C by submerging in an ice bath, before quenching with saturated 
NH4Cl(aq). EtOAc (3 mL) was added and the phases were separated. The aqueous layer was re-
extracted with dichloromethane (5 x 10 mL). The combined organic layers were washed with brine.  
The combined organic phases were dried Na2SO4, filtered and concentrated under reduced pressure 
and the crude product was purified by flash silica chromatography. The crude product was purified 
by flash column chromatography (95 : 5 CH2Cl2 : MeOH). 
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Synthesis of 2-(but-3-en-1-yl)-1-methylpyridin-4(1H)-one (245a) and 2-(hepta-1,6-dien-4-yl)-1-
methylpyridin-4(1H)-one (246). 
 
Following general procedure IV, the reaction of 1,2-dimethylpyridin-4(1H)-one 226b (76 mg, 0.62 
mmol) in THF (5.0 mL), KHMDS (3.1 mL, 1.5  mmol) and allylbromide (60 µL, 0.74 mmol) in THF (1.0 
mL) was carried out. The crude product was purified by silica chromatography (95 : 0.5 CH2Cl2 : 
MeOH) to afford compound 245a as a white oil (10 mg, 10%) and compound 246 as a yellow oil (49 
mg, 38%).  
2-(but-3-en-1-yl)-1-methylpyridin-4(1H)-one (245a). 
 
IR (Neat) 2923 (CHsp3), 1636 (C=O), 1541 (C=C) cm-1. 1H NMR (CDCl3, 400MHz):  (ppm) 7.29 (s, 1H, 
H-2), 6.30 - 6.36 (m, 2H, H-3, H-5), 5.80 - 5.91 (m, 1H, H-9), 5.07 - 5.17 (m, 2H, H-10), 3.62 (s, 3H, 
CH3), 2.62 - 2.68 (m, 2H, H8), 2.37 - 2.45 (m, 2H, H-7). 
13C NMR (CDCl3, 101MHz):  (ppm) 179.6 
(C=O), 151.3 (C), 142.2 (CH), 135.7 (CH), 118.2 (CH), 117.5 (CH), 116.8 (CH2), 40.5 (CH3), 31.8 (CH2), 
31.7 (CH2). HRMS (ESI): calcd. for C10H14NO (M+H)
+: 164.1070 found 164.1064. HRMS (ESI): calcd. for 
C10H13NONa (M+Na)
+: 186.0889 found 186.0884. 
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2-(hepta-1,6-dien-4-yl)-1-methylpyridin-4(1H)-one (246). 
 
IR (Neat) 3077 (CHsp2), 2927 (CHsp3), 1634 (C=O), 1542 (C=C) cm-1. 1H NMR (CDCl3, 400MHz):  
(ppm) 7.22 (d, J=7.2 Hz, 1H, H-2), 6.29 (d, J=2.8 Hz, 1H, H-5), 6.22 (dd, J=7.8, 2.8 Hz, 1H, H-3), 5.50 - 
5.66 (m, 2H, H-9, H-9’), 4.97 (m, 4H, H-10, H-10’), 3.54 (s, 3H, H-11), 2.67 - 2.81 (m, 1H, H-7), 2.21 - 
2.40 (m, 4H, H-8, H-8’). 13C NMR (CDCl3, 101MHz):  (ppm) 179.3 (C, C-4), 154.9 (C, C-6), 142.5 (CH, 
C-2), 134.4 (CHx2, C-9, C-9’), 118.3 (CH2x2, C-10, C-10’), 117.3 (CH, C-3), 116.9 (CH, C-5), 41.4 (CH3, C-
11), 40.3 (CH, C-7), 39.1 (CH2x2, C-8, C-8’). HRMS (ESI): calcd. for C13H18NO (M+H)
+: 204.1383 found 
204.1378. HRMS (ESI): calcd. for C13H17NONa (M+Na)
+: 226.1202 found 226.1199. 
 
Synthesis of 2-(2-hydroxy-3,3-dimethylbutyl)-1-methylpyridin-4(1H)-one (245b) and (E)-2-(3,3-
dimethylbut-1-en-1-yl)-1-methylpyridin-4(1H)-one (247). 
 
 
 
Following general procedure IV, the reaction of 1,2-dimethylpyridin-4(1H)-one 226b (62 mg, 0.50 
mmol) in THF (5.0 mL), KHMDS (2.5 ml, 1.3  mmol) and trimethylacetaldehyde (60 µL, 0.60 mmol) in 
THF (1.0 mL) was carried out. The crude product was purified by silica chromatography (95 : 5 CH2Cl2 
: MeOH) to afford compound 245b as a white oil (10 mg, 10%) and compound 247b as a yellow oil 
(16 mg, 17%).  
 
221 
 
2-(2-hydroxy-3,3-dimethylbutyl)-1-methylpyridin-4(1H)-one (245b) 
 
IR (Neat) 3412 (OH), 2959 (CHsp3), 2921 (CHsp3), 2872 (CHsp3), 2850 (CHsp3), 1636 (C=O), 1528 
(C=C), 1201 (C-O) cm-1. 1H NMR (CDCl3, 400MHz):  (ppm) 7.21 - 7.26 (m, 2H), 6.29 (d, J=3.2 Hz, 1H), 
6.19 (d, J=7.8 Hz, 1H), 3.67 (d, J=2.7 Hz, 3H), 3.48 - 3.58 (m, 1H), 2.64 - 2.72 (m, 1H), 2.51 - 2.61 (m, 
1H), 0.99 (d, J=2.7 Hz, 9H). 13C NMR (CDCl3, 101MHz):  (ppm) 179.1 (C=O), 152.1 (C), 142.5 (CH), 
119.4 (CH), 117.2 (CH), 79.1 (CH), 41.6 (CH3), 35.5 (C), 34.8 (CH2), 25.8 (CH3). HRMS (ESI): calcd. for 
C12H20NO2 (M+H)
+: 210.1489 found 210.1483. HRMS (ESI): calcd. for C12H19NO2Na (M+Na)
+: 232.1308 
found 232.1304. 
(E)-2-(3,3-dimethylbut-1-en-1-yl)-1-methylpyridin-4(1H)-one (247). 
 
IR (Neat) 3000 (CHsp2), 2958 (CHsp3), 1632 (C=O), 1539 (C=C) cm-1. 1H NMR (CDCl3, 400MHz):  
(ppm) 7.20 (dd, J=7.6, 4.4 Hz, 1H), 6.40 - 6.45 (m, 1H), 6.22 - 6.31 (m, 2H), 6.08 (dd, J=15.6, 4.1 Hz, 
1H), 3.54 (d, J=4.1 Hz, 3H), 1.07 (d, J=4.1 Hz, 9H). 13C NMR (CDCl3, 101MHz):  (ppm) 179.5 (C=O), 
151.9 (CH), 149.9 (C), 141.5 (CH), 117.8 (CH), 117.0 (CH), 116.4 (CH), 41.1 (CH3), 34.1 (C), 29.0 (CH3). 
HRMS (ESI): calcd. for C12H18NO (M+H)
+: 192.1383 found 192.1378.  
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4-Quinolizinones. 
 
Attempted synthesis of 1-(pyridin-2-yl)pentane-2,4-dione (259). 
 
A solution of 2-picoline 141 (0.46 g, 5.0 mmol) in THF (15 mL) at -20°C was stirred for 20 min, n-
butyllithium (3.8 mL, 5.5 mmol) was added dropwise to the reaction mixture which was then stirred 
for 1 h. 2,2,6-Trimethyl-4H-1,3-dioxin-4-one 251 was previously dissolved in THF (3 mL) and the 
solution was added dropwise to mixture and the resulting mixture was stirred at room temperature 
overnight. The reaction mixture was quenched with few drops of MeOH and 20 mL of H2O. The 
reaction mixture was extracted with CH2Cl2 (3 x 20 mL) and the organic layer was washed with brine 
and dried over magnesium sulfate and filtered. The filtrate was concentrated under reduced 
pressure and the product was purified by flash chromatography column to afford a brown solid (0.29 
g, 40%). m.p. decomposes above 190 °C. IR (Neat) 3368, 2970 cm-1. 1H NMR (CDCl3, 400MHz):  
(ppm) 8.51 (d, J=4.0 Hz, 1H), 7.636 (dt, J= 7.6, 1.6 Hz, 1H), 7.17 (m, 1H), 7.13 (d, J=7.6 Hz, 1H), 5.81 
(br. s., 1H), 2.92 (s, 2H), 1.22 (s, 6H). 13C NMR (CDCl3, 101MHz):  (ppm) 160.0 (C), 148.4 (CH), 136.8 
(CH), 124.4 (CH), 121.5 (CH), 70.7 (C), 48.6 (CH2), 29.5 (CH3x2). HRMS [ES] calcd. for C9H14NO (M+H)
+:  
152.1025 found 152.1069. 
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Preparation of 1-(1-acryloylpyridin-2(1H)-ylidene)but-3-en-2-one (275): 
 
A solution of 2-picoline 141 (0.19 g, 2.0 mmol) in dry DCM (10 mL) under a N2 atmosphere was 
stirred for 10 min. The reaction was cooled to 0 °C and acryloyl chloride 264a (0.18 g, 2.0 mmol) 
previously dissolved in DCM (5 mL) was added and the reaction mixture stirred overnight while 
warming to room temperature. The crude product was purified by silica chromatography with 
elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford an orange oil, (9 mg, 10%). IR 
(Neat) 1742 (C=O), 1607, 1146 cm-1 . 1H NMR (CDCl3, 400MHz):  (ppm) 8.54 (d, J=8 Hz, 1H), 7.60 (dd, 
J= 8.0, 8.0 Hz, 1H), 7.40 (d, J= 8.0 Hz, 1H), 7.10 (dd, J= 8.0, 8.0 Hz, 1H), 6.62 (s, 1H), 6.52 – 6.34 (m, 
3H), 6.05 (dd, J= 10.4, 1.3 Hz, 1H), 5.45 (1 H, d, J =17.1 Hz, 1H), 5.31 (d, J=10.4 Hz, 1H). 13C NMR 
(CDCl3, 101MHz):  (ppm) 163.3, 153.1, 149.6, 147.7, 136.2, 132.7, 132.2, 127.7, 123.8, 122.0, 120.2, 
116.6.  
Synthesis of 1-(2-ethoxy-2-oxoethyl)-2-methylpyridin-1-ium (276a)86. 
 
A mixture of 2-picoline 141 (3.9 mL, 40 mmol) and ethyl bromoacetate 222a (2.2 mL, 20 mmol) in 
EtOAc (100 mL) was vigorously stirred under reflux for 24 h. The product that precipitated out was 
filtered and washed with cold EtOAc to afford a pale yellow solid (4.4 g, 85% yield). m.p. 115 °C. IR 
(neat) 3077, 2963, 1747 (C=O), 773 cm-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 9.07 (d, J=6.0 Hz, 
1H), 8.63 (t, J=8.0 Hz, 1H), 8.18 (d, J=8.0 Hz, 1H), 8.10 (t, J=6.9 Hz, 1H), 5.77 (s, 2H), 4.26 (q, J=7.1 Hz, 
2H), 2.78 (s, 3H), 1.26 (t, J=7.1 Hz, 3H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 165.9 (C=O), 156.3 (C), 
146.8(CH), 146.7(CH), 129.7(CH), 125.6(CH), 62.5(CH2), 57.7 (CH2), 19.61(CH3), 13.87(CH3). HRMS 
(ES): calcd. for C10H14NO2
+ (M-Br)+: 180.1025 found 180.1014.  
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Synthesis of 1-benzyl-2-methylpyridin-1-ium bromide (276b)89. 
 
To a solution of 2-picoline 141 (2.0 mL, 20 mmol) in acetone (15 mL), was added benzyl bromide 
222c (1.2 mL, 10 mmol) in one portion and the resulting mixture was heated under reflux overnight. 
The product precipitated out, and was filtered off to afford a white solid (3.0 g, 56%). m.p. 62-64 °C. 
1H NMR (DMSO-d6, 400MHz):  (ppm) 9.22 (d, J= 6.4 Hz, 1H), 8.59 (dd, J= 8.0, 7.6 Hz, 1H), 8.14 (d, J= 
8.0 Hz, 1H), 8.09 (dd, J= 7.6, 6.4 Hz, 1H), 7.47-7.41 (m, 3H), 7.38-7.28 (m, 2H), 5.97 (s, 2H), 2.77 (s, 
3H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 155.5 (C), 146.0 (CH), 145.8 (CH), 133.0 (C), 130.33 (CH), 
129.2 (CH), 129.2 (CH), 128.8 (CH), 127.6 (CH), 127.6 (CH), 125.9 (CH), 60.1(CH2), 19.99 (CH3). HRMS 
(ES): calcd. for C13H14N
+ (M-Br)+: 184.1126 found 184.1128. 
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Synthesis of 2,3-dimethylquinolizin-5-ium bromide (279a).86 
 
A mixture of 2,3-butanedione 232c (3.12 mL, 38.3 mmol) and triethylamine (5.38 mL, 38.3 mmol) 
was added dropwise to a solution of pyridinium salt 276a (8.3 g, 31.9 mmol) in THF (6.0 mL) under 
reflux, and then the mixture was heated under reflux for 3 h. When the reaction was complete, the 
resulting solid was immediately collected by filtration and washed with boiling acetone. The solid 
was purified by recrystallization from methanol by addition of diethyl ether to afford a white solid 
(6.6 g, 90%). m.p. 115-116 °C. IR (KBr) 3062 (CHsp2), 3029 (CHsp2),, 3007 (CHsp2), 2952 (CHsp3), 1646 
(C=C), 1635 (C=C), 1495 (C-CArom), 1405 (C-CArom), 1158 (C-N) cm
-1. 1H NMR (CDCl3, 400MHz):  (ppm) 
9.15 (s, 1H), 9.06 (d, J=6.6 Hz, 1H), 8.24 - 8.32 (m, 2H), 8.16 (t, J=7.8 Hz, 1H), 7.89 (t, J=6.7 Hz, 1H), 
2.41 (br. s., 6H). 1H (δ ppm, 400 MHz, DMSO-d6) 
86 9.28 (s, 1H), 9.17 (d, J= 6.8 Hz, 1H), 8.39 (s, 2H), 
8.26 (t, J= 7.8 Hz, 1H), 7.99 (t, J = 6.8 Hz, 1H), 2.59 (s, 3H), 2.5 (s, 3H). 13C NMR (DMSO-d6, 101MHz): 
 (ppm) 149.9, 140.8, 135.7, 135.3, 134.7, 134.0, 125.8, 125.1, 122.7, 19.5, 16.5. HRMS (ES): calcd. 
for C11H12N
+ (M-Br)+: 158.0964 found 158.0960.  
Literature reference: 1H (δ ppm, 400 MHz, DMSO-d6) 9.350 (s, 1H), 9.232 (d, 1H), 8.411 (d, 2H), 
8.269 (t, 1H), 7.999 (t, 1H), 2.597 (s, 3H), 2.480 (s, 3H); 13C NMR (DMSO-d6, 101MHz):  (ppm)  
149.9, 140.8, 135.7, 135.2, 134.7, 134.0, 125.8, 125.1, 122.7, 19.5, 16.5. 
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Synthesis of 2,3-diphenylquinolizin-5-ium bromide (279b). 
 
A mixture of benzil (1.1 g, 5.2 mmol) and triethylamine (0.73 mL, 5.2 mmol) was added dropwise to a 
solution of pyridinium salt 276a (1.1 g, 4.3 mmol)  in THF (20 mL) under reflux, and then the mixture 
was heated under reflux for 4 h. When the reaction was complete, the resulting solid was 
immediately collected by filtration and washed with acetone. The solid was purified by 
recrystallization from methanol by addition of diethyl ether to afford a pale orange solid (0.76 g, 
50%). 1H NMR (DMSO-d6, 400MHz):  (ppm) 9.58 (s, 1H), 9.38 (d, J=6.8 Hz, 1H), 8.75 (s, 1H), 8.62 (d, 
J=8.4 Hz, 1H), 8.42 (t, J=7.6 Hz, 1H), 8.11 - 8.20 (m, 1H), 7.38 - 7.50 (m, 6H), 7.29 - 7.38 (m, 4H). 13C 
NMR (DMSO-d6, 101MHz):  (ppm) 148.2, 141.4, 136.8, 136.6, 136.1, 135.7, 135.6, 134.2, 129.7, 
129.7, 129.4, 129.3, 129.3, 128.8, 128.8, 128.7, 126.7, 126.7, 123.8.  HRMS (ES): calcd. for C21H16N
+ 
(M-Br)+: 282.1283; found: 282.1271. 
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Synthesis of 1-(2-hydroxy-3-oxo-1-phenyl-2,3-di-p-tolylpropyl)-6-methylpyridin-2(1H)-one (303) 
and 3-hydroxy-4-phenyl-2,3-di-p-tolyl-3H-quinolizin-6(4H)-one (304). 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with N-benzyl-6-methyl-2-pyridone 228c (0.22 g, 1.2 mmol) and 
4,4'-dimethylbenzil 232a (0.33 g, 1.4 mmol) and the reagents were dissolved in dry THF and  the 
reaction mixture was stirred for 20 min at room temperature. The flask was cooled to -78 °C by 
immersion in a bath of dry ice/acetone and LDA (1.5 mL, 2.9 mmol, 1.9 M) was added to the flask 
dropwise over 5 min. The reaction mixture was stirred at -78 °C for 3 h, and was then warmed up at 
room temperature and stirred for 12 h. The reaction was worked-up with H2O (5 mL) and the solvent 
was removed under vacuum. The crude product was purified by silica chromatography with elution 
gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford compound 303 as a yellow oil, (0.12 g, 
25% yield) and compound 304a, also a yellow oil (40 mg, 10% yield). 
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1-(2-hydroxy-3-oxo-1-phenyl-2,3-di-p-tolylpropyl)-6-methylpyridin-2(1H)-one(303). 
 
IR (Neat) 3413 (OH), 3025 (CHsp2), 2989 (CHsp3), 1679 (C=O), 1650 (C=O), 1064 (CO), 771-720 
(CHArom) cm
-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 9.03 (s, 1H), 7.86 (d, J=8.4 Hz, 2H), 7.39 (d, J=8.0 
Hz, 2H), 7.17 - 7.36 (m, 7H), 7.10 (d, J=8.0 Hz, 4H), 6.88 (s, 1H), 6.28 (d, J=8.8 Hz, 1H), 6.22 (d, J=6.8 
Hz, 1H), 2.42 (s, 3H), 2.31 (s, 3H), 2.19 (s, 3H). 13C NMR (DMSO-d6, 101MHz):  (ppm)  
198.2(C=O),164.7(C=O), 147.1 (C ), 142.9 (C), 140.6 (CH), 136.6 (C), 136.5 (C), 135.1 (C), 131.2 (C), 
130.3 (CH), 130.3 (CH), 128.5 (CHx2), 128.1 (CHx2), 127.7 (CHx2), 127.0 (CHx2), 126.5 (CH), 124.1 
(CHx2), 117.7 (CH), 108.6 (CH), 85.2 (C), 67.1 (CH), 20.6 (CH3), 20.5 (CH3), 20.0 (CH3). HRMS (ES): 
calcd. for C29H27NO3 (M+H)
+: 438.2075 found: 438.2063. 
 3-hydroxy-4-phenyl-2,3-di-p-tolyl-3H-quinolizin-6(4H)-one (304a). 
 
IR (Neat) 3302 (OH), 3030 (CHsp2), 2962 (CHsp3), 1656 (C=O), 1539 cm-1. 1H NMR (DMSO-d6, 
400MHz):  (ppm) 7.44 (d, J=8.4 Hz, 2H), 7.34 - 7.41 (m, 3H), 7.19 - 7.29 (m, 6H), 7.15 (d, J=8.4 Hz, 
2H), 7.07 (d, J=8.4 Hz, 2H), 6.99 (s, 1H), 6.45 (d, J=6.8 Hz, 1H), 6.13 (dd, J=9.0, 1.2 Hz, 1H), 6.03 (s, 
1H), 5.69 (s, 1H), 2.28 (s, 3H), 2.25 (s, 3H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 159.5 (C=O), 144.0 
(C), 141.6 (C), 140.7 (CH), 139.0 (C), 137.0 (C), 136.5 (C), 136.4 (C), 133.0 (C), 129.0 (CHx2), 128.4 
(CHx2), 127.7 (CHx2), 127.6(CHx2), 126.9 (CHx2), 126.7 (CH), 125.0 (CHx2), 120.4 (CH), 118.3 (CH), 
105.7 (CH), 75.2 (C), 62.4 (CH), 20.2 (CH3), 20.0 (CH3). HRMS (ES): calcd. for C29H25NO2 (M+H)
+: 
420.1958 found: 420.1967. 
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Synthesis of 7,8-di-p-tolyl-4H-quinolizin-4-one (292c). 
 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was charged with ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228a (0.19 g, 
0.95 mmol) and 4,4'-dimethylbenzil 232a (0.30 g, 1.2 mmol) and the mixture was dissolved in THF 
(10 mL). The flask was cooled to -78 °C by immersion in a bath of dry ice/acetone. KHMDS (5.2 mL, 
2.6 mmol, 0.5 M) was added at -78 °C and the reaction mixture was stirred at -60 °C to -30 °C  for 6 
hours and then the reaction was slowly warmed up to room temperature (20 °C) and stirred 
overnight. The reaction was worked-up with saturated NH4Cl(aq) (6 mL). The solvent was removed 
under vacuum and the product was extracted with EtOAc (3 x 25 mL) and the combined organic 
layers were washed with brine to afford a dark yellow oil. The crude product was purified by silica 
chromatography with elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford a yellow 
solid. The product fraction was recrystallized from ethanol to afford a yellow solid, (30 mg, 20%).  1H 
NMR (DMSO-d6, 400MHz):  (ppm) 7.28 - 7.34 (m, 3H), 7.22 (d, J=8.2 Hz, 2H), 7.07 (d, J=7.6 Hz, 4H), 
6.83 (s, 1H), 6.30 (d, J=6.4 Hz, 1H), 6.10 (d, J=9.0 Hz, 1H), 5.14 (br. s., 1H), 2.26 (s, 3H), 2.24 (s, 3H). 
HRMS (ESI): calcd. for C23H20NO (M+H)
+: 326.1539 found 326.1538. (The sample was very weak to 
run 13C). 
 
 
 
 
 
 
 
230 
 
Synthesis of (2aR,9aS)-2a,3-diphenyl-2,2a-dihydro-1H-azeto[2,3-c]quinolizine-1,8(9aH)-dione (293). 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228 (0.36 
g, 1.8 mmol) and benzil (0.37 g, 1.7 mmol) and the mixture was dissolved in THF (10 mL). The flask 
was cooled to -78 °C by immersion in a bath of dry ice/acetone and stirred for 10 min. KHMDS (10 
mL, 5.1 mmol, 0.5 M) was added at -78 °C and then the reaction mixture and warmed up to room 
temperature and stirred overnight. The reaction was worked-up with saturated NH4Cl(aq) (6mL). The 
solvent was removed under vacuum and the product was extracted with EtOAc (3 x 25 mL) and the 
combined organic layers were washed with brine to afford a dark yellow oil. The crude product was 
purified by silica chromatography with elution gradient 0 to 100% EtOAc in petroleum ether 40-60 ° 
to afford 78 mg of yellow solid. The fraction was recrystallized in ethanol to afford yellow solid, (80 
mg, 12% yield). (the compound crystallized with one molecule of ethanol, this is the reason why the 
weigh increased from 78 mg to 80 mg)  m.p. 249-250 °C. IR (KBr) 1776 (C=O), 1654 (C=O), 1535 (NH), 
1613 (C=C), 795-731 (CHArom.) cm
-1. 1H NMR (DMSO-d6, 400MHz):  (ppm) 10.25 (s, 1H), 7.50 (dd, 
J=9.2, 6.8 Hz, 1H), 7.36 - 7.42 (m, 2H), 7.26 - 7.35 (m, 5H), 7.19 - 7.25 (m, 4H), 6.57 (d, J=6.8 Hz, 1H), 
6.41 (d, J=9.2 Hz, 1H), 5.52 (s, 1H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 164.7 (CO), 160.5 (CO), 
141.7 (C), 140.7 (CH), 140.5 (C), 140.3 (C), 135.4 (C), 129.6 (CHx2), 129.3 (CH), 129.0 (CHx2), 128.4 
(CH), 128.0 (CHx2), 125.3 (CHx2), 120.6 (CH), 120.2 (CH), 108.9 (CH), 68.1 (CH) 60.5 (C). HRMS (ES): 
calcd. for C22H17N2O2 (M+H)
+ 341.1285 found 341.1286. 
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Synthesis of 2,3-dihydroxy-4-phenyl-2,3-di-p-tolyl-3,4-dihydro-1H-quinolizin-6(2H)-one (305a). 
Procedure 1. 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with 1-benzyl-6-methylpyridin-2(1H)-one 228c (0.70 g, 3.5 
mmol) and dissolved in dry THF (15 mL). The flask was cooled to -78 °C by immersion in a bath of dry 
ice/acetone. LDA (4.4 mL, 3.5 mmol, 0.8 M) was added to the solution dropwise over 5 min. The 
reaction mixture was warmed up to 0 °C, and then the reaction was cooled to -78 °C. Concurrently, 
an additional oven-dried flask was purged with N2 and then was charged with a solution of 1,2-di-p-
tolylethane-1,2-dione 232a (1.0 g, 4.2 mmol) in dry THF (6.0 mL). The electrophile solution was 
added dropwise to the pyridone solution at -78 °C via syringe over 5 min. The reaction was allowed 
to proceed for 1 h at -78 °C. LDA (4.4 mL, 3.5 mmol, 0.8 M) was added to the mixture at -78 °C and 
the reaction mixture was stirred at -78 °C for 1 h before quenching with saturated NH4Cl(aq) (10 mL). 
EtOAc (10 mL) was added and the phases were separated. The aqueous layer was re-extracted with 
EtOAc (3 x 15 mL). The combined organic layers were washed with brine and dried over MgSO4, 
filtered and concentrated under reduced pressure. The crude product was purified by silica 
chromatography with elution gradient 0 to 100% EtOAc in petroleum ether 40-60° to afford 2,3-
dihydroxy-4-phenyl-2,3-di-p-tolyl-3,4-dihydro-1H-quinolizin-6(2H)-one 305a (0.21 g, 14%) as a pale 
yellow solid. 1H NMR (DMSO-d6, 400MHz):  (ppm) 7.44 (dd, J=9.0, 6.8 Hz, 1H), 6.98 (d, J=7.2 Hz, 
2H), 6.90 (t, J=7.6 Hz, 2H), 6.77 - 6.87 (m, 5H), 6.54 - 6.66 (m, 4H), 6.26 (d, J=6.8 Hz, 1H), 6.22 (d, 
J=9.0 Hz, 1H), 5.91 - 5.98 (m, 2H), 5.86 (s, 1H), 3.96 - 4.09 (m, 1H), 3.04 (d, J=18.0 Hz, 1H), 2.18 (s, 
3H), 2.02 (s, 3H). 13C NMR (DMSO-d6 ,101MHz):  (ppm) 162.6 (C), 147.2 (C), 139.4 (C), 138.7 (CH), 
138.7 (C), 136.5 (C), 135.4 (C), 134.6 (C), 128.5 (CHx2), 127.2 (CHx2), 127.0 (CHx2), 126.9 (CHx2), 
126.4 (CHx2), 126.2 (CHx2), 125.1 (CH), 116.5 (CH), 105.9 (CH), 80.6 (C), 74.4 (C), 68.2 (CH), 39.3 
(CH2), 20.5 (CH3), 20.4 (CH3). 
Procedure 2:  
232 
 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with 1-benzyl-6-(2-hydroxy-3-oxo-2,3-di-p-tolylpropyl)pyridin-
2(1H)-one 231d (0.30 g, 0.69 mmol) and dissolved in dry THF (14 mL). The flask was cooled to -78 °C 
by immersion in a bath of dry ice/acetone. nBuLi (0.87 mL, 1.4 mmol, 1.6 M) was added to the 
solution dropwise over 5 min. The reaction mixture was warmed up to 0 °C, and then was cooled to -
78 °C. The reaction mixture was then stirred at -78 °C for 1 h before quenching with saturated 
NH4Cl(aq) (15 mL). EtOAc (10 mL) was added and the phases were separated. The aqueous layer was 
re-extracted with EtOAc (3 x 15 mL). The combined organic layers were washed with brine.  The 
combined organic phases were dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude product was purified by silica chromatography with elution gradient 0 to 100% 
EtOAc in heptane to afford 2,3-dihydroxy-4-phenyl-2,3-di-p-tolyl-3,4-dihydro-1H-quinolizin-6(2H)-
one 305a (90 mg, 30%) as a pale yellow solid. 1H NMR (DMSO-d6, 700MHz):  (ppm) 7.44 (dd, J=9.0, 
6.8 Hz, 1H), 6.98 (d, J=7.7 Hz, 2H), 6.90 (t, J=7.9 Hz, 2H), 6.79 - 6.86 (m, 5H), 6.61 - 6.65 (m, J=8.4 Hz, 
2H), 6.57 - 6.61 (m, J=8.1 Hz, 2H), 6.25 (d, J=6.8 Hz, 1H), 6.21 (d, J=9.0 Hz, 1H), 5.96 (s, 1H), 5.93 (s, 
1H), 5.83 (s, 1H), 4.01 - 4.06 (m, 1H), 3.04 (d, J=17.8 Hz, 1H), 2.18 (s, 3H), 2.02 (s, 3H). 13C NMR 
(DMSO-d6, 176MHz):  (ppm) 162.5 (C), 147.1 (C), 139.4 (C), 138.7 (CH), 138.6 (C), 136.5 (C), 135.3 
(C), 134.6 (C), 128.4 (CHx2), 127.2 (CHx2), 126.94 (CHx2), 126.85 (CHx2), 126.33 (CHx2), 126.2 
(CHx2), 125.1 (CH), 116.4 (CH), 105.8 (CH), 80.6 (C), 74.4 (C), 68.2 (CH), 39.3 (CH2), 20.4 (CH3), 20.3 
(CH3). 
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Synthesis of 4-(4-fluorophenyl)-2,3-dihydroxy-2,3-di-p-tolyl-3,4-dihydro-1H-quinolizin-6(2H)-one 
(305b). 
 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with 1-(4-fluorobenzyl)-6-(2-hydroxy-3-oxo-2,3-di-p-
tolylpropyl)pyridin-2(1H)-one 231b (0.33 g, 0.73 mmol) and dissolved in dry THF (15 mL). The flask 
was cooled to -78 °C by immersion in a bath of dry ice/acetone. nBuLi (0.91 mL, 1.5 mmol, 1.6 M) 
was added to the solution dropwise over 2 min. The reaction mixture was warmed up to 0 °C, and 
then was cooled to -78 °C. The reaction mixture was then stirred at -78 °C for 3 h before quenching 
with saturated NH4Cl(aq) (5 mL). The aqueous layer was extracted with EtOAc (3 x 20 mL). The 
combined organic layers were washed with brine and dried over MgSO4, filtered and concentrated 
under reduced pressure to afford a yellow solid. The crude product was recrystallized in CH2Cl2 to 
obtain 4-(4-fluorophenyl)-2,3-dihydroxy-2,3-di-p-tolyl-3,4-dihydro-1H-quinolizin-6(2H)-one 305b (30 
mg, 10%) as a white solid. 1H NMR (DMSO-d6, 400MHz):  (ppm) 7.48 (dd, J=9.2, 6.8 Hz, 1H), 6.87 - 
6.98 (m, 8H), 6.79 (d, J=8.4 Hz, 2H), 6.69 (d, J=8.4 Hz, 2H), 6.31 (d, J=6.8 Hz, 1H), 6.22 (d, J=9.2 Hz, 
1H), 5.81 (s, 1H), 5.74 (s, 1H), 5.58 (s, 1H), 4.67 (s, 1H), 3.45 (d, J=17.5 Hz, 1H), 3.34 (d, J=17.5 Hz, 
1H), 2.22 (s, 3H), 2.21 (s, 3H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 161.8 (C), 160.6 (C, d, JF = 239 
Hz), 146.8 (C), 139.9 (C), 139.5 (CH), 139.1 (C), 136.2 (C), 136.0 (C), 135.9 (C), 131.2 (CH), 131.2 (CH), 
127.5 (CHx2), 127.4 (CHx2), 127.1 (CHx2), 126.9 (CHx2), 116.8 (CH), 113.0 (CH), 112.8 (CH), 105.3 
(CH), 77.0 (C), 74.8 (C), 66.2 (CH), 39.9 (CH2), 20.5 (CH3x2). UPLC, MS, r.t: 1.09 min, m/z: ES
+ [M+H]+ 
456. HRMS (ESI): calcd. for C29H26FNO3 (M+H)
+: 456.1969 found 456.1969. 
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Synthesis of 2-hydroxy-2,4-diphenyl-1H-quinolizine-3,6(2H,4H)-dione (307). 
 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with methyl 3-(1-benzyl-6-oxo-1,6-dihydropyridin-2-yl)-2-
hydroxy-2-phenylpropanoate 231n (0.44 g, 1.2 mmol) and was dissolved in dry THF (20 mL). The 
flask was cooled to -78 °C by immersion in a bath of dry ice/acetone. nBuLi (1.5 mL, 2.4 mmol, 1.6 M) 
was added to the solution dropwise. The reaction mixture was warmed up to 0 °C, and then the 
reaction was cooled to -78 °C. The reaction mixture was then stirred at -78 °C for 2 h before 
quenching with saturated NH4Cl(aq) (5 mL). The reaction mixture was extracted with EtOAc (3 x 20 
mL) and the organic layers were dried over MgSO4, filtered and evaporated to afford a green oil. The 
crude product was purified by flash silica chromatography, elution gradient 5 to 100% EtOAc in 
heptane. Pure fractions were evaporated to dryness to afford 2-hydroxy-2,4-diphenyl-1H-
quinolizine-3,6(2H,4H)-dione a pale yellow solid (82 mg, 21%). 1H NMR (DMSO-d6, 700MHz):  (ppm) 
7.53 (dd, J=9.2, 6.8 Hz, 1H), 7.39 - 7.44 (m, 2H), 7.35 - 7.38 (m, 1H), 7.25 - 7.30 (m, 3H), 7.15 (dd, 
J=8.1, 1.1 Hz, 2H), 7.04 - 7.10 (m, 2H), 6.90 (s, 1H), 6.48 (s, 1H), 6.42 (d, J=9.2 Hz, 1H), 6.37 (d, J=6.8 
Hz, 1H), 3.46 (d, J=16.8 Hz, 1H), 3.19 (d, J=16.8 Hz, 1H). 13C NMR (DMSO-d6, 176MHz):  (ppm) 200.8 
(C=O), 161.0 (C=O), 144.2 (C), 140.7 (C), 140.1 (CH), 134.0 (C), 129.0 (CHx2), 128.1 (CH), 127.8 
(CHx2), 127.6 (CH), 125.7 (CHx2), 125.5 (CHx2), 117.0 (CH), 106.3 (CH), 74.4 (C), 62.9 (CH), 41.4 (CH2). 
UPLC, MS, r.t: 0.85 min, m/z: ES- [M-H]- 330. 
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Synthesis of 6-phenyl-7,8-di-p-tolyl-4H-quinolizin-4-one (287a). 
 
p-Toluenesulfonic acid monohydrate (0.16 g, 0.82 mmol) was added to a solution of 2,3-dihydroxy-4-
phenyl-2,3-di-p-tolyl-3,4-dihydro-1H-quinolizin-6(2H)-one 305a (0.13 g, 0.29 mmol) in toluene (7.0 
mL). The resulting solution was stirred at 120 °C for 2 h with a Dean-Stark apparatus. The reaction 
mixture was washed sequentially with saturated aqueous Na2CO3 (2 x 5 mL). The organic layer was 
dried over MgSO4, filtered and evaporated to afford the crude product. The crude product was 
purified by preparative HPLC (Waters SunFire column, 5µ silica, 19 mm internal diameter, 100 mm 
length), using decreasingly polar mixtures of water (containing 0.1% formic acid) and MeCN as 
eluents. Fractions containing the desired compound were evaporated to dryness to afford 6-phenyl-
7,8-di-p-tolyl-4H-quinolizin-4-one 287a as a dark yellow solid (12 mg, 10%). The amount of product 
that had been submitted for purification was 60 mg, and it yielded 12 mg of pure compound. 
Therefore, the real yield of the reaction should be 19%. 1H NMR (DMSO-d6, 700MHz):  (ppm) 7.62 
(dd, J=8.4, 7.0 Hz, 1H, H-4), 7.59 (s, 1H, H-7), 6.97 - 7.03 (m, 7H), 6.92 - 6.97 (m, 2H), 6.75 - 6.79 (m, 
2H), 6.8 (d, J=7.0 Hz, 1H, H-5), 6.71 - 6.75 (m, 2H), 6.14 (dd, J=8.4, 1.3 Hz, 1H, H-3), 2.20 (s, 3H), 2.08 
(s, 3H). 13C NMR (DMSO-d6, 176MHz):  (ppm) 159.8 (C=O), 143.4 (C, C-6), 142.3 (C, C-10), 139.7 (C), 
137.8 (CH, C-4), 137.3 (C), 136.7 (C), 135.3 (C), 135.2 (C), 132.9 (C), 131.0 (CHx2), 130.7 (C), 128.7 
(CHx2), 128.3 (CHx4), 127.5 (CHx2), 126.0 (CHx2), 125.9 (CH), 125.0 (CH, C-7), 111.2 (CH, C-3), 102.8 
(CH, C-5), 20.5 (CH3 x2). UPLC, MS, r.t: 1.31 min, m/z: ES
+ [M+H]+ 401.9. HRMS (ESI): calcd. for 
C29H25NO (M+H)
+: 402.1852 found 402.1852. 
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Synthesis of 4-(4-fluorophenyl)-3-hydroxy-2,3-di-p-tolyl-3H-quinolizin-6(4H)-one (304b). 
 
p-toluenesulfonic acid monohydrate (15 mg, 0.080 mmol) was added to a solution of 4-(4-
fluorophenyl)-2,3-dihydroxy-2,3-di-p-tolyl-3,4-dihydro-1H-quinolizin-6(2H)-one 305b (15 mg, 0.030 
mmol) in toluene (0.78 ml). The resulting solution was stirred at 120 °C for 2 h with a Dean-Stark 
apparatus. The reaction mixture was washed sequentially with saturated aqueous Na2CO3 (3 x 2 mL). 
The organic layer was dried over MgSO4, filtered and evaporated to afford crude product. The crude 
product was purified by flash silica chromatography, elution gradient 0 to 100% EtOAc in heptane. 
Pure fractions were evaporated to dryness to afford 4-(4-fluorophenyl)-3-hydroxy-2,3-di-p-tolyl-3H-
quinolizin-6(4H)-one (7.0 mg, 49%) as a yellow gum.  1H NMR (DMSO-d6, 700MHz):  (ppm) 7.42 (d, 
J=8.1 Hz, 2H), 7.35 - 7.39 (m, 3H), 7.19 - 7.21 (m, J=8.1 Hz, 2H), 7.12 - 7.15 (m, J=8.1 Hz, 2H), 7.04 - 
7.08 (m, 4H), 6.96 (s, 1H), 6.43 (dd, J=7.0, 1.2 Hz, 1H), 6.12 (dd, J=9.1, 1.2 Hz, 1H), 6.00 (s, 1H), 5.61 
(s, 1H), 2.26 (s, 3H), 2.24 (s, 3H). 13C NMR (DMSO-d6, 176MHz):  (ppm) 160.7 (C), 159.9 (C), 144.5 
(C), 141.9 (C), 141.0 (C), 139.5 (CH), 137.6 (C), 137.0 (C), 133.4 (C), 133.1 (C),131.3 (CHx2), 128.9 
(CHx2), 128.3 (CHx2), 128.1 (CHx2), 125.5 (CHx2), 120.9 (CH, C-7), 118.8 (CH), 114.3 (CH), 114.2 (CH), 
106.2 (CH), 75.6 (C), 62.3 (CH, C-11), 20.7 (CH3), 20.4 (CH3). UPLC, MS, r.t: 1.15 min, m/z: ES
+ [M+H]+ 
438. HRMS (ESI): calcd. for C29H24FNO2 (M+H)
+: 438.1864 found 438.1864.  
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Alkylation at benzylic position and N-methyl position. 
 
Deuteration at benzylic position of ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate (301). 
 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum was purged 
with N2. The flask was then charged with ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228a 
(0.078 g, 0.4 mmol) and dissolved in dry THF (6.0 mL). The flask was cooled to -78 °C by immersion in 
a bath of dry ice/acetone. KHMDS (0.8 mL, 0.4 mmol, 5 M) was added to the flask dropwise over 5 
min. The reaction mixture was warmed up to 0 °C and then was cooled to -78 °C. D2O solution was 
then added to the deprotonated pyridone solution at -78 °C via syringe. The reaction was allowed to 
proceed for 10 min at -78 °C, and then saturated NH4Cl(aq) was added (1 mL). EtOAc (10 mL) was 
added and the phases were separated. The aqueous layer was re-extracted with EtOAc (3 x 10 mL). 
The combined organic layers were washed with brine.  The combined organic phases were dried 
over MgSO4, filtered and concentrated under reduced pressure to afford a yellow oil, (0.0236 g, 
30%). 1H NMR (DMSO-d6 ,400MHz):  (ppm) 7.36 (dd, J=9.2, 6.8 Hz, 1H), 6.29 (d, J=9.2 Hz, 1H), 6.16 
(d, J=6.8 Hz, 1H), 4.76 - 4.80 (m, 1H), 4.15 (q, J=7.1 Hz, 2H), 2.28 (s, 3H), 1.22 (t, J=7.1 Hz, 3H). 13C 
NMR (DMSO-d6, 101MHz):  (ppm) 166.5 (CO), 160.5 (CO), 145.4 (C), 138.1 (CH), 114.3 (CH), 104.1 
(CH), 59.3 (CH2), 43.5 (CH), 43.3 (t, JC-D=21.7, CH2D), 18.1 (CH3), 12.2 (CH3). 
 
 
 
 
 
238 
 
Synthesis of afford ethyl 3-hydroxy-2-(6-methyl-2-oxopyridin-1(2H)-yl)-4-oxo-3,4-di-p-
tolylbutanoate (302). 
 
An oven-dried flask equipped with a stirrer bar, thermometer and fitted with a septum and purged 
with N2. The flask was then charged with ethyl 2-(6-methyl-2-oxopyridin-1(2H)-yl)acetate 228a (0.41 
g, 2.1 mmol) and dissolved in dry THF (10 mL). The flask was cooled to -78 °C by immersion in a bath 
of dry ice/acetone. nBuLi (1.3 ml, 2.1 mmol, 1.6 M) was added to the solution dropwise. The 
resulting solution was stirred at -78 °C for 10 min. Concurrently, an additional oven-dried flask was 
purged with N2 and was charged with a solution of 1,2-di-p-tolylethane-1,2-dione 232a (0.60 g, 2.5 
mmol) in THF (4 mL). The electrophile solution was added dropwise to the pyridone solution via 
syringe over 2 min. The resulting mixture was stirred at -78 °C for 30 min.  The reaction mixture was 
quenched with saturated NH4Cl(aq) (2 mL) and neutralised with 2M HCl. It was then extracted with 
EtOAc (3 x 15 mL), and the organic layer was dried over MgSO4, filtered and evaporated to afford 
ethyl 3-hydroxy-2-(6-methyl-2-oxopyridin-1(2H)-yl)-4-oxo-3,4-di-p-tolylbutanoate 302 (0.32 g, 35%) 
as a  crystalline solid.  1H NMR (DMSO-d6, 400MHz):  (ppm) 9.14 (s, 1H), 7.69 (dd, J=8.2, 4.2 Hz, 4H), 
7.47 (dd, J=8.8, 8.8 Hz, 1H), 7.23 (d, J=8.2 Hz, 2H), 7.11 (d, J=8.2 Hz, 2H), 6.47 (d, J=6.6 Hz, 1H), 6.36 
(d, J=8.4 Hz, 1H), 5.74 (s, 1H), 3.98 - 4.04 (m, 1H), 3.87 (dd, J=10.9, 7.1 Hz, 1H), 2.60 (s, 3H), 2.29 (s, 
3H), 2.25 (s, 3H), 0.96 (t, J=7.1 Hz, 3H). 13C NMR (DMSO-d6, 101MHz):  (ppm) 199.3 (CO), 165.2 (C), 
164.7 (C), 148.1 (C), 142.8 (C), 141.1 (CH), 137.0 (C), 136.8 (C), 132.0 (C), 129.8 (CH), 128.9 (CH), 
128.4 (CH), 126.0 (CH), 117.8 (CH), 109.5 (CH), 83.7 (C), 71.3 (CH), 61.1 (CH2), 21.0 (CH3), 20.9 (CH3), 
20.5 (CH3), 13.6 (CH3). m/z: ES+ [M+H]+ 434. 
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Appendix I: X-Ray Crystallography Data 
2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (14a) 
 
 
 
ii 
 
 
 
 
 
 
iii 
 
 
 
 
 
iv 
 
 
 
 
 
 
 
 
 
v 
 
Table 1.  Crystal data and structure refinement for compound 14a. 
 
Identification code  14a 
Chemical formula  C11H12N2O3 
Formula weight  220.23 
Temperature  150(2) K 
Radiation, wavelength  MoK, 0.71073 Å 
Crystal system, space group  monoclinic, P21/n 
Unit cell parameters a = 4.7298(7) Å  = 90° 
 b = 7.0031(11) Å  = 92.212(2)° 
 c = 31.563(5) Å  = 90° 
Cell volume 1044.7(3) Å
3
 
Z 4 
Calculated density  1.400 g/cm
3
 
Absorption coefficient  0.104 mm1 
F(000) 464 
Crystal colour and size colourless, 0.68  0.26  0.09 mm3 
Reflections for cell refinement 2300 ( range 2.58 to 28.05°) 
Data collection method Bruker APEX 2 CCD diffractometer 
  rotation with narrow frames 
 range for data collection 2.58 to 28.32° 
Index ranges h 6 to 6, k 9 to 9, l 41 to 42 
Completeness to  = 28.32° 99.6 %  
Intensity decay 0% 
Reflections collected 10138 
Independent reflections 2604 (Rint = 0.0393) 
Reflections with F
2
>2 1835 
Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.933 and 0.991 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F
2
 
Weighting parameters a, b 0.0430, 0.3057 
Data / restraints / parameters 2604 / 0 / 193 
Final R indices [F
2
>2] R1 = 0.0453, wR2 = 0.1003 
R indices (all data) R1 = 0.0720, wR2 = 0.1095 
Goodness-of-fit on F
2
 1.048 
Largest and mean shift/su 0.000 and 0.000 
Largest diff. peak and hole 0.207 and 0.182 e Å3 
vi 
 
Table 2.  Atomic coordinates and equivalent isotropic displacement parameters (Å
2
) 
for 14a.  Ueq is defined as one third of the trace of the orthogonalized U
ij
 tensor. 
 
      x      y      z      Ueq 
 
N(1) 0.5940(3) 0.55917(18) 0.11805(4) 0.0258(3) 
C(2) 0.7257(3) 0.3880(2) 0.11402(5) 0.0267(3) 
C(3) 0.9388(3) 0.3280(2) 0.14124(5) 0.0289(4) 
C(4) 1.0373(3) 0.4394(2) 0.17585(5) 0.0282(4) 
O(1) 1.2257(2) 0.40186(18) 0.20244(4) 0.0385(3) 
N(5) 0.8898(3) 0.62027(18) 0.17918(4) 0.0246(3) 
C(6) 0.9698(3) 0.7399(2) 0.21255(5) 0.0288(4) 
C(7) 0.8393(3) 0.9089(2) 0.21806(5) 0.0303(4) 
C(8) 0.6196(3) 0.9665(2) 0.18915(5) 0.0297(4) 
C(9) 0.5423(3) 0.8507(2) 0.15615(5) 0.0272(3) 
C(9A) 0.6762(3) 0.6718(2) 0.15038(4) 0.0243(3) 
C(10) 0.6235(4) 0.2680(3) 0.07738(6) 0.0340(4) 
C(11) 0.0422(3) 0.7708(2) 0.05373(5) 0.0289(4) 
C(12)  0.1781(4) 0.7720(3) 0.01835(6) 0.0364(4) 
O(2) 0.1781(2) 0.60650(17) 0.05728(4) 0.0344(3) 
O(3) 0.0927(3) 0.90522(19) 0.07658(5) 0.0525(4) 
 
 
 
 
Table 3.   Bond lengths [Å] and angles [°] for 14a. 
 
N(1)–C(9A)  1.3359(19) N(1)–C(2)  1.359(2) 
C(2)–C(3)  1.365(2) C(2)–C(10)  1.495(2) 
C(3)–C(4)  1.407(2) C(4)–O(1)  1.2290(19) 
C(4)–N(5)  1.452(2) N(5)–C(9A)  1.3808(18) 
N(5)–C(6)  1.387(2) C(6)–C(7)  1.349(2) 
C(7)–C(8)  1.415(2) C(8)–C(9)  1.359(2) 
C(9)–C(9A)  1.419(2) C(11)–O(3)  1.204(2) 
C(11)–O(2)  1.3204(19) C(11)–C(12)  1.498(2) 
 
C(9A)–N(1)–C(2) 118.13(13) N(1)–C(2)–C(3) 122.86(15) 
N(1)–C(2)–C(10) 115.64(14) C(3)–C(2)–C(10) 121.50(15) 
C(2)–C(3)–C(4) 122.16(15) O(1)–C(4)–C(3) 128.42(15) 
O(1)–C(4)–N(5) 118.36(14) C(3)–C(4)–N(5) 113.22(13) 
C(9A)–N(5)–C(6) 120.87(13) C(9A)–N(5)–C(4) 121.46(13) 
C(6)–N(5)–C(4) 117.66(13) C(7)–C(6)–N(5) 121.01(15) 
C(6)–C(7)–C(8) 119.67(16) C(9)–C(8)–C(7) 119.58(16) 
C(8)–C(9)–C(9A) 121.13(15) N(1)–C(9A)–N(5) 122.17(14) 
N(1)–C(9A)–C(9) 120.10(13) N(5)–C(9A)–C(9) 117.73(13) 
O(3)–C(11)–O(2) 123.07(15) O(3)–C(11)–C(12) 123.93(16) 
O(2)–C(11)–C(12) 112.99(15)  
 
vii 
 
Table 4.   Hydrogen coordinates and isotropic displacement parameters (Å
2
) for 14a. 
 
      x       y       z       U 
 
H(3) 1.025(4) 0.206(3) 0.1371(5) 0.037(5) 
H(6) 1.126(4) 0.691(3) 0.2302(5) 0.034(5) 
H(7) 0.904(3) 0.989(3) 0.2417(5) 0.032(5) 
H(8) 0.521(4) 1.091(3) 0.1922(5) 0.037(5) 
H(9) 0.390(4) 0.878(3) 0.1354(6) 0.037(5) 
H(10A) 0.731(5) 0.144(3) 0.0779(6) 0.059(6) 
H(10B) 0.417(5) 0.237(3) 0.0792(7) 0.056(6) 
H(10C) 0.643(5) 0.340(3) 0.0510(7) 0.060(6) 
H(12A)  0.099(6) 0.823(4)  0.0061(10) 0.104(10) 
H(12B)  0.318(6) 0.869(4) 0.0241(8) 0.099(10) 
H(12C)  0.259(6) 0.650(5) 0.0134(9) 0.103(10) 
H(2) 0.324(5) 0.609(4) 0.0813(8) 0.081(8) 
 
 
 
 
Table 5.  Torsion angles [°] for 14a. 
 
C(9A)–N(1)–C(2)–C(3)  0.7(2) C(9A)–N(1)–C(2)–C(10) 179.69(14) 
N(1)–C(2)–C(3)–C(4) 0.4(2) C(10)–C(2)–C(3)–C(4) 179.99(16) 
C(2)–C(3)–C(4)–O(1) 179.95(16) C(2)–C(3)–C(4)–N(5) 0.1(2) 
O(1)–C(4)–N(5)–C(9A) 179.90(14) C(3)–C(4)–N(5)–C(9A)  0.21(19) 
O(1)–C(4)–N(5)–C(6)  0.5(2) C(3)–C(4)–N(5)–C(6) 179.44(14) 
C(9A)–N(5)–C(6)–C(7) 0.7(2) C(4)–N(5)–C(6)–C(7)  178.97(14) 
N(5)–C(6)–C(7)–C(8)  0.7(2) C(6)–C(7)–C(8)–C(9) 0.0(2) 
C(7)–C(8)–C(9)–C(9A) 0.7(2) C(2)–N(1)–C(9A)–N(5) 0.5(2) 
C(2)–N(1)–C(9A)–C(9)  179.20(13) C(6)–N(5)–C(9A)–N(1)  179.72(14) 
C(4)–N(5)–C(9A)–N(1)  0.1(2) C(6)–N(5)–C(9A)–C(9) 0.0(2) 
C(4)–N(5)–C(9A)–C(9) 179.64(13) C(8)–C(9)–C(9A)–N(1) 179.06(15) 
C(8)–C(9)–C(9A)–N(5)  0.7(2)  
 
 
 
 
Table 6.  Hydrogen bonds for 14a [Å and °]. 
 
D–H...A d(D–H) d(H...A) d(D...A) <(DHA) 
 
O(2)–H(2)...N(1) 1.01(3) 1.73(3) 2.7141(17) 166(2) 
C(9)–H(9)...O(3) 0.975(18) 2.292(18) 3.250(2) 167.2(15) 
C(6)–H(6)...O(1) 0.971(18) 2.264(18) 2.683(2) 104.9(12) 
C(10)–H(10A)...O(3') 1.00(2) 2.40(2) 3.374(2) 164.7(18) 
C(7)–H(7)...O(1") 0.973(17) 2.509(16) 3.183(2) 126.2(13) 
 
Symmetry operations for equivalent atoms 
'   x+1,y1,z      "   x+5/2,y+1/2,z+1/2        
 
 
viii 
 
Diethyl 1-((1-methyl-6-oxo-1,6-dihydropyridin-2-
yl)methyl)hydrazine-1,2-dicarboxylate (293) 
 
 Figures & Description. 
Formula. 
C13H19N3O5. One molecule in the asymmetric unit. 
Disorder & Solvent of Crystallisation. 
No disorder or solvent of crystallisation 
Packing. 
Molecules pair up into centro-symmetric dimers via pairs of NH···O H-bonds. There are weaker 
supporting CH···O H-bonds, but these are much less significant. Atoms C(2) and C(2’) are the closest 
contacts at 3.454Å in a very slipped π···π stack from one side of the dimer to the other. 
 
 
ix 
 
 
 
x 
 
 
 
xi 
 
 
 
xii 
 
 
 
xiii 
 
 
 
 
 
Crystal data 
C13H19N3O5 Dx = 1.367 Mg m
-3
 
Mr = 297.31 Mo K radiation,  = 0.71073 Å 
Orthorhombic, Pbca Cell parameters from 10817 reflections 
a = 9.6539 (4) Å  = 2.7–30.5° 
b = 14.0840 (6) Å  = 0.11 mm-1 
c = 21.2528 (9) Å T = 150 K 
V = 2889.6 (2) Å
3
 Tablet, colourless 
Z = 8 0.51 × 0.47 × 0.14 mm
3
 
F(000) = 1264  
 
Data collection 
Bruker APEX 2 CCD area detector  
diffractometer 
4416 independent reflections 
xiv 
 
Radiation source: fine-focus sealed tube 3768 reflections with I > 2(I) 
Graphite monochromator Rint = 0.026 
 rotation with narrow frames scans max = 30.6°, min = 1.9° 
Absorption correction: multi-scan  
SADABS v2012/1, Sheldrick, G.M., (2012) 
h = -1313 
Tmin = 0.948, Tmax = 0.985 k = -1920 
32659 measured reflections l = -3029 
 
Refinement 
Refinement on F
2
 Primary atom site location: structure-invariant 
direct methods 
Least-squares matrix: full Hydrogen site location: difference Fourier map 
R[F
2
 > 2(F2)] = 0.036 All H-atom parameters refined 
wR(F
2
) = 0.102 w = 1/[2(Fo
2
) + (0.0566P)
2
 + 0.6405P]  
where P = (Fo
2
 + 2Fc
2
)/3 
S = 1.03 (/)max = 0.001 
4416 reflections max = 0.39 e Å
-3
 
266 parameters min = -0.23 e Å
-3
 
0 restraints  
 
 
 
 
 
 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters 
(Å2) 
 x y z Uiso*/Ueq 
C1 0.79965 (10) 0.48822 (7) 0.51167 (5) 0.02382 (19) 
H1A 0.8641 (15) 0.5296 (11) 0.5306 (7) 0.037 (4)* 
H1B 0.8478 (14) 0.4452 (10) 0.4852 (7) 0.036 (4)* 
H1C 0.7505 (16) 0.4502 (12) 0.5430 (7) 0.044 (4)* 
N1 0.70134 (7) 0.54202 (5) 0.47287 (3) 0.01741 (15) 
C2 0.61159 (9) 0.48628 (7) 0.43714 (4) 0.01952 (17) 
O1 0.61785 (7) 0.39786 (5) 0.44243 (3) 0.02520 (15) 
C3 0.51936 (10) 0.53588 (7) 0.39595 (5) 0.02442 (19) 
H3A 0.4558 (14) 0.4994 (10) 0.3716 (7) 0.033 (3)* 
C4 0.51971 (10) 0.63243 (7) 0.39298 (5) 0.02532 (19) 
H4 0.4543 (15) 0.6668 (10) 0.3660 (7) 0.034 (4)* 
C5 0.61047 (10) 0.68563 (7) 0.43124 (4) 0.02188 (18) 
H5 0.6118 (13) 0.7526 (10) 0.4301 (6) 0.026 (3)* 
xv 
 
C6 0.69843 (9) 0.64008 (6) 0.47120 (4) 0.01800 (16) 
C7 0.78544 (9) 0.69553 (6) 0.51721 (4) 0.02027 (17) 
H7A 0.8811 (14) 0.6743 (9) 0.5194 (6) 0.025 (3)* 
H7B 0.7812 (12) 0.7619 (9) 0.5048 (5) 0.021 (3)* 
N2 0.72925 (8) 0.68437 (6) 0.58100 (4) 0.02131 (16) 
N3 0.59883 (8) 0.72226 (6) 0.59146 (4) 0.02182 (16) 
H3 0.5296 (15) 0.6847 (10) 0.5847 (7) 0.032 (3)* 
C8 0.58813 (9) 0.80735 (6) 0.62146 (4) 0.01908 (17) 
O2 0.68372 (7) 0.85676 (5) 0.63828 (3) 0.02468 (15) 
O3 0.45251 (7) 0.82767 (5) 0.62847 (3) 0.02427 (15) 
C9 0.42164 (11) 0.91478 (7) 0.66237 (5) 0.02460 (19) 
H9A 0.4839 (14) 0.9638 (10) 0.6486 (6) 0.029 (3)* 
H9B 0.3253 (15) 0.9288 (10) 0.6499 (6) 0.031 (3)* 
C10 0.43224 (14) 0.90060 (9) 0.73242 (5) 0.0329 (2) 
H10A 0.4093 (16) 0.9609 (12) 0.7550 (8) 0.047 (4)* 
H10B 0.5258 (19) 0.8810 (13) 0.7460 (8) 0.050 (4)* 
H10C 0.372 (2) 0.8523 (13) 0.7466 (9) 0.058 (5)* 
C11 0.80952 (9) 0.65383 (6) 0.63010 (4) 0.01976 (17) 
O4 0.93011 (7) 0.63036 (5) 0.62402 (3) 0.02372 (15) 
O5 0.73852 (7) 0.65242 (5) 0.68422 (3) 0.02476 (15) 
C12 0.81889 (11) 0.62878 (8) 0.73990 (5) 0.0290 (2) 
H12A 0.9093 (16) 0.6641 (11) 0.7379 (7) 0.041 (4)* 
H12B 0.8383 (15) 0.5605 (11) 0.7383 (7) 0.035 (4)* 
C13 0.73334 (12) 0.65536 (9) 0.79608 (5) 0.0329 (2) 
H13A 0.6503 (17) 0.6182 (12) 0.7980 (7) 0.044 (4)* 
H13B 0.7853 (16) 0.6453 (11) 0.8355 (8) 0.042 (4)* 
H13C 0.7088 (16) 0.7229 (12) 0.7946 (7) 0.044 (4)* 
 
Geometric parameters (Å, º) for (gw122) 
C1—N1 1.4680 (11) N3—C8 1.3615 (12) 
C1—H1A 0.943 (15) N3—H3 0.865 (15) 
C1—H1B 0.948 (15) C8—O2 1.2098 (11) 
C1—H1C 0.976 (16) C8—O3 1.3484 (11) 
N1—C6 1.3819 (11) O3—C9 1.4537 (11) 
N1—C2 1.3942 (11) C9—C10 1.5056 (15) 
C2—O1 1.2518 (11) C9—H9A 0.961 (14) 
C2—C3 1.4308 (13) C9—H9B 0.987 (14) 
C3—C4 1.3613 (15) C10—H10A 1.000 (17) 
C3—H3A 0.954 (14) C10—H10B 0.988 (18) 
C4—C5 1.4108 (14) C10—H10C 0.945 (19) 
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C4—H4 0.981 (14) C11—O4 1.2171 (11) 
C5—C6 1.3615 (12) C11—O5 1.3389 (11) 
C5—H5 0.943 (13) O5—C12 1.4537 (12) 
C6—C7 1.5072 (12) C12—C13 1.4993 (15) 
C7—N2 1.4686 (12) C12—H12A 1.005 (16) 
C7—H7A 0.972 (13) C12—H12B 0.980 (15) 
C7—H7B 0.972 (13) C13—H13A 0.958 (17) 
N2—C11 1.3692 (11) C13—H13B 0.986 (16) 
N2—N3 1.3854 (10) C13—H13C 0.981 (17) 
    
N1—C1—H1A 110.3 (9) C8—N3—H3 124.0 (9) 
N1—C1—H1B 108.3 (9) N2—N3—H3 116.1 (9) 
H1A—C1—H1B 108.9 (12) O2—C8—O3 125.87 (8) 
N1—C1—H1C 110.5 (9) O2—C8—N3 125.93 (9) 
H1A—C1—H1C 111.6 (13) O3—C8—N3 108.19 (7) 
H1B—C1—H1C 107.0 (13) C8—O3—C9 115.65 (7) 
C6—N1—C2 122.43 (7) O3—C9—C10 111.36 (8) 
C6—N1—C1 122.92 (7) O3—C9—H9A 109.1 (8) 
C2—N1—C1 114.65 (7) C10—C9—H9A 110.7 (8) 
O1—C2—N1 118.76 (8) O3—C9—H9B 103.2 (8) 
O1—C2—C3 124.81 (8) C10—C9—H9B 110.8 (8) 
N1—C2—C3 116.42 (8) H9A—C9—H9B 111.4 (11) 
C4—C3—C2 120.97 (9) C9—C10—H10A 110.3 (10) 
C4—C3—H3A 121.0 (8) C9—C10—H10B 112.9 (10) 
C2—C3—H3A 118.0 (8) H10A—C10—H10B 107.4 (14) 
C3—C4—C5 120.35 (9) C9—C10—H10C 111.6 (11) 
C3—C4—H4 121.2 (8) H10A—C10—H10C 108.8 (15) 
C5—C4—H4 118.4 (8) H10B—C10—H10C 105.6 (15) 
C6—C5—C4 119.78 (9) O4—C11—O5 125.23 (8) 
C6—C5—H5 118.6 (8) O4—C11—N2 123.07 (8) 
C4—C5—H5 121.7 (8) O5—C11—N2 111.69 (8) 
C5—C6—N1 119.97 (8) C11—O5—C12 115.43 (7) 
C5—C6—C7 120.54 (8) O5—C12—C13 107.28 (8) 
N1—C6—C7 119.33 (7) O5—C12—H12A 108.4 (9) 
N2—C7—C6 109.73 (7) C13—C12—H12A 112.8 (9) 
N2—C7—H7A 105.9 (8) O5—C12—H12B 107.4 (8) 
C6—C7—H7A 113.7 (8) C13—C12—H12B 112.2 (8) 
N2—C7—H7B 109.8 (7) H12A—C12—H12B 108.6 (12) 
C6—C7—H7B 107.4 (7) C12—C13—H13A 111.0 (10) 
H7A—C7—H7B 110.4 (10) C12—C13—H13B 111.1 (9) 
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C11—N2—N3 120.87 (8) H13A—C13—H13B 108.1 (13) 
C11—N2—C7 121.88 (7) C12—C13—H13C 110.4 (9) 
N3—N2—C7 116.27 (7) H13A—C13—H13C 109.2 (13) 
C8—N3—N2 118.89 (8) H13B—C13—H13C 106.8 (13) 
    
C6—N1—C2—O1 -178.07 (8) C6—C7—N2—C11 125.92 (9) 
C1—N1—C2—O1 2.57 (12) C6—C7—N2—N3 -65.34 (10) 
C6—N1—C2—C3 2.80 (12) C11—N2—N3—C8 67.68 (12) 
C1—N1—C2—C3 -176.57 (8) C7—N2—N3—C8 -101.18 (10) 
O1—C2—C3—C4 -179.78 (9) N2—N3—C8—O2 3.22 (14) 
N1—C2—C3—C4 -0.70 (13) N2—N3—C8—O3 -177.56 (8) 
C2—C3—C4—C5 -0.75 (15) O2—C8—O3—C9 -3.42 (13) 
C3—C4—C5—C6 0.20 (14) N3—C8—O3—C9 177.36 (8) 
C4—C5—C6—N1 1.83 (13) C8—O3—C9—C10 -80.22 (11) 
C4—C5—C6—C7 -173.61 (8) N3—N2—C11—O4 -171.28 (8) 
C2—N1—C6—C5 -3.42 (12) C7—N2—C11—O4 -3.05 (14) 
C1—N1—C6—C5 175.89 (8) N3—N2—C11—O5 9.36 (12) 
C2—N1—C6—C7 172.07 (8) C7—N2—C11—O5 177.59 (8) 
C1—N1—C6—C7 -8.62 (12) O4—C11—O5—C12 5.78 (13) 
C5—C6—C7—N2 106.06 (9) N2—C11—O5—C12 -174.88 (8) 
N1—C6—C7—N2 -69.41 (10) C11—O5—C12—C13 165.46 (9) 
 
 
 
 
 
 
Hydrogen-bond geometry (Å, º) for (gw122) 
 D—H···A D—H H···A D···A D—H···A 
C1—H1A···O4 0.943 (15) 2.521 (15) 3.3607 (12) 148.3 (12) 
C1—H1C···O2i 0.976 (16) 2.498 (16) 3.2703 (12) 135.8 (12) 
C7—H7B···O1ii 0.972 (13) 2.525 (12) 3.3937 (11) 148.9 (9) 
N3—H3···O1iii 0.865 (15) 1.926 (15) 2.7850 (11) 172.1 (13) 
C9—H9A···O4ii 0.961 (14) 2.542 (14) 3.4541 (12) 158.4 (11) 
C13—
H13B···O1
iv
 
0.986 (16) 2.532 (16) 3.5073 (13) 169.9 (12) 
 
Symmetry codes:  (i) -x+3/2, y-1/2, z;  (ii) -x+3/2, y+1/2, z;  (iii) -x+1, -y+1, -z+1;  (iv) -x+3/2, -y+1, 
z+1/2. 
Document origin: publCIF [Westrip, S. P. (2010). J. Apply. Cryst., 43, 920-925]. 
Computing details 
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Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2014/7 (Sheldrick, 2014); molecular graphics: Bruker SHELXTL; software used to prepare 
material for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated 
using the full covariance matrix. The cell esds are taken into account individually in the estimation 
of esds in distances, angles and torsion angles; correlations between esds in cell parameters are 
only used when they are defined by crystal symmetry. An approximate (isotropic)   treatment of 
cell esds is used for estimating esds involving l.s. planes. 
 
Table 1 
Experimental details 
Crystal data 
Chemical formula C13H19N3O5 
Mr 297.31 
Crystal system, space group Orthorhombic, Pbca 
Temperature (K) 150 
a, b, c (Å) 9.6539 (4), 14.0840 (6), 21.2528 (9) 
V (Å
3
) 2889.6 (2) 
Z 8 
Radiation type Mo K 
 (mm-1) 0.11 
Crystal size (mm
3
) 0.51 × 0.47 × 0.14 
 
Data collection 
Diffractometer Bruker APEX 2 CCD area detector  
diffractometer 
Absorption correction Multi-scan  
SADABS v2012/1, Sheldrick, G.M., (2012) 
Tmin, Tmax 0.948, 0.985 
No. of measured, independent and 
observed [I > 2(I)] reflections 
32659, 4416, 3768   
Rint 0.026 
(sin /)max (Å
-1
) 0.715 
 
Refinement 
R[F
2
 > 2(F2)], wR(F2), S 0.036,  0.102,  1.03 
No. of reflections 4416 
No. of parameters 266 
xix 
 
H-atom treatment All H-atom parameters refined 
max, min (e Å
-3
) 0.39, -0.23 
 
Computer programs: Bruker APEX 2, Bruker SAINT, SHELXS97 (Sheldrick, 2008), SHELXL2014/7 
(Sheldrick, 2014), Bruker SHELXTL. 
Table 2 
Hydrogen-bond geometry (Å, º) for (gw122) 
 D—H···A D—H H···A D···A D—H···A 
C1—H1A···O4 0.943 (15) 2.521 (15) 3.3607 (12) 148.3 (12) 
C1—H1C···O2i 0.976 (16) 2.498 (16) 3.2703 (12) 135.8 (12) 
C7—H7B···O1ii 0.972 (13) 2.525 (12) 3.3937 (11) 148.9 (9) 
N3—H3···O1iii 0.865 (15) 1.926 (15) 2.7850 (11) 172.1 (13) 
C9—H9A···O4ii 0.961 (14) 2.542 (14) 3.4541 (12) 158.4 (11) 
C13—
H13B···O1
iv
 
0.986 (16) 2.532 (16) 3.5073 (13) 169.9 (12) 
 
Symmetry codes:  (i) -x+3/2, y-1/2, z;  (ii) -x+3/2, y+1/2, z;  (iii) -x+1, -y+1, -z+1;  (iv) -x+3/2, -y+1, 
z+1/2. 
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2a,3-diphenyl-2,2a-dihydro-1H-azeto[2,3-c]quinolizine-1,8(9aH)-
dione (239e). 
 
Formula. 
C22H16N2O2·C2H6O 
Disorder & Solvent of Crystallisation. 
No disorder. One molecule of ethanol per formula unit, hydrogen bonded. 
Packing. 
Pairs of molecules form head-to-tail H-bonded pairs via inserted ethanol molecules. There are very 
weak, possibly simply coincidental, contacts between O(1) and H(2’), but these are probably not so 
significant. 
Planar atoms C(2) > C(10), N(2), C(17) > C(22) align with the equivalent group by symmetry with 
closest atom···atom contacts of ca. 3.37 – 3.68Å. These planes are ca. 3.30 – 3.45Å apart. 
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Crystal data 
C22H16N2O2·C2H6O Z = 2 
Mr = 386.43 F(000) = 408 
Triclinic, P¯1 Dx = 1.355 Mg m
-3
 
a = 9.106 (3) Å Synchrotron radiation,  = 0.7749 Å 
b = 9.418 (3) Å Cell parameters from 3347 reflections 
c = 11.674 (4) Å  = 3.0–33.6° 
 = 84.373 (5)°  = 0.11 mm-1 
 = 85.471 (5)° T = 100 K 
 = 72.114 (5)° Plate, yellow 
V = 946.9 (5)  Å
3
 0.12 × 0.12 × 0.02 mm 
 
Data collection 
Bruker APEX 2 CCD diffractometer 5677 independent reflections 
Radiation source: ALS Station 11.3.1 4237 reflections with I > 2(I) 
silicon 111 Rint = 0.050 
 rotation with narrow frames scans max = 33.6°, min = 3.0° 
Absorption correction: multi-scan  
SADABS v2012/1, Sheldrick, G.M., (2012) 
h = -1212 
Tmin = 0.987, Tmax = 0.998 k = -1313 
12999 measured reflections l = -1616 
 
Refinement 
Refinement on F
2
 Primary atom site location: structure-invariant 
direct methods 
Least-squares matrix: full Secondary atom site location: difference Fourier 
map 
R[F
2
 > 2(F2)] = 0.055 Hydrogen site location: difference Fourier map 
wR(F
2
) = 0.157 All H-atom parameters refined 
S = 1.05 w = 1/[2(Fo
2
) + (0.0773P)
2
 + 0.1504P]   
where P = (Fo
2
 + 2Fc
2
)/3 
5677 reflections (/)max < 0.001 
350 parameters max = 0.45 e Å
-3
 
0 restraints min = -0.35 e Å
-3
 
 
 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å
2
) 
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 x y z Uiso*/Ueq 
N1 -0.08285 (14) 0.34249 (13) 0.37677 (10) 0.0177 (2) 
H1 -0.180 (3) 0.387 (2) 0.3492 (18) 0.037 (6)* 
C1 -0.03210 (16) 0.33761 (14) 0.48322 (11) 0.0180 (3) 
O1 -0.09742 (13) 0.37781 (11) 0.57416 (8) 0.0221 (2) 
C2 0.13537 (16) 0.26170 (14) 0.44119 (11) 0.0169 (3) 
H2 0.1917 (19) 0.3346 (19) 0.4284 (14) 0.013 (4)* 
C3 0.06436 (16) 0.24559 (14) 0.32727 (11) 0.0165 (2) 
O2 0.30291 (14) 0.28322 (12) 0.60835 (10) 0.0282 (3) 
C4 0.05698 (16) 0.08932 (14) 0.31621 (11) 0.0167 (2) 
C5 0.13844 (16) -0.02428 (15) 0.38725 (11) 0.0178 (3) 
H5 0.136 (2) -0.126 (2) 0.3817 (16) 0.025 (5)* 
C6 0.23273 (16) -0.01142 (15) 0.47751 (11) 0.0177 (3) 
C7 0.32567 (17) -0.13534 (16) 0.53644 (12) 0.0202 (3) 
H7 0.326 (2) -0.234 (2) 0.5165 (17) 0.033 (5)* 
C8 0.41548 (17) -0.11745 (17) 0.62393 (12) 0.0222 (3) 
H8 0.481 (2) -0.209 (2) 0.6690 (18) 0.035 (5)* 
C9 0.41047 (17) 0.02109 (17) 0.65009 (12) 0.0225 (3) 
H9 0.476 (2) 0.033 (2) 0.7130 (16) 0.027 (5)* 
C10 0.31475 (17) 0.15297 (16) 0.58994 (12) 0.0201 (3) 
N2 0.22871 (13) 0.12879 (13) 0.50449 (9) 0.0172 (2) 
C11 0.13197 (16) 0.31154 (14) 0.22015 (11) 0.0172 (3) 
C12 0.25559 (17) 0.22031 (16) 0.15790 (12) 0.0207 (3) 
H12 0.298 (2) 0.112 (2) 0.1830 (18) 0.034 (5)* 
C13 0.32048 (18) 0.27899 (17) 0.05988 (13) 0.0234 (3) 
H13 0.406 (3) 0.214 (2) 0.0180 (18) 0.035 (5)* 
C14 0.26180 (18) 0.42911 (17) 0.02284 (13) 0.0236 (3) 
H14 0.305 (2) 0.470 (2) -0.0481 (18) 0.031 (5)* 
C15 0.13981 (19) 0.52069 (17) 0.08537 (13) 0.0248 (3) 
H15 0.091 (2) 0.628 (2) 0.0582 (17) 0.033 (5)* 
C16 0.07534 (18) 0.46287 (16) 0.18417 (13) 0.0224 (3) 
H16 -0.010 (2) 0.528 (2) 0.2267 (18) 0.033 (5)* 
C17 -0.04192 (16) 0.06715 (15) 0.22894 (11) 0.0175 (3) 
C18 -0.04797 (17) -0.07602 (16) 0.21046 (13) 0.0216 (3) 
H18 0.016 (2) -0.172 (2) 0.2584 (17) 0.029 (5)* 
C19 -0.14239 (18) -0.09504 (17) 0.12970 (13) 0.0240 (3) 
H19 -0.146 (2) -0.196 (2) 0.1180 (17) 0.033 (5)* 
C20 -0.23452 (19) 0.02724 (17) 0.06614 (13) 0.0245 (3) 
H20 -0.304 (2) 0.014 (2) 0.0088 (18) 0.033 (5)* 
C21 -0.23251 (18) 0.16948 (17) 0.08448 (12) 0.0234 (3) 
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H21 -0.298 (2) 0.261 (2) 0.0412 (17) 0.029 (5)* 
C22 -0.13637 (17) 0.18916 (16) 0.16416 (12) 0.0202 (3) 
H22 -0.134 (2) 0.292 (2) 0.1715 (15) 0.022 (4)* 
O3 0.36428 (14) 0.48908 (13) 0.72157 (11) 0.0325 (3) 
H3 0.359 (3) 0.404 (3) 0.682 (2) 0.053 (7)* 
C23 0.5249 (2) 0.47112 (19) 0.72648 (15) 0.0309 (3) 
H23A 0.531 (3) 0.554 (3) 0.7744 (19) 0.043 (6)* 
H23B 0.577 (3) 0.487 (2) 0.6437 (19) 0.043 (6)* 
C27 0.6097 (2) 0.3188 (2) 0.77999 (16) 0.0314 (4) 
H27A 0.603 (3) 0.238 (3) 0.734 (2) 0.044 (6)* 
H27B 0.723 (3) 0.306 (3) 0.786 (2) 0.048 (6)* 
H24C 0.569 (3) 0.295 (3) 0.860 (2) 0.048 (6)* 
 
Geometric parameters (Å, º) 
N1—C1 1.3514 (17) C12—H12 0.99 (2) 
N1—C3 1.4810 (18) C13—C14 1.387 (2) 
N1—H1 0.92 (2) C13—H13 0.96 (2) 
C1—O1 1.2104 (17) C14—C15 1.385 (2) 
C1—C2 1.536 (2) C14—H14 0.98 (2) 
C2—N2 1.4490 (17) C15—C16 1.392 (2) 
C2—C3 1.5638 (18) C15—H15 1.00 (2) 
C2—H2 0.970 (17) C16—H16 0.97 (2) 
C3—C4 1.5122 (18) C17—C22 1.3990 (19) 
C3—C11 1.5131 (19) C17—C18 1.4043 (19) 
O2—C10 1.2367 (18) C18—C19 1.3842 (19) 
C4—C5 1.3484 (18) C18—H18 1.05 (2) 
C4—C17 1.4815 (18) C19—C20 1.385 (2) 
C5—C6 1.4471 (18) C19—H19 0.98 (2) 
C5—H5 0.98 (2) C20—C21 1.383 (2) 
C6—C7 1.3710 (18) C20—H20 1.00 (2) 
C6—N2 1.3763 (17) C21—C22 1.3886 (19) 
C7—C8 1.411 (2) C21—H21 0.997 (19) 
C7—H7 0.98 (2) C22—H22 0.989 (19) 
C8—C9 1.355 (2) O3—C23 1.425 (2) 
C8—H8 1.01 (2) O3—H3 0.98 (3) 
C9—C10 1.434 (2) C23—C27 1.505 (2) 
C9—H9 1.016 (19) C23—H23A 1.02 (2) 
C10—N2 1.3922 (16) C23—H23B 1.06 (2) 
C11—C12 1.390 (2) C27—H27A 0.99 (2) 
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C11—C16 1.3924 (19) C27—H27B 1.01 (2) 
C12—C13 1.391 (2) C27—H24C 1.01 (2) 
    
C1—N1—C3 95.83 (10) C11—C12—H12 120.0 (12) 
C1—N1—H1 130.0 (13) C13—C12—H12 119.6 (12) 
C3—N1—H1 134.1 (13) C14—C13—C12 120.27 (14) 
O1—C1—N1 132.78 (14) C14—C13—H13 120.5 (13) 
O1—C1—C2 135.79 (12) C12—C13—H13 119.2 (13) 
N1—C1—C2 91.43 (11) C15—C14—C13 119.48 (14) 
N2—C2—C1 120.22 (11) C15—C14—H14 120.0 (12) 
N2—C2—C3 119.28 (11) C13—C14—H14 120.5 (12) 
C1—C2—C3 85.49 (10) C14—C15—C16 120.50 (14) 
N2—C2—H2 109.3 (10) C14—C15—H15 121.2 (12) 
C1—C2—H2 110.2 (10) C16—C15—H15 118.2 (12) 
C3—C2—H2 110.5 (9) C15—C16—C11 120.11 (14) 
N1—C3—C4 111.61 (11) C15—C16—H16 119.4 (12) 
N1—C3—C11 115.95 (11) C11—C16—H16 120.4 (12) 
C4—C3—C11 113.50 (11) C22—C17—C18 117.55 (12) 
N1—C3—C2 85.66 (10) C22—C17—C4 120.95 (12) 
C4—C3—C2 113.46 (10) C18—C17—C4 121.48 (12) 
C11—C3—C2 113.82 (11) C19—C18—C17 120.91 (13) 
C5—C4—C17 122.38 (12) C19—C18—H18 117.5 (11) 
C5—C4—C3 118.93 (11) C17—C18—H18 121.6 (11) 
C17—C4—C3 118.68 (11) C18—C19—C20 120.61 (13) 
C4—C5—C6 125.89 (12) C18—C19—H19 119.9 (12) 
C4—C5—H5 120.4 (11) C20—C19—H19 119.5 (12) 
C6—C5—H5 113.7 (11) C21—C20—C19 119.43 (13) 
C7—C6—N2 119.42 (12) C21—C20—H20 120.0 (12) 
C7—C6—C5 121.57 (12) C19—C20—H20 120.6 (12) 
N2—C6—C5 119.01 (12) C20—C21—C22 120.23 (13) 
C6—C7—C8 119.62 (13) C20—C21—H21 122.0 (11) 
C6—C7—H7 118.3 (12) C22—C21—H21 117.7 (11) 
C8—C7—H7 122.1 (12) C21—C22—C17 121.25 (13) 
C9—C8—C7 120.53 (13) C21—C22—H22 117.5 (10) 
C9—C8—H8 120.1 (12) C17—C22—H22 121.2 (10) 
C7—C8—H8 119.3 (12) C23—O3—H3 105.2 (15) 
C8—C9—C10 121.24 (13) O3—C23—C27 111.36 (14) 
C8—C9—H9 120.1 (11) O3—C23—H23A 105.5 (13) 
C10—C9—H9 118.7 (11) C27—C23—H23A 111.4 (12) 
O2—C10—N2 118.68 (12) O3—C23—H23B 111.9 (12) 
xxviii 
 
O2—C10—C9 125.51 (13) C27—C23—H23B 108.7 (12) 
N2—C10—C9 115.81 (12) H23A—C23—H23B 108.0 (18) 
C6—N2—C10 123.38 (11) C23—C27—H27A 111.5 (13) 
C6—N2—C2 120.64 (11) C23—C27—H27B 111.8 (14) 
C10—N2—C2 115.96 (11) H27A—C27—H27B 106.9 (19) 
C12—C11—C16 119.21 (13) C23—C27—H24C 114.3 (14) 
C12—C11—C3 119.47 (12) H27A—C27—H24C 104.9 (19) 
C16—C11—C3 121.29 (13) H27B—C27—H24C 106.9 (18) 
C11—C12—C13 120.41 (13)   
    
C3—N1—C1—O1 -169.50 (15) O2—C10—N2—C6 -179.66 (13) 
C3—N1—C1—C2 10.07 (10) C9—C10—N2—C6 0.0 (2) 
O1—C1—C2—N2 48.6 (2) O2—C10—N2—C2 2.08 (19) 
N1—C1—C2—N2 -130.96 (12) C9—C10—N2—C2 -178.23 (12) 
O1—C1—C2—C3 170.04 (16) C1—C2—N2—C6 91.16 (15) 
N1—C1—C2—C3 -9.51 (10) C3—C2—N2—C6 -11.68 (18) 
C1—N1—C3—C4 103.63 (12) C1—C2—N2—C10 -90.52 (15) 
C1—N1—C3—C11 -124.33 (11) C3—C2—N2—C10 166.63 (12) 
C1—N1—C3—C2 -9.91 (10) N1—C3—C11—C12 -169.74 (12) 
N2—C2—C3—N1 131.01 (12) C4—C3—C11—C12 -38.58 (16) 
C1—C2—C3—N1 8.69 (9) C2—C3—C11—C12 93.21 (14) 
N2—C2—C3—C4 19.32 (17) N1—C3—C11—C16 11.90 (18) 
C1—C2—C3—C4 -103.00 (12) C4—C3—C11—C16 143.06 (13) 
N2—C2—C3—C11 -112.49 (13) C2—C3—C11—C16 -85.15 (16) 
C1—C2—C3—C11 125.18 (12) C16—C11—C12—C13 -0.9 (2) 
N1—C3—C4—C5 -108.95 (14) C3—C11—C12—C13 -179.34 (12) 
C11—C3—C4—C5 117.78 (14) C11—C12—C13—C14 -0.4 (2) 
C2—C3—C4—C5 -14.19 (18) C12—C13—C14—C15 1.1 (2) 
N1—C3—C4—C17 69.97 (15) C13—C14—C15—C16 -0.5 (2) 
C11—C3—C4—C17 -63.30 (16) C14—C15—C16—C11 -0.8 (2) 
C2—C3—C4—C17 164.74 (11) C12—C11—C16—C15 1.5 (2) 
C17—C4—C5—C6 -177.45 (13) C3—C11—C16—C15 179.91 (13) 
C3—C4—C5—C6 1.4 (2) C5—C4—C17—C22 173.82 (14) 
C4—C5—C6—C7 -172.23 (14) C3—C4—C17—C22 -5.06 (19) 
C4—C5—C6—N2 7.7 (2) C5—C4—C17—C18 -4.3 (2) 
N2—C6—C7—C8 0.1 (2) C3—C4—C17—C18 176.83 (13) 
C5—C6—C7—C8 -179.91 (13) C22—C17—C18—C19 1.0 (2) 
C6—C7—C8—C9 0.0 (2) C4—C17—C18—C19 179.15 (13) 
C7—C8—C9—C10 -0.2 (2) C17—C18—C19—C20 -0.7 (2) 
C8—C9—C10—O2 179.80 (15) C18—C19—C20—C21 -0.5 (2) 
xxix 
 
C8—C9—C10—N2 0.1 (2) C19—C20—C21—C22 1.4 (2) 
C7—C6—N2—C10 -0.2 (2) C20—C21—C22—C17 -1.2 (2) 
C5—C6—N2—C10 179.88 (12) C18—C17—C22—C21 0.0 (2) 
C7—C6—N2—C2 178.02 (13) C4—C17—C22—C21 -178.21 (13) 
C5—C6—N2—C2 -1.94 (19)   
 
Hydrogen-bond geometry (Å, º) 
  D—H···A D—H H···A D···A D—H···A 
N1—H1···O3i 0.92 (2) 1.92 (2) 2.8305 (17) 168 (2) 
O3—H3···O2 0.98 (3) 1.71 (3) 2.6651 (16) 165 (2) 
 
Symmetry code:  (i) -x, -y+1, -z+1. 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2013 (Sheldrick, 2013); molecular graphics: Bruker SHELXTL; software used to prepare 
material for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated 
using the full covariance matrix. The cell esds are taken into account individually in the estimation of 
esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used 
when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used 
for estimating esds involving l.s. planes. 
 
 
 
 
 
 
 
 
Tetrahedron Letters 56 (2015) 5120–5122Contents lists available at ScienceDirect
Tetrahedron Letters
journal homepage: www.elsevier .com/ locate / tet letIsolation and structure determination of the first example
of the azeto[2,3-c]quinolizinedione ring systemhttp://dx.doi.org/10.1016/j.tetlet.2015.07.029
0040-4039/ 2015 Elsevier Ltd. All rights reserved.
⇑ Corresponding authors.
E-mail addresses: m.r.j.elsegood@lboro.ac.uk (M.R.J. Elsegood), g.j.pritchard@
lboro.ac.uk (G.J. Pritchard), g.w.weaver@lboro.ac.uk (G.W. Weaver). Figure 1. Azanaphthalene rings employed in medicinal chemistryBeatriz Fernandez a, Mark R. J. Elsegood a,⇑, Gary Fairley b, Gareth J. Pritchard a,⇑, Simon J. Teat c,
George W. Weaver a,⇑
aDepartment of Chemistry, Loughborough University, Loughborough LE11 3TU, UK
bAstraZeneca R&D | Oncology iMed, Darwin Building (310), Cambridge Science Park, Milton Road, Cambridge CB4 0WG, UK
c Lawrence Berkeley National Laboratory, Advanced Light Source, University of California Berkeley, Berkeley, CA 94720, USAa r t i c l e i n f o
Article history:
Received 22 June 2015
Revised 6 July 2015
Accepted 8 July 2015
Available online 13 July 2015
Keywords:
b-Lactam
Quinolizinone
Pyridone
Drug scaffoldsa b s t r a c t
An unexpected azeto[2,3-c]quinolizinedione has been isolated during synthetic studies on the base cat-
alyzed condensation of ethyl 6-methylpyridin-2(1H)-on-1-ylacetate with benzil. Closure of a fused four-
membered azetidinone ring occurred when potassium hexamethyldisilazide was employed as the base.
The structure of the product was confirmed by synchrotron X-ray crystallography. A possible mechanism
for the formation of the product is considered.
 2015 Elsevier Ltd. All rights reserved.Introduction
4H-Quinolizin-4-one1 1 and 2H-quinolizin-2-one2 2 (Fig. 1) rep-
resent neutral carbonyl-bearing derivatives of the quinolizinium
ring3 system 3, a bridgehead azanaphthalene. Such compounds
have potential application in drug development as alternatives to
quinoline 4 and isoquinoline 5 derivatives, which are much
exploited in medicinal chemistry.4
A number of quinolizin-4-one based drug candidates have been
developed,5,6 but considerable scope remains to employ this ring as
a central building block in drug discovery. As part of a project to
develop synthetic routes to quinolizin-4-ones 1 as new drug
scaffolds we investigated the deprotonation of 1(N)-alkyl-6-
methylpyridin-2-ones and the possibility of condensation with
1,2-dicarbonyl compounds to form the second fused pyridine ring.
In this Letter we report the unexpected formation of an azeto[2,
3-c]quinolizinedione that was isolated from the reaction of 6 with
benzil 7a (Scheme 1).
Results and discussion
During a study on the deprotonation of pyridone 6 (Scheme 1)
with potassium hexamethyldisilazide (KHMDS), we investigatedthe reaction with benzil 7a as a 1,2-bis electrophile, using
2.75 equiv of the base, with the expectation of performing a
Westphal-type condensation7 to form quinazolin-4-one 8.
However the reaction formed a complex mixture of products,
and none of the expected quinolizinone ester 8 was obtained after
chromatographic separation of the crude reaction mixture.8
Surprisingly, the only compound that could be obtained pure was
the fused azetidinone 9, in which the quinolizin-4-one ring skele-
ton had formed, but which bore a fused 4-membered lactam ring.
The presence of a 4-membered lactam ring in the molecule was
strongly suggested by a combination of IR and NMR spectroscopy.
In particular, the IR spectrum showed a signal at 1776 cm1 indi-
cating the presence of a small ring carbonyl group. The 1H NMR
spectrum showed an exchangeable signal at d 10.29 ppm consis-
tent with an NH and a methine singlet at d 5.86 ppm (H-9a). The
absence of signals for an ethyl ester indicated that this group had.
Scheme 1. Reaction of activated pyridone 6 with benzil.
Table 1
Hydrogen-bond geometry (Å, ) for 9EtOH
D—H  A D—H H  A D  A D—H  A
N1—H1  O3(A) 0.92 (2) 1.92 (2) 2.8305 (17) 168 (2)
O3—H3  O2 0.98 (3) 1.71 (3) 2.6651 (16) 165 (2)
Symmetry code: (A) x, y + 1, z + 1.
Scheme 2. Possible mechanism for formation of azeto[2,3-c]quinolizine 9.
B. Fernandez et al. / Tetrahedron Letters 56 (2015) 5120–5122 5121been transformed. The 13C NMR spectrum exhibited a signal at d
68.1 ppm consistent with a saturated CH (C-9a) and two carbonyl
signals at d 164.7 and 160.5 ppm. The structure of the molecule
was verified by single crystal X-ray diffraction analysis, confirming
the presence of the 4-membered lactam, which was shown to exist
as a mono-ethanol solvate 9EtOH (Fig. 2).
Yellow crystals with a plate morphology were formed after slow
evaporation of an ethanolic solution of 9. Due to their small size
and weak diffracting power, data were collected using synchrotron
radiation.9 The molecules were found to form head-to-tail R44(18)
H-bonded pairs via inserted ethanol molecules.10–12 The hydrogen
bond geometry is given in Table 1.
The formation of the fused azetidinone product 9 was unex-
pected and several mechanisms for generation of the 4-membered
lactam ring compound can be considered. It is not clear how the
nitrogen atom of the 4-membered lactam ring was introduced into
the molecule, or the order of the ring forming steps. The azetidi-
none nitrogen is most likely derived from the hexamethyldisi-
lazane (HMDS) formed as a by-product during deprotonation.
The most plausible mechanism we propose here (Scheme 2)
involves formation of the ester enolate 10 by deprotonation of 6
with KHMDS, and reaction of the resulting HMDS, or the excess
KHMDS, with benzil 7a to form either the mono- (7b) or bis-imine
(7c). Either electrophile could then condense with anion 10 to form
the azetidinone derivative 11. The reaction of imines with ester
enolates is a well established method to form medicinally impor-
tant 4-membered lactams.13 Subsequent deprotonation of the 6-
methyl group of the pyridone ring would generate enolate 12,
the cis diastereoisomer of which could undergo intramolecular
aldol reaction with the ketone (X = O) or silylimine (X = NSiMe3)
group forming 13. Subsequent elimination would then generate
the observed product 9, which was isolated after aqueous work-up.Figure 2. X-ray crystal structure of azeto[2,3-c]quinolizinedione, 9EtOH, showing
the ethanol-inserted hydrogen-bonds between pairs of molecules of 9.An initial aldol reaction occurring next to the ester group was
supported by the observation that deprotonation of 6 with one
equivalent of KHMDS and quenching with D2O at 78 C led to
deuterium incorporation predominantly at the methylene group
of the acetate [dH (CD3)2SO 4.79 (s, CH2), 4.77 (bs, CHD) and dC
43.5 (CH2), 43.3 (t, JCD = 22 Hz, CHD)] rather than at the pyridone
methyl substituent. Other pathways to give 9 can be conceived,
and the mechanism of the reaction is under further investigation.
Very few examples of compounds in which a b-lactam ring is fused
to an otherwise unsaturated naphthalene type ring are known,14–17
and, to the best of our knowledge, none to an unsaturated hetero-
cyclic framework. Compounds of type 9 are likely to exhibit useful
biological activity, and further work to improve the yield and scope
of this reaction is in progress.
Conclusion
The first example of a derivative of the tricyclic azeto[2,3-
c]quinolizine-1,8-dione ring system has been isolated and its
structure confirmed by NMR spectroscopy, mass spectrometry,
and single crystal synchrotron X-ray diffraction analysis.
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